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SUMMARY 
The thesis describes the synthesis of novel bridged thebaine 
derivatives with heterocyclic rings attached to C-7 and a study of the 
associated chemistry. 
Use has been made of the ~-hydrazide (3) formed from the ~-ester 
(2), itself prepared by Diels-Alder addition of methyl acrylate to thebaine 
(1). From this hydrazide, either directly or via other novel open-chain 
precursors, three new heterocyclic ring systems attached to the 6, 14-endo-
etheno-6, 7, 8, 14-tetrahydrothebaine moiety (T) have been obtained. These 
are the~- and ~-1, 2, 4-triazines (4 and 5), the 1, 2, 4-triazol-5-thione 
(6) and the 1, 3, 4-oxadiazole (7). 
The synthesis of 1, 2, 4-triazines met with only limited success, 
the products proving difficult to isolate and purify. An interesting 
observation with the triazines was that both the C-7~-compound (4) and 
its C-7~-epimer (5) were produced in the same reaction. 
Efforts towards 1, 2, 4-triazole synthesis have been more successful, 
four 1, 2, 4-triazol-5-thiones (6, X= NH2, CH3, Et, Ph) having been 
produced and fully characterised. 
General procedures have been established for the synthesis of the 
1, 3, 4-oxadiazole system attached at C-7 which avoid ring opening 
' 
complications that are the principle problem associated with the chemistry 
of the bridged thebaine unit. As well as the parent 1, 3, 4-oxadiazole 
we have synthesised by differing routes analogues carrying at the C-5 
position alkyl (7, X = CH 3, Et), aryl (7, X = Ph, _E-tolyl), sulphur 
(7, X= SCH3, SEt, SCH(CH3)2) and nitrogen (7, X= NH2, 1-pyrrolidyl, 
4-morpholinyl, 1-piperidyl) substituents. In addition the 1, 3, 4-oxadiazol-
5-one (8, X= 0, R =H) and corresponding oxadiazol-5-thione (8, X = S, 
R =H), as well as the Mannich base (8, X = S, R = 4-morpholinylmethyl) 
have been prepared. 
The reaction between the hydrazide (3) and two aryl-isocyanates 
unexpectedly gave not the 4-aryl-semicarbazides (9) but compounds shown 
to be biuret derivatives (10). Sublimation of either of these biurets 
resulted in smooth formation of the oxadiazolone (8, X = 0, R =H) by 
elimination of the sym-diarylurea. This novel method for the formation 
of the oxadiazole ring has been shown to be of general application and 
similar novel cyclisations have also been achieved with a primary amine 
or a mercaptan as leaving group. 
Thirtyseven new compounds have been examined pharmacologically and 
twentythree of these show analgesic activity. Two are more active than 
morphine, viz. the phenyloxadiazole (7, X= Ph) and the dimethyldithio-
carbazate (11). The latter shows some comparison sterically with methionine-
enkephalin. 
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INTRODUCTION 
1. Analgesics related to morphine 
An effective remedy for the relief of severe pain has been one of 
mankind's most fervent aspirations since the earliest times. It is well 
known that opium, an extract from the seed of the poppy Papaver somniferum, 
offered the world the first ray of hope that this goal could be attained. 
The powerful analgesic effect of opium was recognized many centuries ago 
and its use in clinical medicine became widespread. This culminated in 
the isolation and identification of its most important active constituent, 
the alkaloid morphine (1), in 1805. 
(1) 
morphine 
Morphine, thereafter, took over from opium as the drug to be 
administered and has held its position as the foremost major analgesic 
in the world ever since. However, the drug is by no means ideal and its 
clinical use is greatly restricted by a number of unwanted side-effects.1 
One of the most serious of these effects is the production of physical 
dependence on the drug and this becomes manifest when the supply of 
- z -
morphine is discontinued. Dangerous and painful withdrawal symptoms set 
in, which can be alleviated by recommencing the administration of morphine 
or certain related compounds. Allied to physical dependence is the phenomenon 
of tolerance whereby a greater and greater dose of morphine is required to 
achieve the desired result. Another particularly serious consequence of 
administration is respiratory depression which renders morphine unsuitable 
for use in many instances. 
In addition to the problems of clinical usage, the euphoric effect 
induced by morphine has led to its large-scale world-wide abuse, both in 
its natural form and, more often, as its easily produced diacetyl derivative 
heroin (2). For these reasons it is necessary to find a good analgesic which 
possesses none of the drawbacks associated with morphine and all of its 
simple derivatives, such as heroin (2) and codeine (3). 
AcO CHp 
AcO"' 
(2) (3) 
heroin codeine 
With this information in mind there has been intensive research 
in the last fifty years into the chemistry of the opium alkaloids and 
related compounds. The direction of this work has evolved into three 
main areas~ 
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These are:-
a) modifications of morphine itself, retaining the pentacyclic system: 
b) the synthesis of simpler compounds possessing only part of the 
morphine skeleton: 
c) the construction of molecules more complex than morphine with particular 
emphasis on altering the peripheral shape. 
In this last area of study lie many Diels-Alder adducts of thebaine (4), 
which itself is a medically useless alkaloid present in opium. Much of 
' the work described in this thesis involves the use of the Diels-Alder adducts. 
CHj) 
( 4) 
thebaine 
In order to gain an appreciation of where this latter approach, the 
synthesis of molecules more complex than morphine, relates to the overall 
framework of analgesic research related to morphine, we summarize first 
the main areas of study reported on the other two lines. 
a) Modifications of morphine itself retaining the pentacyclic system 
Alkylation of the phenolic hydroxyl group decreases the analgesic 
activity. This is illustrated by codeine (3), the methyl ether· of morphine 
(1), which shows about one tenth the potency of morphine itself. 2 Acetylation 
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of both hydroxyl groups to give heroin (2) produces a slightly stronger 
analgesic but the dependence liability and toxicity are also greater. 2 
14-Hydroxydihydromorphinone (5) is still further active (6 to 8 times that 
of morphine),3 but is addictive. 
(5) 
14-hydroxydihyromorphinone 
Indeed, it appears that all bases in this series with an ~-methyl 
substituent have a propensity to be addictive. However, in stepping away" 
from the ~-methyl group,compounds having properties radically different 
to those already mentioned can be obtained. It has been observed that many 
~-allyl compounds, such as nalorphine (6) ([-allylnormorphine), and naloxone 
(7), are morphine antagonists.4a 
HO 
HO~ 
(6) (7) 
nalorphine naloxone 
Antagonists have the remarkable quality of reversing all the effects 
of morphine or any other opiate agonist (the agonist being the active drug). 
Antagonists are, in consequence, useful in the treatment of a narcotic over-
- 5 -
dose. 
In general only a small amount of the antagonist. is needed and its' 
action is very rapid. 2 Although the mechanism of their action has not 
been fully elucidated, it seems that they compete with the agonists for 
receptor sites in the central nervous system and block these sites 
without causing any pharmacological effect themselves. 5a Nevertheless, 
nalorphine (6), when used on its own, does have a strong analgesic action 
in man and is non-addictive. However, its clinical use is vitiated by the 
fact that it induces bizzare mental effects in many patients. 2 Naloxone 
(7) on the other hand is a relatively 'pure' antagonist with little or 
no analgesic properties. 5b 
Antagonist action is not confined solely to compounds with N-allyl 
and . 
substituents. Other short-chain/unsaturated groups, e.g. ~-cycloproP,Yl-
methyl,6 ~-cyclobutylmethyl, and ~-propargyl may be equally effective. 2 
b. Compounds possessing only part of the morphine skeleton 
Here we discuss briefly the three principal classes. 
i) morphinans 
ii) benzomorphans 
iii) 4-phenylpiperidines. 
i) Morphinans 
Morphinans (8) contain the complete carbon-nitrogen skeleton of 
morphine (1) but lack the dihydrofuran oxygen. 
7 
(8) 
morphinan series 
- 6 -
2 
HO -?" 
7 
( 1 ) 
morphine 
This class of compound is obtained by total synthesis. Much of 
the pioneering work was performed by Grewe and is exemplified by his 
classical synthesis of ~-methylmorphinan (9) from benzyl magnesium chloride 
(10) and 2-methyl-5, 6, 7, 8-tetrahydroisoquinolinium iodide (11) 
(Scheme 1) _7 
Scheme 1 
~-Methylmorphinan (9) has about one fifth of the analgesic activity 
of morphine. Introduction of a hydroxyl group into the 3-position (as in 
morphine) leads to a substantial rise in potency, (-)-levorphanol (12) 
being four times as active as morphine. In parallel with morphine, replace-
ment of ~-methyl by~-ellyl leads to an antagonist, (-)-levallorphan (13), 
which is more than twice as effective as nalorphine (6). 8 
HO 
(12) (13) 
(-)-levorphanol (-)-levallorphan 
- 7 -
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Of the many hundreds of morphinans synthesised 'and screened for medical 
applications it seems that only a handful of compounds possess a satisfactory 
balance of reasonable therapeutic properties and limited unwanted side 
effects. 9• 10 One of the most recent is butorphanol (14), an analgesic 
now in clinical use, synthesised by a modification of the Grewe approach.lla 
HO 
(14) 
butorphano 1 
ii) Benzomorphans 
The 6, 7-benzomorphans (15) follow the theme of simplification of 
the morphine molecule with only the A, B and D rings of morphine being 
retained.llb 
HO·" 
(15) ( 1 ) 
6, 7-benzomorphan morphine 
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The prototype, benzomorphan (16), can be obtained from p-methoxybenzyl 
magnesium chloride (17) and 3, 4-lutidine methiodide (18) in a variation 
of the Grewe morphi nan synthesi s.12 
CH:P HBr 
CH3 
(16) 
Benzomorphans have been extensively studied and numerous examples 
evaluated for pharmaceutical use. The most useful so far is probably 
pentazocine (19), !:!- (3, 3-dimethylallyl) benzomorphan, an analgesic of 
less potency than morphine but one showing greatly diminished addiction 
potential when compared with the classic narcotic analgesics)·J 
- 10 -
(1 9) 
pentazocine 
iii) 4-Phenylpiperidines 
The 4-phenylpiperidines constitute the oldest class of synthetic 
morphine-like analgesics. The first important member, pethidine (20), 
1-methyl-4-carbethoxy-4-phenylpiperidine, was discovered in 1g39) 4 
Although, as conventionally depicted (20), this compound would seem to 
bear no resemblance at all to morphine (1), rewriting in a different manner 
(20a) shows that it can be thought of as containing both the A and D rings 
of the alkaloid. 
- 11 -
(20a) 
pethidine pethidine 
morphine 
Despite having analgesic activity compounds of this class, almost 
without exception, share the abuse and addiction potential of their 
polycyclic counterparts and are far from ideal~ 
c) Molecules more complex than morphine. The Diels-Alder adducts of thebaine. 
The compounds discussed so far either closely resemble morphine in 
shape or else are simplified molecules thought to contain some of the 
structural features which are believed to make morphine a potent analgesic._ 
It is possible, however, that the compounds with greater stereochemical 
flexibility might fit just as easily into the receptor sites responsible 
for side effects, such as respiratory depression and addiction liability, 
as into the analgesic receptor itself. This situation would lead to no 
significant separation of desirable and undesirable effects, and this is 
- 12 -
usually found to be the case. Bentley15 conceived the idea that compounds 
of more elaborate structure than morphine, particularly in regard to 
peripheral shape and rigidity, might prov8 to be unacceptable at some of 
the other receptor sites and so furnish a better analgesic. The gateway 
to such compounds was provided by the Diels-Alder reaction between thebaine 
(4) and various dieneophiles, in particular vinyl ketones and alkyl 
acrylates~ 5 • 16 • 17a The adducts formed in this manner have the general 
formula (21). 
6, 14-endo-etheno -6, 7, 8, 14-tetrahydro-
thebaine series 
Attack of the dieneophile occurs on to the outer face of the diene, 
from the same side as the nitrogen bridge, and hence the resultant adducts 
have the etheno bridge disposed on the underside of the molecule compared 
with the nitrogen bridge. The etheno bridge in this relative stereochemistry 
is described as endo, and this is observed in all cycloadditions. Also 
it should be noted that the 17, 18-olefinic bond has cis stereochemistry 
although in the conventional representation of the bridged thebaine moiety 
(21) it is depicted as being trans. The stereochemistry is better illustrated 
in (22). 
- 13 -
(22) 
6, 14-endo-etheno -6, 7, 8, 14-tetrahydrothebaine series 
The dienophile adds regiospecifically and no trace of a C-8 substituent 
has been detected} 5 This is in accord with a nucleophilic C-14 in thebaine 
and an electrophilic ~- carbon in the a, ~-unsaturated ketone (see curly 
arrowsin equation above) and is also predicted from a consideration of the 
frontier orbitals concerned~ 7b Stereoisomers at C-7 can, however, be 
produced depending upon the relative positions of the diene and dieneophile 
during formation of the new bonds. This is pictured for the reaction 
between methyl vinyl ketone and thebaine (4) (scheme 2). The a-and~­
epimers correspond to the endo and~ stereochemistries normally obtained 
in Diels-Alder cycloadditions involving a cyclic diene. However the terms a 
and B are preferred to avoid confusion with the endo terminology mentioned 
above to describe the disposition of the etheno bridge. 
- 14 -
! j 
(23) (24) 
7a-epimer 7t~-epimer 
Scheme 2 
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As is usual in Diels-Alder reactions the endo adduct predominates i.e. 
the 7a-epimer (23). This is in accord with the secondary effects of orbital 
"d t" 17c overlap cons1 era 1ons. The 7~ is normally produced in small amounts, 
if at all. In addition to the molecular orbital considerations just 
mentioned there is unfavourable steric interaction between the group on 
the dieneophile double bond and the C-5 and axial C-15 hydrogens of thebaine. 
The cycloaddition of acrylonitrile provides an exception to this rule 
and a substantial amount of the ~-isomer (~40%) is formed15 This could 
be due to the linear stereochemistry of the nitrile group (so reducing 
interaction with the C-15 axial H) or possibly that the conditions of 
reaction favour the thermodynamic product in this case. 
In general,almost all work has been centred on the 7a-epimers and this 
stereochemistry is normally retained through successive transformations. 
The presence of the etheno bridge' adds greater rigidity to the molecule 
and the new centre at C-19 offers the opportunity for tangible changes to 
be made in both peripheral shape and polarity. By far the most important 
transformations that have been studied concern the reaction of a wide 
variety of Grignard reagents with the ?a-methyl ketone (23)}8a 
- 16 -
RMgi 
H 
(23) 
! 
(25) (25) 
Scheme 3 
As can be seen from Scheme 3 above, Grignard addition is observed to 
occur stereoselectively. The Grignard reagent is thought to co-ordinate 
as in (23a) such that the less hindered "top side" approach of R to the 
carbonyl carbon can be effected~Sa A similar stereoselectivity has 
also been observed in simpler bridged-isoquinoline ketones~Sb 
- 17 -
The carbinols (25) produced in this manner are in many instances 
. highly potent analgesics, for example (25, R = CH2CHlhl with an activity 
500 times that of morphine 'in the rat tail pressure test! 8a 
Structure-activity relationships in this series have been thoroughly 
investigated. Demethylation of the C-3 methoxyl normally results in a 
large increase in analgesic strength and by this means compounds with 
potencies at a level hitherto unknown have been obtained~° Catalytic 
reduction of the etheno bridge increases the activity further still,whilst 
as expected, replacement of the ~-methyl group by substituents such as 
allyl or cyclopropylmethyl bestows antagonist properties?0 
Three important compounds have come out of this research. Etorphine 
(26) is a very powerful analgesic used in veterinary medicine and also for 
the immobilisation of wild game. (See ref. 20 and refs. therein). 
Diprenorphine (27) is in use as its specific antagonist. The most signi-
ficant compound to spring from this line of research is probably 
buprenorphine (28), a powerful analgesic in man and now in clinical use, 
which goes a long way towards meeting the full requirements of a major 
non-addictive analgesic21 
~ 
~'""CH3 
HO CH 
I 2 
CH I 2 
CH 3 
(2 6) 
etorphi ne 
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H 
CHp 
= 
I\"'''CH3 
HO C-CH 
CH/\ 3 3 CH 3 
(28) 
buprenorphine 
(27) 
diprenorphine 
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Part of the value of buprenorphine is that at· higher doses the 
. 21 
compound begins to antagonise itsel~ and this alleviates in some measure 
the danger of overdosage. 
2. Enkephalins and opiate binding to the analgesic receptor 
The term opiate is used to refer to any centrally acting analgesic 
(i.e. acting on the central nervous system, in contrast to peripherally 
acting analgesics) and is not restricted to analgesics occurring in 
opium. The terms analgesic receptor and opiate receptor are synonymous 
in this context. 
In 1954 Beckett and Casey19b came to the conclusion that the 
differing levels of biological activity of analgesics and antagonists 
were due to their fit on to a receptor surface rather than any differences 
in their distribution and metabolism. On the basis of the structure and 
stereochemistry of all the analgesics and antagonists known at that time 
a rE:>ceptor site as in Fig. 1 below was postulated.·lga 
receptor site 
A = flat surface 
B = cavity 
C = anionic site 
Fig. 1 
( 1) 
morphine 
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In this model the aromatic A-ring of morphine, for example,would 
be associated with the flat surface A, and the nitrogen atom (presumed 
protonated at physiological pH) with the anionic site C. The cavity B 
would accommodate the C-15 and C-16 methylene groups. 
Subsequently, the remarkable activity of some of the Diels-Alder 
adducts of thebaine, in particular the phenethyl carbinol (25b), gave rise 
, to the theory that the analgesic receptor contained an additional lipophilic 
site4b which could not be occupied by morphine or most wholly synthetic 
analgesics, but with which the C-7 substituent of the 6, 14-endo-
ethenotetrahydrothebaines could interact. 
(25b) 
The ~odel of the analgesic receptor and its approximate molecular 
dimensions, as extended by Lewis, Bentley and Cowan4b to take account of these 
findings, is shown in Fig. 2. 
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A. Flat surface for aromatic ring-A. 
B. Cavity for C-15 and C-16. 
c. Anionic site. 
D. lipophilic site. 
Fig. 2 
However, theories concerning analgesia and the opiate receptor 
have been the subject of further speculation since the discovery, in 
1975, of a natural morphine-like substance in the brain of pigs.22a The 
substance isolated, termed 'enkephalin' (Greek for "in the head"), was 
soon found to be a mixture of two pentapeptides viz., methionine-enkephalin 
(H-Tyr-Gly-Gly-Phe-Met-OH) and leucine-enkephalin (H-Tyr-Gly-Gly-Phe-Leu-OH), 
in the ratio 3 to 1 respectively~2a 
- 22 -
Tyr Gly Gly Phe Met 
methionine-enkephalin 
Tyr Gly Gly Phe Leu 
leucine-enkephalin 
Although these peptides show potent morphine-like activity using 
isolated tissue preparations such as the guinea pig ileum and mouse vas 
deferens, in vivo analgesic activity was difficult to demonstrate due to 
rapid degradation by enzymes~2b However, their discovery opened up the 
way for a whole new area of analgesic research based on synthetic peptides 
and, as the flood of papers over the last three years testifies, scientists 
in many disciplines have not been slow to appreciate their significance. 
(For reviews see 5a, 23,24). 
Indeed, such has been the rapid progress that at least one derivative 
of methionine-enkephalin, namely Tyr-Q-Ala-Gly-MePhe-Met(O)-ol~5a has 
already undergone clinical trials in man, though with disappointing 
results?5b 
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The discovery of the enkephalins has prompted proposals concerning 
their structural similarity with morphine and related opiates~6 • 28 Snyder5a 
and Bradbury, Smyth and Sne11 22c have compared the structure of methionine-
enkephalin to that of morphine (1) (see Fig. 3), and have commented on the 
similarity in orientation between the hydroxyl group on the aromatic ring-A 
of morphine and the phenolic OH of the tyrosine residue in methionine-
enkephalin, suggesting that this group binds to the opiate receptor in 
both cases. Snyder27 agrees with the idea of an additional lipophilic 
site on the receptor, as proposed by Lewis, Bentley and Cowan4b, and considers 
that in methionine-enkephalin the aromatic ring of phenylalanine is able 
to interact with the opiate receptor in much the same way as the phenyl 
ring of the phenethyl group in Fig. 2. 
Hence, at the outset of our work in October 1976, it was evident 
from a comparison of the marked potencies of C-7 substituted bridged 
thebaines such as etorphine (26), buprenorphine (28), and the phenethyl 
carbinol {25b), with the lesser potency of morphine itself, that the 
C-7 substituent was of considerable importance. Secondly, structural and 
stereochemical similarities between C-7 substituted bridged thebaines 
and the endogenous enkephalins had been pointed out~a, 27 • 22c We 
therefore set out further to explore the analgesic receptor for bridged 
thebaines. Only a small number of such compounds containing a heterocyclic 
ring at C-7 had been reported (summarized below, p 31) and we have studied 
the synthesis of 6, 14-endo-ethenotetrahydrothebaines with other heterocycles 
attached to position 7. 
Since the commencement of our work many further studies of the 
opiate receptor have been reported. It was becoming evident, in 1976, 
that any single generalisation of structural requirements for an analgesic.· 
failed to account for the activities of all known analgesics. For example, 
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tyrosine 
ring-A 
morphine 
phenyl al anine 
met hi onine-enkephali n 
Carbon 
Hydrogen 
Oxygen 
Nitrogen 
Sul phur 
Space-fi ll ing mol ecul ar models of morphine (bottom) and methionine-
enkephalin (top) , showing some structural features in common. 
Fig. 3 
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Snyder's emphasisSa, 27 on the similar relative positions in space of the 
phenyl ring (called the F-ring) of the phenethyl carbinol (25b) and that 
in the phenylalanyl moiety of methionine-enkephalin obscured28 the significant 
opioid activity of members of the morphine, n1orphinan, and etorphine 
families which do not possess an F-ring. 
Martin et a1 29a have proposed that there are three or more different 
opiate receptors. Three were classified as: 
i) the ~-receptor at which morphine is prototype agonist, responsible. 
for the supra-spinal type of analgesia, euphoria and a proportion of 
morphine-like physical dependence; 
ii) the K-receptor at which ketocyclazocine and cyclazocine are proto-
type agonists, responsible for spinal analgesia, sedation and signs 
of nalorphine-like dependence; and 
iii) the cr-receptor which is responsible for the dysphoria and hallucinations 
of nalorphine-like agent~23~ 23c 
ketocyclazocine cyclazocine 
Hughes and Kosterlitz et a1 29b concluded that the opioidpeptides 
could interact with more than one type of receptor including the ~-receptor. 
In the mouse vas deferens the enkephalins ~et at 6-receptors, different 
from those on which morphine and its classical surrogates act •. Presumably 
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the enkephalins adopt different confonnations at_ the different receptors. 
The bridged thebaine derivative buprenorphine (28), first marketed in 
1978~9c is classed as a partial agonist reacting at the ~-receptor. 
3. Chemistry of the Diels-Alder adducts of thebaine 
a) Rearrangements of 6, 14-endo-ethenotetrahydrothebaines in base 
Syntheses involving 6,14-endo-ethenotetrahydrothebaines present 
particular difficulties because of the readiness with which many of the 
d d t 0 "d30 b 31 compoun s un ergo rearrangemen 1n ac1 or ase. We now summarize 
this behaviour considering first rearrangements which occur in the presence 
of base. 
The ester (29) (the methyl derivative of which was to be used as the 
starting point in our work) is rearranged by the strong base ~But to 
give the phenol (31). 31 
CHp ~ 
" 0
-"' ,. 
OEt 
(29) 
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--
CHp /"' 
{\ 
• 
c~o 
~ 
(30) 
! 
~ OEt 
(31) 
The nitrile adducts behave similarly giving {31, CN for co2Et) .
31 
With the related ketones (29, Me or Ph for OEt) the phenate ion {32) 
generated is not stable {unless alkylated) and attacks the cyclopropane 
ring. This is due to the greater electron accepting power of the ketone 
over the ester carbonyl. 
- 28 -
(32) (33) 
In methanolic base the cyclopropane ring may also be opened by 
attack on C-6 (34), C-17 (36), or C-19 (38) (Scheme 4). 32 
b) Rearrangements of 6, 14-endo-ethenotetrahydrothebaines in acid 
The ?a-ethyl ester (29) does not rearrange on boiling in 2 M 
hydrochloric acid; the only product is the 7a-acid. 15 ' The methyl ketone 
(23) is attacked by acids only under conditions where the products react 
further and pure compounds have not been isolated. 33 The aryl ketone 
nepenthone (40) is stable to dilute but not to concentrated acids. 16 
. - 29 -
HO C6 attack 
CHp 
a 
cf'\'Ph 
(37) 
(39) 
Scheme 4 
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(41) 
nepenthone l 
(42) 
These rearrangements and the chemistry of derivatives (e.g. 
C-19 alcohols) of the Diels-Alder adducts have been reviewed by 
K.W.Bentley. 33 Hence syntheses are required by us which in general 
avoid strong acid or strong base. 
4. Heterocycles as C-7 substituents of 6, 14-endo-ethenotetrahydrothebaines 
a) Previous studies 
Up to date only one report has appeared on the synthesis of C-7 
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heterocyclic substituents in the 6, 14-endo-ethenotetrahydrothebaine 
series, the ring systems being 1-H pyrazole (43), isoxazole (44), and 
pyrimidine (45). 34 
(43) (44) 
The R groups have been varied as follows: 34 
1 R = H, CH3 
R2 = H, CN, CH3, -CH2-<J , -Cil~ , 
R3 =e.g. ll, Cll3, Ph,_!i\ .o~F• 
-\N.=/ - etc. 
These compounds were made by the following general route. 34 
c~ 
RLN' I 
'N-
(43, R1= ~= CH3) 
- 32 -
HC(OC H3)3/ HCl04 
CH pH 
CHP--J"-..c H 
~0 3 (4 6) 
I Vilsmeier 
' COCl2 /DMF 
- 33 -
The report34 lists the results of the screening of fourteen of 
these compounds by the phenyl-.E_;.quinone writhing test in mice. Ten 
of the compounds were shown to elicit analgesia at doses between 
100-200 mg/kg of body weight. Two compounds showed analgesic activity 
at 25 mg/kg. However, the two other compounds were very much more 
active and one, the phenyl pyrazole (48), exhibited an ED50 of 0.01 mg/kg. 
This compares to a value of 2 mg/kg for morphine when administered by 
the subcutaneous route ( RTf' test ). 
(as citrate) 
Ph-N' I 
'N-
(48) 
The high potency of compounds such as (48) provided added impetus 
for our studies. 
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b) Present studies 
The ring systems we chose for construction at the C-7 position of 
the 6, 14-endo-ethenotetrahydrothebaine were the 1, 2, 4-triazole (49), the 
1, 3, 4-oxadiazole (50), the 1, 3, 4-thiadiazole (51), and the 1, 2, 4-triazine 
(52) systems. 
3 4/ N2 
HN I 
'S'=N1 
(49) 
3 
4~N2 
s~Nl 
6 
(52) 
These rings differ from those already described in that they 
contain a third heteroatom. The influence of this additional heteroatom 
on such properties as stereochemistry, lipophilicity and basicity may have 
a marked effect on the eventual pharmacology of each series. 
We now summarize the main known methods for the formation of these 
rings, which are appropriate to the problem in hand. 
i) 1, 2, 4-Triazines 
Almost all syntheses of 1, 2, 4-triazines {52) involve ring closure 
of an a-diketone. 35 
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Monoacylhydrazones (55) of a-diketones (53) have been ring closed 
in alcoholic ammonia under high pressure. 36 
R 
"'c=o 
. I + 
c=o Rv 
(53) 
R"CONHNH 2 
(54a) 
• R =alkyl or heterocycle 
' R= R= alkyl 
,, 
FfC-NH-N=C-R 
11 I 
0 O=C-R' 
(55) 
150oC/7h.l NHJ/EtOH 
sealed tube 
R" 
N~N 
~N 
R 
(56) 
Monoaroyl hydrazones of benzil can be cyclised by ammonium acetate 
in hot acetic acid to 3, 5, 6-triaryl -1, 2, 4-triazines (59) in favourable 
yield. 37 The yields of the intennediate hydrazones (58) if isolated, 
are poor and hence the procedure is carried out as a one-pot reaction. 
Ph 
'c=o 
I 
c=o Ph/ 
. (57) 
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ArCO NH NH2 Ar-C -NH-N=C -Ph 
11 I 
0 O=C-Ph 
(5SJ l CH,COONH4 
Ar 
4NJ.zN2 
- ~ ......... 11 
Ph" ){N1 
Ph 
(59) 
The required starting hydrazide (54) for our studies is accessible 
from the Diels-Alder adduct of thebaine and ethyl acrylate (29), by 
treatment with hydrazine hydrate. 38 
44% 
(2 9) (54) 
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ii) 1, 3, 4-0xadiazoles 
Substituted 1, 3, 4-oxadiazole-thiones (61) can be produced from 
* potassium dithiocarbazate salts (60) by prolonged reflux in ethanol 
which effects ring closure. 39 The salts are usually generated in situ 
by treatment of a hydrazide (54) with carbon disulphide and potassium 
hydroxide. 
EtOH 
reflux 24 h. 
R 
O~NHNHCSE>K® 
11 
s 
! (6 0) 
R 
t N3 1 I~ 5 NH s 
(61) 
* The nomenclature is derived from the theoretical carbazinic acid (62), 
which in turn is derived from carbamic acid (63). Hence compound (60) is 
an N-acyldithiocarbazate salt. 
NH 2NHC-OH 11 
0 
NH2 C-OH 11 
0 
(62) (63) 
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The corresponding oxadiazol-5-ones (64) can be obtained from hydrazides 
and pho~gene. 40 
tR NJ I 14 5 NH 0 
(64) 
The reaction between a carboxylic acid hydrazide (65) and cyanogen 
bromide provides access to amino-oxadiazoles (66). 42 • 43 
R R O~HNH2 CNBr ~N -~ 
N 2 
(65) (66) 
Dialkyl,diaryl, and aryl-alkyl 1, 3, 4-oxadiazoles (68) are commonly 
prepared by dehydration of the appropriate~.~ -diacylhydrazines (67). 45 
Several different dehydrating agents have been used for this purpose, 
such as phosphorus oxychloride,46 • 47a phosphorus pentoxide,47b and, acetic 
anhydride. 48 
I HH 
RCONNCOR 
(67) 
-HO 2 
- 39 -
(68) 
R = Ar or A 1 kyl 
R' = Ar or Alkyl 
Another route reported for oxadiazole formation involves the 
condensation of ortho-esters and hydrazides (69) developed by Ainsworth, 49 
which proceeds under mild conditions. 
(69) 
(70) 
iii) 1, 2, 4-Triazoles (s-triazoles) 
The most widely applied preparation of 1, 2, 4-triazoles (73) and 
(74) is the ring closure of semicarbazides (71, X= 0), thiosemicarbazides 
(71, X= S), and aminoguanidines (72) in alkaline solution. 50 
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R ~ I R R 
0-;:::.C-......NH 4)3 N2 /C........_ ~> N2 0....- NH I HN I I HN I 
H2N"-c/NH ?/s-NH H2N, /NH )FN X 1 c NH 1 11 11 X NH 2 
(71) (73) (72) (74) 
The starting materials are formed by acylation of semicarbazide, 
thiosemicarbazide or their derivatives. We were hopeful that this could 
be achieved by use of an ester as this would represent a convenient 
starting point for our investigation into this system. 
i.e. 
However, this conversion is unknown in the literature and the acid 
chloride or anhydride is used instead. 51 A closely related route requires 
the addition of anisothiocyanate to a hydrazide. Dehydration, under 
basic conditions, of the thiosemicarbazide (75) so-produced should afford 
a 4-substituted-1, 2, 4-triazol-5-thione (76). 52 The thiosemicarbazides 
(75), if obtainable, would be key intermediates because when treated with 
acid they are reported to cyclise to 5-amino -1, 3, 4-thiadiazoles (77). 40 • 52 
R 
O~HNH2 
(54 a) 
R 
~-===~ 
1 rs=-1 
s N 
NHR' 
4 
( 77) 
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R'Ncs 
R=a[ky[ or 
ary[ 
acid 
R 
~ . 
0 NHNHCNHR'-g 
( 7 5) 
base 
R 
, ,y •N2 
R-N l1 
)rs-NH 
s 
(76) 
We also hoped to employ the corresponding semicarbazides (78) 53 
and to examine their cyclisation in a similar manner. 54 
- 42 -
i.e. 
R'Nco 
base 
~~ R 2 , 4)3 N 1 I R-N I 
N (rs--NH 
NHR' ~ a , 
(80) (79) 
Another popular route to 1, 2, 4-triazoles which we envisaged studying 
entails the potassium dithiocarbazate salts (60) which were discussed in 
connection with oxadiazole synthesis (p 37). This method, developed by 
Hoggarth,55 has been used for a wide variety of R groups56 • 57 and 
nonnally gives good yields for each step (Scheme 5). 
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R I . ~"'-NH NHCS8 K ® 
11 EtOH I R.T 
s (60) 
I CH,I 
R 
\3 2 
4;::::=N 
H2N-Nrsl 
5 NH s 1 ( 81) 
(82) 
Scheme 5 
Se vera 1 authors have a 1 so made use of pre-formed heterocycl ic rings; 
for instance, 1, 3, 4-oxadiazoles (66) can be transformed into 4-amino 
-1, 2; 4-triazoles (83) by hydrazinolysis under relatively mild conditions. 42 •51 
(c~ the conversion of furans into pyrroles with amines). 
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R 
reflux 
>=N 
H2N-N I 
) N 
NH2 
(83) 
iv) 1, 3, 4-Thiadiazoles 
A number of syntheses of 1, 3, 4-thiadiazoles proceed from thio-· 
semicarbazide or substituted thiosemicarbazides and these, together with 
other methods, have been reviewed by Sherman. 59 (See also pp. 40-41). 
The potassium dithiocarbazate salts (60) already mentioned as 
possible precursors in 1, 3, 4-oxadiazole and 1, 2, 4-triazole formation 
have been cyclised to 1, 3, 4-thiadiazol-5-thiones (84) in cold concentrated 
sulphuric acid. 60 • 61 
(60) 
R 
..,\ 3 
;->=N 
1 s 14 
Cs---NH 
s 
(84) 
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1, 3, 4-Thiadiazoles (86) may also be obtained by condensation of 
a thiohydrazide (85) and an ortho-ester. 49 This route is of limited 
utility because of the great difficulty in making thiohydrazides; the 
reaction between phosphorus pentasulphide and hydrazides is capricious 
and in many cases fails. 62 A more usual approach to 1, 3, 4-thiadiazoles 
is to go via 1, 2-diacylhydrazines(87). 59 • 63 Treatment of i, 3, 4-
oxadiazoles (70) with phosphorus pentasulphide has also been used to the 
same end. 60 (Scheme 6). 
I 
RCOCI 
(87) 
Scheme 6 
R 
'>L-~ ~~-, 
~N R'- 4 
(86) 
R 
2 3 
-N -~ 
1 5 4 
(70) 
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DISCUSSION 
Part 1 Synthesis of 1, 2, 4-Triazines 
For our initial investigation of 1, 2, 4-triazine synthesis we 
envisaged using the method of Laakso, Robinson and Vandrewala37 which 
involves the reaction of a hydrazide and a 1, 2-diketone in acid medium. 
It was thus necessary to synthesise the C-7a-hydrazide. This is a 
known compound which has been obtained in fair yield (44%) from the 
ethyl acrylate adduct of thebaine. We decided to vary the route slightly 
and use the methyl acrylate adduct. 38 
The Diels-Alder reaction between thebaine {4) and methyl acrylate, 
using an excess of the latter as solvent, proceeded smoothly and gave 
the la-methyl ester, (88) m.p. 148-149°C, in good yield (85%). After 
careful examination of the mother liquors a small amount of what proved 
to be the a-isomer (89) (8%), m.p. 187-188°C was isolated, with difficulty, 
by fractional crystallisation from methanol. The a-epimer is a new compound 
and was characterised by ir, n.m.r. (see below), and microanalysis. 
Both isomers were converted into their respective hydrazides (90) 
and (91) on refluxing in 2-ethoxyethanol with hydrazine hydrate for 
several hours. In several runs with the ?a-methyl ester the yield of 
the hydrazide (90) was higher than that given38 by the la-ethyl ester 
in the literature method, 65---) 79% as against 44%. The use of the 
methyl ester is, therefore, advantageous. The melting point of the 
la-hydrazide (90), 13l-13B°C, was at variance with the literature38 
value, 205°C. Our compound gave correct microanalytical and spectral 
data. 
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, CH 0 :::-0-
3 
(4) ~ 
;J-ocH3 
/ \ 
cf'"ucH3 
(88) 
l NH2NH2 
cf'"-NHNH2 
(90) 
+ 
cf CH3 
(89) 
! NH2NH2 
(91) 
' 
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The assignment of stereochemistry at C-7 was based on n.m.r. evidence. 
The spectra of the 7a- and 7s-cyano epimers ((92) and (93) respectively) 
have been studied by Fulmar et al., who determined the configuration at 
C-7 by spin decoupling experiments. 64 They found in the case of the 7a-
nitri 1 e (Fig .4a) that H-18 was part of a four spin system. Coupling was 
observed with H-17 (J18_17 9.0 Hz), H-5s (J18_5s 2Hz), and H-7s (J18_7S 
<l.OHz). The latter two long-range couplings are through distorted "W" 
configurations. 55 However, in the 7a-epimer (Fig.4b) H-18 was established 
as part of a three spin system only ~1ith coupling to H-17 (.118_17 9 Hz) 
and H-5s (J18_5a 2 Hz). Long range coupling to H-7a cannot occur because 
this proton is not correctly oriented. 
To conduct these experiments successfully, Fulmar et al., had to 
locate the C·-7 proton in both epimers. This is part of a three spin 
system involving H-8a and H-Bs, and in order to establish its position 
they had to carefully irradiate the four-line pattern of H-8a which 
appeared at ol.50 and ol.70 in the 7a- and 7S-nitriles respectively. 
We had hoped to confirm the stereochemistry of our novel ?a-ester 
(89) and 7s-hydrazide (91) by following the same spin decoupling methods 
as the previous authors. Unfortunately, in the n.m.r. spectrum of these 
compounds between ol and o2 where one expects to see the resonance of 
ll-8a there were a 1 so resonances for two other protons, presumably those at 
C-15. This region at~ ol.5 could not be simplified by decoupling and the 
failure to see the H-8a "handle" meant that the stereochemistry at C-7 could 
not be verified in this way. 
However, in three examples studied by Fulmar et al. of substituents 
with differing diamagnetic anisotropies, v·iz. ,J::N, COCH3 and C(CH3)20H, it 
' ••• 
•• 
1 
H I 0 
1a 1 
H CH3 
- 49 -
0 1a; 
H CH3 
(92) 7cx-nitril e (93) ?s-nitrile 
.... 
'• 
'·" (' ~. 
I 
' 
' .. 
C3·0CH.t 4-0CHJ 
3.61 ,, 
' ao 
Fig. 4a., n.m.r. spectrum of ?ex-nitrile (92) 
<t 
::r 
I c, 
:.54 
0 
0 
• 
•• •• 
Fig. 4b., n.m.r. spectrum of 7s-nitrile (93) 
' 
••• 
' lA 
THS 
TMS 
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was noticed that in each case the H-5S resonated at lower field in the 7s-
isomer than in the 7a-isomer. 64 This effect was put down to steric 
compression66 and the assignments were backed-up by spin decoupling. In 
subsequent work with epimeric vinyl sulphone adducts, 17a(substituents 
so2cH3 and so2Et), the stereochemistry was based entirely on the chemical 
shift of H-5s without resort to spin decoupling. Pleasingly,we observed 
that the chemical shifts of H-5s in our epimeric pairs corresponded with 
this observation in accord with the anticipated stereochemistries. In 
the table below we compare the values for our compounds with those reported 
by Fulmar et al. 
CHp 
R 
Chemical shift of H-5s in C-7 epimers (in o) 
R a ~ 
CN 4.50 4.98 ) 
) 
COCH3 4.53 4.98 ) Ref. 64 ) 
C(CH3)2DH 4.50 5.26 ) 
so2cH3 4.50 5.54 ) ) Ref. 17a 
S02Et 4.41 5.54 ) 
co2CH3 4.60 5. 21 this thesis 
CONHNH 2 4.54 4.97 this thesis 
Although, as already stated, the yield of the la-hydrazide (90) 
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from the methyl ester was not low we thought that some hydrolysis or 
hydrazine salt formation67 ,could have been taking place and so we endeavoured 
to make some further improvement by the use of dry solvent and dried 
hydrazine. 68 The dried hydrazine was prepared by standing 100% hydrazine 
hydrate (150 ml) over potassium hydroxide (150g) for 18 days. The hydrazine 
was decanted off from the pellets which remained,but was not distilled 
because of the explosion hazard. 69a The reaction was performed under "dry" 
conditions but the hydrazine had evidently absorbed a large amount of 
potassium hydroxide and an intractable mixture of compounds was produced. 
To assess what effect the alkali might be having,the methyl ester (88) 
was refluxed in 2-ethoxyethanol for 4 h. with an equal weight of potassium 
hydroxide. Again, pure materials could not be isolated nor starting material 
detected. As discussed in the introduction (p 26 ), base (eOBut) can 
cause rearrangements in this series initiated by removal of the 7~-proton. 
In our situation, however, the base used (KOH) was more nucleophilic 
E> t than OBu and attack on carbonyl carbon or, say, at C-5 or at,C-6 may 
also have occurred under these circumstances. The reaction was not investigate' 
further. 
Several attempts to make the phenyl hydrazide (g4) from the methyl 
ester (88) all failed and the starting material was recovered in high 
yield. The non-success of this reaction was presumably due to the lower 
nucleophilicity of phenyl hydrazine as against hydrazine, a fair measure 
of which can probably be obtained by comparing their basicities (PhNHNH2 
70 71 pKb = 8.80 , NH2NH2 pKb = 5.77 ). 
CH30 
~= 
o/"DCH3 
(88) 
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PhNHNH2 
EtOC2H40H )( .. 
reflux 
CH 3 
Continuing our synthetic pathway towards triazines the la-hydrazide 
(90) and benzil were refluxed in acetic acid containing ammonium acetate 
(acting as a source of ammonia). A non-crystalline material was finally 
extracted from the reaction mixture which t.l.c. and n.m.r. showed to be 
a mixture of two compounds, the 7a- and 7fl- 4, 5-diphenyl-1, 2, 4-triazines,, 
(95a) and (95b) respectively. 
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CHp 
cf~HNH2 
Fhx;~ 
Ph 
(90) 
CH3C02H 
CH3C02NH4 
+ 
(95a l 11% 
Ph-C=O 
I 
Ph-c=o 
" 
PhAyN 
Ph 
(95b) 4~ 
These isomers were eventually separated and isolated by preparative 
t.l.c. The stereochemistry was again allocated on the basis of the relative 
n.m.r. chemical shifts of the 5~-protons, these being o4.93 for the a-isomer 
and o5.46 for the ~-isomer. Howeve~ the triazine and phenyl rings will be 
exerting an anisotropic effect on the space around them, which would cause 
deshielding to protons edge-on and shielding to those face-on. Models 
suggest the 7~-triazine ring would, on average, adopt neither of these 
"extreme" positions with respect to the C-5 proton but a more intermediate 
position, making it difficult to forecast which effect would predominate, 
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quite apart from steric compression factors. 
Unfortunately these compounds were not sufficiently stable for 
prolonged spectral study and complete oxidation occurs within a day. 
Mass spectral and elemental analyses were not obtained. 
In a parallel experiment using diacetyl instead of benzil a mixture 
' 
of epimers (96a) and (96b) in the ratio of 2:1 was given. 
CHV 
CH3 CH3 
(96a) 7a-epimer (96b) 7s-epimer 
The stereochemistry was again allocated by the relative shifts of 
the C-5 protons, the values being o4.84 {for a-epimer 96a) and o5.34 {for 
s-epimer 96b). Unfortunately the epimers could not be separated even 
after careful preparative t.l.c. 
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A small amount of a third product of unknown structure was 
separated by chromatography and crystallised from ethanol, with m.p. 
266-267°C. Its accurate mass as determined by mass spectrometry corresponded 
to a molecular formula of c29 H35 N5 o5 but this was not in accord with the 
microanalytical data. The latter corresponded with c25 H29 N3 05, the 
molecular formula of, for example, the C-14 substituted codeinone (97), 
whose formation could be rationalized under the conditions concerned. 
(97) 
-1 However, although the i.r. spectrum shows bands at 1675 cm, 
(a, a-unsaturated C = 0) and 3460 (with shoulder at 3270 cm-1) NH, the methyl 
signals in the n.m.r. are at variance with structure (97). They resonate 
at o3.86 and 3.73 (typical of thevinoyl C-3 and C-6 OCH3 signals), 2.40 
(NCH3} and 2.19 (CH3-c = 0). Two alkene protons appear at o5.98 and 5.62. 
The formation of epimeric triazines in both the benzil and diacetyl 
experiments was unexpected and we set about trying to see if the hydrazide 
(90) would epimerise under similar conditions in the absence of the 
diketones. Such a process could be acid catalysed for example. 
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CHp CHp 
HO 
(90) 
Refluxing (90) in acetic acid for up to 48 h. afforded only the 
7a-~-acetylhydrazide (98b),in the presence or absence of ammonium acetate. 
Similarly, refluxing in stronger or weaker acids, formic or propionic 
respectively, gave only the appropriate diacylhydrazine (98), with no 
epimeri sati on. 
cf'~NHNH2 
(90) 
R= H (98a) 
CH3 (98b) 
Et (98c) 
This suggests epimerisation may be occurring after formation of the 
triazine, by protonation of a ring nitrogen ortho to the C-7-position~ 
- 57 -
CH 
NH 
jJ "I 
R'YN 
R 
In this respect it can be mentioned that the 3-hydroxy-1, 2, 4-triazine' 
normally exists as the keto-tautomer, e.g. 5, 6-diphenyl-1, 2, 4-triazin-3-
(2H)-one (99). 69b 
Ph 
0 
Ph 
(99) 
The hydrazide ( 90) also underwent ready condensation with a 
monoketone (acetone) to give the hydrazone (lOO) in good yield (81%), 
with no epimerisation. 
It was noticed that in the n.m.r. the signal for the c6-ocH3 group in 
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(lOO) was broad. We have observed this with one or two other thevinoyl 
compounds and we discuss the observation later (p 96); 
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Part 2 Synthesis of 1, 3, 4-0xadiazoles 
A. Alkyl- and aryl-1, 3, 4-oxadiazole syntheses 
We first sought to make 1, 3, 4-oxadiazoles containing 5-alkyl-
and 5-aryl-substituents, i.e. relatively non-polar groupings. The 
pharmacological activity should then reflect principally the_steric 
effects of the substituents rather than electronic ones. 
i) Ortho-ester route 
The condensation between hydrazides and ortho-esters is a relatively 
mild method for the formation of 1, 3, 4-oxadiazoles49 and so we chose·to 
study this first. 
RC(OR' )3 
P 3 1 4 
(90) (1 02 ) 
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A likely mechanism is shown below. 
CHp = 
~NH R'O~C==~ AH ~ 
-2 R'OH 
CHp 
<d 
R 
Refluxing the ?a-hydrazide (90) in triethylorthoformate for 24 h. 
provided the parent 1, 3, 4-oxadiazole (102a) in good yield (70%}. The 
product separated out after removal of the excess ortho-ester and proved 
easy to purify. 
Structure proof was based on the disappearance of the strong hydrazide 
carbonyl band at 1630 cm-l and NH-NH2 absorptions at 3420 and 3270 cm-l in 
the infrared. In the n.m.r. a singlet occurs a o8.43, assigned to the 
Note: The part structure used here and elsewhere 
in this thesis represents the 6, 14-endo-etheno-6, 7, 8, 14-tetrahydro-
thebaine unit, 
CHp 
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proton on the (aromatic) oxadiazole ·ring, which is at considerably lower 
field than the aromatic ring-A protons of the thebaine unit (at o6.70), 
due to additional deshielding by the adjacent heteroatoms. The 5a-proton 
resonated at o4.75. 
Encouraged by this result we extended the series to produce some 
5-substituted oxadiazoles. Reaction of the hydrazide with the appropriate 
ortho-esters gave 5-alkyl-and 5-aryl -1, 3, 4-oxadiazoles (102) in 
moderate to good yield, see table below. 
Yields ot alKYl-ana aryl·l, J, q-oxaa1azo1es tram tne ortho-ester route 
R' R % 
( 1 02a) Et H 70 
( 1 02b) Et CH3 86 
( 1 02c) Et Et 42 
( 1 02d) CH3 Ph <ulOO 
( 1 02e) CH3 £_-tolyl 55 
The main drawback to this synthesis concerns the availability of 
the ortho-esters. Triethylorthoformate is relatively cheap whereas 
trimethylorthobenzoate (for 102d) is rather costly. 72 Furthermore 
the commercial supply of different ortho-esters is severely 1 imited. 
Trimethylortho-~-toluoate (for l02e) was prepared by the method of Kw~rt 
and Price73 by treating~toluonitrile with dry methanol and HCl gas 
followed by boiling the intermediate imidate salt with methanol. 
However, the yield was disappointingly low (13%). 
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CH pH 
HC! 
Even more frustrating was an attempt to make triethylorthovalerate, 
CH3{CH2)3C(OEt)3, by the method of McElvain and Nelson,
74 which 
failed completely. This involved heating the imidate salt (as above) 
with alcohol and ether. 75 
ii) Diacylhydrazine dehydration 
Because of these limitations we sought another pathway to 5-
substituted-1, 3, 4-oxadiazoles and our attention turned to one of the 
more widely used synthetic routes, namely the dehydration of diacyl-
hydrazines.45 A variety of dehydrating agents, such as anhydrides,' 
phosphorus pentoxide,47b and phosphorus oxychloride,47a have been 
employed. Use was made of the acetyl hydrazide (98b) we had already 
prepared in our work on triazines (p 56). Refluxing this in phosphorus 
oxychloride for 1 h. followed by basification and work-up afforded the 
same 5-methyl-1, 3, 4-oxadiazole (102b) as obtained via the ortho-ester 
route described previously, (identical ir, undepressed mixed m.p.), 
but in rather lower yield (35% as against 70%). 
- ' 
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(98b) 
( 103) 
However, use of acetic anhydride as the desiccant with diacylhydrazine 
(98b)did not provide the expected oxadiazole. The crystalline compound 
(103) obtained, m.p. l86-187°C, had the following interesting features. 
The n.m.r. spectrum showed no exchangeable protons but, in addition to· 
the peaks for the alkaloid methoxy groups (63.85 and 63.66), contained 
four further methyl groups as sharp singlets at 62.48 (3H), o2.41 (3H), 
and o2.37 (6H), i.e. the last signal representing two methyls. We 
obviously assigned the ~methyl group to one of the three signals but 
this nevertheless indicated two extra methyl groups as compared to 
the starting material (98b). Their spectrum surprisingly displayed 
strong absorbances in the carbonyl region, 1725 cm-l with a shoulder at 
1740 cm-1• This was in contrast to the starting material (98b)which 
absorbed at 1605 cm-1• An accurate mass measurement showed the new 
compound to have the molecular formula c28 H33 N3 Or Accordingly 
we propose the tetraacylhydrazine structure (l03a) for the novel 
compound and this fits all of the data mentioned so far. 
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(103a) 
On searching the literature for reactions of diacylhydrazines we 
discovered that they can be converted into tetraacylhydrazines by 
refluxing in an excess of acid anhydride. 76 • 77 • 78 • 79a Some supple-
mentary evidence for this structure accrued from infrared spectral 
comparisons. On going from the diacylhydrazine (98b)to the proposed 
tetraacylhydrazine (l03a) the carbonyl stretch appears at a higher 
frequency. Of the few tetraacylhydrazines given in the literature 
none recorded relevant infrared data. We therefore prepared tetra-
acetylhydrazine itself (106a) by treating hydrazine with excess acetic 
anhydride for 48 h. 79aand found it absorbed in the infrared at 1730 cm~ 1 . 
We summarize typical frequencies overleaf. 
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(104) HCNHNHCH ,, 
" 0 0 
(1 05) CH3C NHN HCC H 3 8 8 
(107) 
V 
, max 
1605 cm - 1 
1600 cm - 1 
1730 cm - 1 
-1 1880 cm_1 1820 cm 
1715 cm-1 
1750 cm:~ 
1770 cm 
Ref. 
80a 
SOb 
79a for preparatior 
79b 
80c 
1725 cm:~ 
1740 cm (sh1d.) this thesis 
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' Despite this evidence two additional structures (103b) and (l03c) 
could possibly, be written. Attack of acetic anhydride on the methyloxadiazole, 
once it had been formed might give (l03c). However, this was shown n~t 
the case because the authentic 5-methyl-1, 3, 4-oxadiazole (102b), 
(prepared by the ortho-ester route), was recovered unchanged after 
refluxing in acetic anhydride for 24 h. 
CH CO/~N-N=C-OCCH 311 I 11 3 
0 CH3 0 
(103b) 
CHp 
-
"' N CH~~-~CH3 
3 g 0 0 
CH3 
(1 03c J 
To eliminate the bis-~-acylimidate (103b) we examined the compound 
by natural abundance 15N n.m.r. spectroscopy.ala, 82a The broad-band 
decoupled spectrum showed bands at +191.6, +193.4 and +352.4 ppm upfi,eld82b 
of the external standard CH 3No2 (0.0 ppm). These 
15N screening constants 
(i.e. chemical shifts) are as expected for the tetraacylhydrazine (103a), 
the two peaks atlower field being comparable with a screening constant 
of +199 ppm for succinimide. 81 c Also, the signal for the ring-D N-CH3 
accords with the~pical range of +320 to +380 ppm for tertiary alkylamine 
methyls. 81 b Structures(l03b) and (l03c) which contain an imine nitrogen 
are eliminated as these would be expected to give imine-!:!_ signals in the 
region -30 to +75 ppm. 81 d 
Unfortunately, the spectrum contained two other peaks at +200.4 ppm 
and +244.0 ppm, we believe due to some partially hydrolysed material 
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resulting, possibly, from wet solvent {DMSO) and the long accumulation 
period (498, 104 scans). The,+244 ppm resonance was inverted, suggesting 
NH or NH2•
8le, 82c Signal inversion in proton decoupled spectra is due 
to the negative magnetogyric ratio of 15N. 
Of the two methods we had evaluated for 5-alkyl-1, 3, 4-oxadiazole 
synthesis viz., the dehydration of a diacylhydrazine,and the reaction 
between the hydrazide and ortho-esters, we found the latter route to be 
more straightforward in our case. For this reason we applied that route 
to the production of a 7a-oxadiazole from the ?a-hydrazide (91), which, 
we had in small amounts only. Refluxing in triethylorthoformate for 24 h., 
(identical conditions to those for the 7a-epimer) failed to produce any 
7a-oxadiazole (108). Instead the ?a-hydrazone (109) was isolated and 
identified by means of its i. r. and proton n .m. r. spectra together with 
an accurate mass measurement. Satisfactory microanalytical data were 
not obtained. The infrared showed peaks at 3320 (NH), 1693 (C ~ 0) 
and 1638 (C ~ N). The n.m.r. revealed the ethoxy group pattern and a 
three proton multiplet at o6.59 was assigned to C-1 and C-2 protons of 
ring A and theN~ CH-OEt methine proton of (109). 
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CH30 ~ CHp 
0 NHNH2 ( 91 ) 
HC(0Et)3 
HCWEt)J .. 
H 
/ 
0 NH-N=CH-OEt 
(1 09) 
(108) 
The base peak in the mass spectrum of the la-hydrazone (109) was 
also measured accurately and had the molecular formula c23 H25 N3 o4 
which corresponded exactly to the desired product, the la-oxadiazole 
(108). Hydrazones of the type (109) have been isolated as intermediates 
in the synthesis of oxadiazoles from hydrazides and ortho-esters and can 
themselves be converted into oxadiazoles. 49 
With this in mind and with the indications from the mass spectrum 
we thought that thermolysis of the la-hydrazone might proceed smoothly 
to the la-oxadiazole (108). Accordingly, sublimation of the la-hydrazone 
(109) under high vacuum was performed but the product given could not be 
purified and appeared to be a mixture. 
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B The synthesis of 1, 3, 4-oxadiazoles containing a heteroatom (0, N, S} 
at position 5. 
In this next section we describe our attempts at the synthesis of 
1, 3, 4-oxadiazoles with a heteroatom (oxygen, nitrogen or sulphur} 
attached directly to position 5 of the ring. We hoped that the influence 
of these relatively polar substituents would be reflected in the eventual 
pharmacology. 
i} Oxadiazolone formation using phosgene 
We first examined the formation of a 1, 3, 4-oxadiazole with an 
oxygen at position 5. 
We found the 1, 3, 4-oxadiazol-5-one (llOa} was formed from the 
?a-hydrazide (90} in dilute HCl when phosgene was bubbled through. The 
product precipitated as the hydrochloride salt, which.showed a carbonyl 
stretching frequency at 1780 cm-l (with a shoulder at 1820 cm-1}. 
This compares with 1775 cm-l for 2-(~-nitrophenyl)-1, 3, 4-oxadiazol-5 
83a 
-one. 
o':?''N H N H 2 
( 9 0) 
Cl E) 
~H 
0 
(110a) 
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The crystalline monohydrochloride (llOa) was obtained in fair 
yield (51%), but after basification with ammonium hydroxide only a small 
amount of-the free base (llOb) (non-crystalline) was collected. The 
low yield of free base was possibly due to alkaline cleavage of the 
1, 3, 4-oxadiazole ring, this reaction occurring readily in many other 
instances. 83b, 84 
ii) Aminooxadiazole formation using cyanogen bromide 
We next studied the reaction of the ?a-hydrazide (90) with cyanogen 
bromide and found this gave the aminooxadiazole (111)' in 50% yield. 
CHp 
i) CNBr 
ii l NHtOH CH
3 
CH3 
~~ 
A )=h 
NH2 
( 111 ) 
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A likely mechanism for this conversion is as shown. 
H 
b NH-N-H 
~ ·~e-N 
o cl 
Br 
( 111 ) 
J 
The infrared spectrum of the product showed the starting hydrazide 
-1 ' 
carbonyl band at 1630 cm to be absent but included bands at 3300 and 
3150 cm-l (NH2) and at 1650 cm-l (C = N). Microanalysis and an accurate 
mass measurement were also in accord with structure (111). 
The compound provides a second example of a 1, 3, 4-oxadiazole with 
a polar grouping at position - 5. The heteroatom is similar in size to 
the oxygen of the oxadiazolone (llOb) but more basic, and hence should 
show modified binding properties at the opiate receptor. 
We attempted to convert the aminooxadiazole (111) into the oxadiazolone 
(llOa) via the diazonium salt (112). 
CHp 
CHp 
E~ ~ 0 
'-----'N=O I 
(111) OH 
~N ~H 
0 
(110a) 
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( 112 ) 
Sd 
OH 
(110d) 
This type of transformation has been achieved in the 1, 3, 4-thiadiazole 
series. 43 
NH2 
( 113 ) 
i) HN02/10°C 
ii)AcOH/RT. 
-N 
n---~H 
0 
( 114) 
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However, our aminooxadiazole was recovered unchanged from nitrous acid 
solution and diazotisation had obviously failed to take place. This 
result is interesting when consideration is made of the relevant chemistry 
of amino-1, 3, 4-oxadiazoles. Werber andMaggio85 found the amino-
phenyloxadiazole (115) to be bidentate, alkylation (e.g. with methyl iodide) 
taking place at position 3 and acylation (e.g. with acetic anhydride) 
at the nitrogen attached to position 2. 
Ph 
AcfJ 
• ~ l-== ~ N N I I N ~H N NHAc NH e 7H 2. 
N=O 
( 116) (117) 
Jf 
~H 
N 
\ 
N=O 
(117a) 
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Treatment with nitrous acid proceeded only as far as the primary 
nitrosamine (117).85 On the basis of these and other similar findings 
an aminooxadiazole (115)/iminooxadiazoline {115a) equilibrium was suggested 
with the amino-form predominating. 86 Subsequent work by Yale and Losee87a 
showed that on protonation the endocyclic cation (116) was formed. This 
chemistry indicates why our aminooxadiazole failed to diazotise but the 
primary nitrosamine (118) might still have been expected. 
CHp 
Sd NHNO 
(118) 
Treatment of the aminooxadiazole {111) with an excess of acetic 
anhydride at 85°C for 3 h. appeared to give the amide (119) (extra 3 proton 
singlet in the n.m.r. spectrum at o2.25), but this could not be purified. 
( 111 ) ( 119 ) 
- 75 -
iii) Formation and modification of oxadiazolthione derivatives 
a) Oxadiazolthione synthesis and formation of a Mannich base. 
To provide a further contrast with the~- and N- substituents·at 
position-S we sought to incorporate anS atom there. This is considerably 
larger than 0 or N, though less electronegative. 
Hoggarth55 found that potassium ~-acyldithiocarbazate salts, 
RCONHNHCS 2~e. could be cyclised in the basic medium to give 1, 3, 4-
oxadiazol-5-thiones. Isolation of the salt is not essential, or even 
desirable, and prolonged reflux of a hydrazide with carbon disulphide and 
KOH in ethanol gives the heterocycle. We applied this method to our 
hydrazide (90) and the expected thione (121) was formed as a crystalline 
product. 
cs2 pyridine 
c~o 
(120) 
l 
= N ~~H 
s 
(121 ) 
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However, we found this to be an unreliable synthesis with yields 
varying between 10% and· 60%. We preferred an alternative procedure of 
Hoggarth's involving pyridine as both solvent and base: 55 this was more 
efficient and reliable (yields~ 90%). 
The product showed a broad NH band at 3440 cm-l in the infrared 
and the carbonyl region was vacant. The compound gave the correct 
accurate mass and microanalytical data. 
It can be mentioned that the microanalysis of this and several 
other of the thebaine derivatives (see Experimental) revealed the incorporation 
of a molecule (and/or a half) of solvent into the crystal. This observation 
has been made and commented on before by other workers with morphine 
related compounds. 87b 
The oxadiazolthione (121) underwent a Mannich reaction when treated 
with morpholine and formaldehyde in ethanol. Simpler 1, 3, 4-oxadiazolones 
are known to undergo this reaction. 40 The morpholino-Mannich base (122) 
was isolated in poor yield {20%). The gem-diamino methylene group 
appeared as a singlet at o4.95 in the n.m.r. 
~~H 
s 
(121 ) 
HCHO 
Et OH 
- N 
~-CH-N~ 
s 2 \...;__/ 
( 12 2) 
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Repetition of the same reaction conditions but using piperidine 
instead of morpholine gave a product which could not be purified. 
b) Conversion of the oxadiazolthione to 5-alkylthio-derivatives 
Formation of the Mannich base (122) would provide some information 
concerning the receptor site beyond the 4, 5-bond of the oxadiazole ring,·· 
and this could be further studied by the introduction of groups larger 
than sulphur alone at the 5-position, for example, 5-alkylthio-substituents. 
Three 5-alkylthio-1, 3, 4-oxadiazoles (123a, b, and c) were produced' 
in reasonable yields by refluxing the thione (121) with alkyl iodides in 
their corresponding alcohols. The ~-alkylation procedure has been 
reported for simple 1, 3, 4-oxadiazol-5-thiones. 40 • 41 
RI 
ROH 
. 
~~ N 
SR 
(12 3) 
R % Yield 
(123a} CH3 70 
(123b} Et 51 
( l23c) (CH3}2CH 38 
In the methylthio-derivative (123a) the SCH3 signal appeared at 
o2.68. Accurate mass measurement of the molecular ion in the mass 
spectrum corresponded with the expected value as did the microanalysis. 
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Refluxing the thione with an excess of 1-bromooctane in absolute ethanol 
for 18 h. did not produce any pure products. 
c) Formation of a ring opened $-benzyl-derivative and study of its 
cyclisation 
For a similar reaction between the oxadiazolthione (121) and benzyl 
bromide a crystalline product (m.p. 120-123°C from EtOH) was obtained 
after basification, but the spectral data were not fully in accord with 
the expected structure (124). 
CHp 
6-~ )r-NH 
s 
(121) 
il PhCH2Br/EtOH 
)( r-
CH.P 
The crystalline free base showed the presence of'a benzyl group in 
the n.m.r. spectrum (o4.03, s, ~-benzylic methylene, o7.16, s, phenyl 
group) but the i.r. spectrum intimated the presence of carbonyl group 
absorption (1680 cm-1, strong) and NH's (3460 cm-l and 3250 cm-1). 
These data suggested ring opening had taken place and we postulate structure 
(125) for the unknown in which ring opening by water has occurred. This 
presumably happens after the thione has become benzylated and the difference 
between this reaction and other alkylations which proceed without ring 
opening can possibly be ascribed to the slight electron-withdrawing effect 
of the benzyl group in comparison to the electron-donating effect of the 
alkyl groups,88a thus making the heterocyclic ring carbon less susceptible 
to nucleophilic attack by water in the latter cases. The small trace of_ 
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water required to effect this ring opening could easily have come from the 
solvent. 
( 12 5) 
Mechanism: 
~H 
s 
(121) 
PhC 
1 
= 
cf"-NHNHCSCH2Ph 11 . 
0 
(125) 
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The structure (125) was confirmed by elemental analysis and a molecular 
weight determination by vapour pressure osmometry. The latter gave a 
value within the normal 10% accuracy of the method. This slightly unusual 
method of molecular weight determination was adopted because the mass 
spectrum of (125) failed to show the expected molecular ion at 547 corres-
ponding to c30 H33 N3 05 S but showed instead the highest fragment at 
m/e 423, (measured accurately as c23 H25 N3 o5), which corresponds to the 
oxadiazolone (llOb), and a base peak of 124 (C6 H5 CH2SH). These fragments 
suggested that under electron impact (125) was cyclising to the oxadiazolone 
(llOb) with loss of benzylmercaptan, c6 H5 CH2SH. A concerted cyclic 
electron movement involving 6 atoms can be written. Since both fragments 
appear in the mass spectrum charge retention can occur on 'either. 
+ + .
In view of the similarity sometimes observed between fragmentations 
induced under electron impact and fragmentations induced thermallyBBb we 
decided to subject the open-chain compound (125) to vacuum sublimation. 
Pleasingly, we obtained the oxadiazolone (llOb) in 68% yield and· 
characterised this as its hydrochloride salt (llOa) identical with the 
sample we had made earlier from the la-hydrazide and phosgene (p 69). 
. 
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~ 
OANHNHCSCH2Ph 11 
0 
(12 5) 
= N s;:~H 
0 
(110bl 
The thermal cyclisation therefore represented potentially a new 
method of synthesis of the 1, 3, 4-oxadiazol-(4H)-5-one ring system and 
so we sought to see if the method could be proved more g~neral by the 
use of a simpler oxadiazolthione. 
We chose the known phenyl-1, 3, 4-oxadiazolthione (127), m.p. 219-220°C 
for this purpose. This compound was synthesised from benzoic acid 
hydrazide (126) following Hoggarth's method, 55 with carbon disulphide 
and pyridine in 71% yield. Benzhydrazide (126),m.p. 112-113°C, was 
synthesised in 48% yield from ethyl benzoate and hydrazine hydrate. 
Treating the phenyl-1, 3, 4-oxadiazolthione (127) with benzyl 
bromide produced the open-chain compound (128) in 54% yield, with unambiguous 
analytical and spectroscopic data. Again we concluded that the water 
necessary to effect ring opening was provided by the solvent, (ethanol). 
0 HNH 2 
(126) 
0 
(129) 
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0 
-N 
s 
(127) 
(128) 
54% 
Sublimation of the open-chain compound (128) afforded 2-phenyl-1, 3, 
4-oxadiazol-(4H)-5-one (129), m.p.l38°C in 22% yield. The phenyloxadiazole 
is a known compound,89 m.p. l38°C. We prepared a sample by a literature 
method83a (benzhydrazide and phosgene). Close inspection of the i.r. 
spectra of the two specimens showed the presence of trace impurity 
(possibly c6 H5 CH2 SH) in the sample derived via the sublimation. The 
' impurity also showed in the mass spectrum providing a peak at m/e 124 (C7H8S) 
which was not found in the spectrum of the oxadiazolone from the phosgene 
route. Nevertheless, it is clear that the thermal cyclisation had 
proceeded smoothly and we consider this to be a new method for obtaining 
oxadiazolones. 
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d) Study of the cyclisation of an N-acyldithiocarbazate ester 
Because of the cyclisation reactions we had witnessed with the~­
acylthiocarbazate esters (125) and (128) we considered the possibility of 
utilizing other of our open-chain compounds in a similar fashion to produce 
heterocycles. Thus we considered that the potassiumJ1-thevinoyldithio-
carbazate salt (120) (the preparation of which is discussed on p.88) 
should react with benzyl bromide to give the ~-acyldithiocarbazate ester. 
This system (120a) would then be comparable with (125a) which gave the 
' oxadiazolone. System (120a) should, however, give an oxadiazolthione. 
R-{-~)-SCH2Ph 
0 s 
(120a) 
R-{N-NJ.-SCH
2
Ph · 
0 0 
( 12 Sal 
Production of the S-benzyl-dithiocarbazate (130a) as its hydro-
bromide salt occurred only in low yield (27%). The free base (130b) 
was obtained after basification with ammonia and was purified by chromato-
graphy. A later fraction gave an oil which was not purified but its 
infrared spectrum suggested the presence of some oxadiazolone (llOb). 
CHi} 
CH!) 
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oANHNHCS8K0 
(120) s 
c(=~ 
_);-NH 
0 
( 11 Oc) 
6. DMF 
c(=~ 
);-NH 
s 
( 121a) 
Thermolysis of the benzyl-dithiocarbazate (130a) by refluxing in 
DMF (ostensibly dry), for 6 h. yielded not the expected oxadiazolthione 
(12la) but instead gave the oxadiazolone (llOc) as its hydrobromide. 
Clearly, water must have been involved in the process. Although 
dry solvent was used the vessel was not maintained under anhydrous· 
conditions throughout. We believe that involvement of water occurs before 
cyclisation because in a separate experiment we showed that the oxadiazol-
thione (121) remains intact after refluxing in DMF under the same 
conditions for 6 h. This suggested the following sequence of events. 
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,A 0 NHNHCSCH2Ph 
" (130a) S 
~ 
1111\l\11 
CHj) 
,,,,,,, 
oANHNHCSCH2Ph 
(12 5) g 
PhCH,SH !6 
CHj) 
/-=7 
fr-NH 
0 
(110c) 
It is known that thioamides are readily converted to amides on 
treatment with aqueous base at room temperature. 103a 
Hence the oxadiazolone system can be fonned from an .!!-acylthiocarbazate 
ester by direct sublimation of the solid or thennolysis in solution. 
e) Displacement of the 5-alkylthio-group to give 5-alkylamino-1, 3, 4-
oxadiazoles 
Displacement of the -SCH3 moiety from a molecule by primary or secondary, 
amines is well known. 41 However, we found the methylthio-function of the 
oxadiazole (123a) was not replaced ~ pyrrolidine after being refluxed 
in benzene for 24 h. with an excess of the amine. Subsequently, after 
trying different conditions, we were happy to find that at least a small 
yield (12%) of pyrrolidino-compound (134a) was obtained upon refluxing the 
reactants in dry £-Xylene for 65 h., (2.7 days). The yield was increased 
to 61% by refluxing for 12 days. The piperidine- and morpholino- derivatives, 
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(134b) and (134c) respectively were prepared similarly, as summarized 
below. 
CHp 
~ ~N 
(123a) 
p-xylene 
(134) 
Yields of 5-alk~lamino-1, 3, 4-oxadiazoles (134). 
Amine Reflux (da~s) 
(134a) Ho 2.7 
" " 12.0 
(134b) Ho 6.0 
(l34c) Ho 6.0 
% 
12 
61 
38 
45 
Unfortunately, attempts to substitute diethylamine and 1, 2, 3, 4-
tetrahydroisoquinoline by prolonged reflux(~ 25 days) were not as successful. 
In the case of diethylamine no pure products were obtained at all, and 
with tetrahydroisoquinoline only a very small amount of crystalline material 
(insufficient for analysis) was collected as colourless needles, m.p. 
217-219°C. This compares with the starting material (123a) melting point 
of 186-187°C. 
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We recognized that the pharmacological activity of the 5-cycloalkyl-
aminooxadiazoles described above would provide an interesting comparison 
with the 5-phenyl- and 5-£-tolyl-analogues prepared earlier. The 
systems would have somewhat similar steric demands but the amino-derivatives 
would be more polar. 
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Part 3 Synthesis of 1, 2, 4-Triazoles and Studies Concerning Open-Chain 
Precursors 
In the previous chapter on 1, 3, 4-oxadiazoles we referred to the work 
of Hoggarth55 on the sy~thesis of 1, 3, 4-oxadiazol-5-thiones from 
potassium dithiocarbazate salts. In addition to their application in 
oxadiazole synthesis Hoggarth55 and others56 • 91 a examined the use of these 
salts in 1, 2, 4-triazole synthesis. It was found that the salts could 
be methylated and the resulting dithiocarbazate esters cyclised in the 
presence of hydrazine to produce 4-amino-1, 2, 4-triazol-5-thiones. 
Already in our work we had been successful in the production of the 
1, 3, 4-oxadiazol-5-thione system attached to C-7 of 6, 14-endo-
ethenotetrahydrothebaine and we postulated the potassium salt (120) as 
an intermediate in this synthesis when the la-hydrazide was treated 
with cs2 and KOH in aqueous ethanol (p 75). At this stage therefore, 
we considered it would be productive to attempt to isolate the dithio-
carbazate salt (120) because this compound, if obtainable, ought to 
provide a convenient route to the 4-amino-1,2, 4-triazol-5-thione system 
by the method described above. 
Accordingly we treated the hydrazide (90) with one mole of potassium 
hydroxide and a slight excess of carbon disulphide in aqueous ethanol,and 
after boiling for five minutes and cooling, the desired potassium ,]a-
thevinoyldithiocarbazate salt (120) was obtained in high yield (80%) 
as an amorphous solid for which satisfactory analytical and spectroscopic 
data (n.m.r., i.r., elemental analysis) were obtained. 
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Et OH 
(136) (135) 
At this point in our studies,a modification of the Hoggarth 
synthesis appeared in the current literature by Reid and Heinde1. 58 
It noted that the potassium dithiocarbazate salts need not be methylated 
but could be ring closed directly to triazoles upon treatment with hydrazine. 
The authors of this development claimed that without the need for 
~-methylation a higher overall yield was given and a shorter working 
time was permitted, thus affording a significant improvement over the original 
method. 
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'we therefore tried this new method and although we succeeded in 
isolating some of the required 4-amino-1, 2, 4-triazol-5-thione (136) 
the yield was only 8%. Even though the reaction conditions were varied 
considerably we could not improve on this yield. Structure proof of (136) 
was based on microanalysis data, the disappearance of the carbonyl stretch 
of the starting material in the infrared and absorptions attributable to 
NH2 and NH at o5.27 and 13.5 (very broad) in the n.m.r. 
In view of the low yield we examined the original method of Hoggarth's 
and attempted to methylate the dithiocarbazate salt. However, treating the 
dithiocarbazate salt in aqueous or methanolic solution with methyl iodide 
at ambient temperature gave only resinous products which could not be 
separated. 
of methyl 
obtained. 
It necessitated heating the dithiocarbazate salt with an excess 
iodide in refluxing methanol before a crystalline product was 
0 ' 
This compound (colourless needles m.p. 211-213 C) was soluble 
in water and therefore probably not the free base. Addition of dilute 
ammonia to a cold aqueous solution gave an immediate precipitate and this 
intimated a hydroiodide. A sodium fusion test proved the presence of 
iodine. Even though we recognized this compound as a hydroiodide there were 
certain features in its n.m.r. spectrum which soon convinced us that this 
was not the hydroiodide of the expected monomethyl-dithiocarbazate ester· 
(135). There were deuterium exchangeable peaks at o8.9 and ol0.41 in' 
the relative ratio of 1 to 5 respectively, the total integral of which' 
came to only one proton. No other exchangeable protons were observed within 
the~ 5 min standing with o2o. In addition to the methyl signals at 
o3.85 (C30CH3) and o3.75 (C6ocH3) there were a further three methyl peaks, 
at o3.21 (slightly broad), o2.56 and o2.44. These data suggested the 
~. ~'-dimethyl-dithiocarbazate (137) as being the correct structure. 
- 91 -
( 137 J 
The lowering of the ~-methyl resonance from its usual position at 
~o2.3 is due to protonation. This is a general observation for protonated 
species in this series. 64 
We obtained the free base (138) after basification of the hydroiodide 
with ammonia, and the free base (138) was also produced (in 20% yield) 
if we treated the potassium dithiocarbazate salt (120) with one mole of 
methyl iodide in place of an excess. 
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62 ·49 
( 138) 
The n.m.r. spectrum of the free base (138) showed several interesting 
features. The two ~-methyl groups appeared as a single peak and we hoped 
that this signal could be resolved into two easily recognizable 3 proton 
peaks by the use of a lanthanide shift reagent. An experiment to do just 
that is discussed on pp. 96-99. Also, the resonance for the C-6 methoxyl group 
(a3.68) was broad, of low peak height, and the integration did not come 
up to the value of three protons. This broadening of the C-6 methoxyl signal 
had been observed before in one of our compounds and this phenomenon is 
also considered in our discussion of the utilization of a lanthanide shift 
reagent (p 96). In addition the NH proton still appeared as two signals 
of unequal intensity, as in the hydroiodide (137), but this time.at oB.BO 
and o9.75 in the ratio of 1 to 4 respectively. We thought that this was 
due to hindered rotation about the C-N single bond of the C-7 substituent. 
Such restricted rotation is seen in amides and arises because of the partial 
double bond character of the C-N bond. 92a In our case this can be visualized 
as overleaf. 
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(140) 
(139a J ( 141 ) 
To test this hypothesis we recorded the NH signal in the n.m.r. 
at increasing temperatures. The two peaks coalesced at 70°C and twin 
peaks reappeared on cooling to 35°C. This confirmed that hindered rotation 
was the cause of the split signa1. 93a The energy barrier to rotation 
(t.G~) was calculated using equations given by Lambert. 94a 
aG: = free energy of activation at the temperature of coalescence, in -
ea 1 mole -l. 
Tc =coalescence temperature (°K) = 343°K (70°C). 
Kc = unimolecular rate constant for the reaction. 
t.v =distance between the two peaks at slow exchange (in ppm), i.e. 
0.29 ppm at 35°C. 
R =gas constant= 1.987 cal °K-l mole-1• 
= II/Iv 
J2 
= 3.142 X 0.29 
1.4142 
KC = 0. 6443 ppm 
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= 2.3 RTc(l0.32 + log Tc) 
Kc 
= 2.3 X 1.987 X 343 (10.32 + log 343 \ 
0.6441) 
~ = 20.5 K cal mole-l (3 sig. figs.) 
•••• equation 1 
•••• equation 2 
This figure is probably not reliable however, because the equations 
should normally be applied when the ground state populations of the two 
rotamers are equal, and this was not so in our compound. 93b When the 
populations are unequal a more complex line shape analysis has to be applied 
to give an accurate figure. 93b, 95 Nevertheless, the value of 20.5 K cal 
mole-l we obtained by this method is close to the 22 K cal mole-l barrier 
generally observed in amides by line shape analysis. 94b The value of 
21 K cal mole-l is recorded for dimethylformamide. 92b 
Returning to the problem of the coincidental ~-methyl resonances at 
62.49 in the n.m.r. spectrum of (138), we were of the opinion that these 
could perhaps be separated out into two distinct signals by the use of a 
lanthanide shift reagent96 and this would provide a useful simplification 
of the spectrum. 97a However, before commencing this experiment, we 
proposed to see what effect a lanthanide shift reagent would have on a 
bridged thebaine compound of unambiguous structure in order to have a 
suitable model with which to compare any results we achieved with the 
~. ~'-dimethyl-dithiocarbazate (138). Accordingly, we chose to do a 
preliminary experiment with the ?a-methyl ester (88), a compound we had· 
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made use of already in our studies and one described in the, 1 iterature. 15 
' ' 
The shift reagent chosen was Eu(fod) 3 (142) which is soluble in a variety 
of organic solventsg7b and causes adequate shifts with relatively little 
line broadening. 97c 
16 
N_.......-CH3~2·39 15 
H 
/(_=0 
Eu 
3 
(142) 
The ester (88) possesses six potential heteroatom co-ordination 
sites. 97d The olefinic protons at C-17 and C-18 were assigned on the basis 
that H18 (85.89) would be expected to resonate at lower field due to the 
closer proximity of the oxygen attached to C-6 (H17 is at 85.57). This 
is in agreement with the assignments made in the spectra of the 7a- and 
7S- nitriles, (H18 at 85.93, H17 at 85.61 in the case of the 7a-nitrile).
64 
Shifted spectra of the ester (88) were produced by the addition of 
Eu(fod) 3 in three portions up to a total of 117 mg of shift reagent 
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to 85 mg of substrate. {This represented a 0.527 mole ratio of Eu(fod) 3 
to substrate). Large downfield shifts of up to 350Hz were observed. 
Further addition of shift reagent resulted in a total loss of instrument 
resolution. The graph of induced shift against mole ratio of shift reagent 
to substrate (Graph 1) shows almost straight line relationships for all the 
protons (as expected). 97e As the graph clearly shows the olefinic proton 
H18 and the methoxy group at C-6 were most affected, closely followed by 
the H5a proton. This suggested that co-ordination was taking place close 
to the C-6 methoxy group. Strong co-ordination to the tertiary nitrogen 
atom might have been expected as this is the most basic centre. 96 • 98 
However, the ~-methyl group was only slightly affected and this is 
probably due to steric hindrance to co-ordination. 99 
When we performed a similar experiment with the~. ~'-dimethyl­
dithiocarbazate {138) we noticed that after the first addition of the 
shift reagent the C-6 methoxy peak sharpened and the peak height and integral 
became identical to that of the C-3 methoxy. We therefore realized that 
the broadening in the unshifted spectrum was due to inefficient relaxation 
of these protons and the introduction of the paramagnetic shift reagent 
had caused the relaxation time to shorten and so produced a sharp signa1. 100 
360 
I 3:;{) 
Graph l 
I 
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16 
H 
\ 19 /H .--&9·75 and 8·80 
/t-N--. 
0/ '\ 
~ 
/c"-
CH3S SCH3 
(138) 62·49 
The observed downfield shifts are given in Graph 2. Straight line 
relationships were again recorded for the shifts of protons with respect 
to the concentration of Eu(fod)3• The six proton signal at o2.49 was 
indeed split into two, and one of these ~methyl groups was shifted very 
rapidly downfield in relation to all the other methyl groups in the 
compound, which in comparison were only slightly affected. This implied 
that the lanthanide atom was co-ordinating at or close to one of the 
sulphur atoms, (possibly at one of the nitrogens of the C-7 substituent), 
rather than at or near the C-6 methoxy has it had done in the 
previous example with the ester (88). 
Several times we repeated the methylation reactions of the 
potassium salt, both with one mole of methyl iodide and with excess. The 
monomethyl compound (135) was never detected. Shafiee et al. have 
recently recorded both ~-monomethyl- and~. ~'-dimethyl-dithiocarbazates 
in their work on thiadiazoles. 41 
- lOO -
80~ 
+ 
N=N ~H2} ~ )===N 
SCH3 15 ~ 
( 143 J 
They converted the dimethyl-dithiocarbazate into the 4-amino-5-
methylmercapto-1, 2, 4-triazole (143) by boiling it for 6 h. with an excess 
of hydrazine in ethanol. When we tried this reaction with our~. ~'-dimethyl­
dithiocarbazate hydroiodide (137) the only product was the unreacted free 
base (138) and not the expected cyclised product (144). 
(13 7 J 
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EtOH 
reflux 6h. 
(144 J 
free base (138) 
"'80% recovery 
Having not been too successful thus far in our efforts towards 
1, 2, 4-triazole synthesis we were pleased to find that the 1, 3, 4-oxadiazol-
5-thione (121) we had already prepared in good yield (p 75) was converted 
into the 4-amino-1, 2, 4-triazol-5-thione (136) by refluxing with a large 
excess of hydrazine in water for 4 h. However, the yield of the triazole 
(136) was low (15%) and taken overall this method had no advantage over the 
modification of Hoggarth's route, using hydrazine on the potassium salt 
(120), which we had employed previously. 
CH:J NH2NH2 CH 
c(==N NH2~( 7 ff-~H (r--NH 
s s 
( 121 ) (136) 
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Another approach to the synthesis of 1, 2, 4-triazoles which we 
hopedwould be more fruitful involved cyclisation of a semicarbazide 
derivative (145). Unfortunately preparation of a semicarbazide proved 
troublesome. The ?a-methyl ester (88) did not react with semicarbazide 
hydrochloride in base (pyridine) and its recovery was quantitative. 
cfAocH 3 
(88) 
NH2NHCONH2 .HCI )( • CH pyndine J 
reflux Sdays aANHNHCNH2 11 
(145 J 0 
We considered the acid chloride (147) would be a more reactive 
starting point for this synthesis than the ester and this was prepared 
from the ester (88). Concentrated hydrochloric acid hydrolysed the ester 
to the acid (146), the bridged thebaine system surviving intact. Conversion 
to the acid chloride (147) used a modification of the literature procedure 
by employing thionyl chloride as the chlorinating agent instead of 
oxalyl chloride. 15 The identity of the acid chloride was proven by its 
conversion into the ethyl ester (148) identical with the compound prepared 
independently by Diels-Alder reaction between thebaine (4) and ethyl 
acrylate. 15 
This approach proved no more productive, however, and treating 
the acid chloride (147) with semicarbazide hydrochloride in pyridine 
under similar conditions to those we had already tried for the ester 
failed to give any identifiable products on work-up. The acid chloride 
was converted to the amide (149), a novel compound, on mixing with cone. 
ammonia solution. 
oAoEt 
( 148) 
(4) 
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conc.HC!~ 
i l EtOH 
o-AoH · 
(146) 
o-Ac1 
(14 7) 
. - 104 -
Although further use of the amide was not made in this work it 
represents a potential precursor to other C-7 heterocyclic ring systems, 
such as oxazole (150).glb 
R 0 R ~ ~NH2 ,11 oANH RCCH 2 Br I )H R,c 2 R 11 
0 (150) 
We finally studied 1, 2, 4-triazole formation from 7a-thevinoyl-
semicarbazides and -thiosemicarbazides. 
llydrazides are known to react with alkyl or aryl isothiocyanates to 
give thiosemicarbazide derivatives which have been cyclised in base to 
4-alkyl- or 4-aryl-1, 2, 4-triazol-5-thiones.40 We applied this scheme 
to our hydrazide (90) and in the first step produced the methyl-, ethyl-, and 
phenyl-thiosemicarbazides (151) in high yield by reaction with the 
appropriate isothiocyanate. These were successfully ring closed to the 
1, 2, 4-triazol-5-thiones (152) smoothly by refluxing in ethanol in the 
presence of base (piperidine). The yield in the last step was very much 
dependent on the length of time of the reflux, longer times giving higher 
yields. These reactions are outlined in Scheme 7 
CHp ~ 
R-~ 
(152) 
' - 105 ..: 
RNCS 
Et OH 
reflux 
OH EtOH 
reflux 
Yields of 1, 2, 4-triazol-5-thiones (152} 
R Hours reflux 
( 152a) CH3 7 
( 152b) Et 7 
" " 24 
" " 72 
(152c) Ph 24 
" " 48 
Scheme 7 
OANHNHCNHR 
. 11 
R 
(15la) CH3 
(15lb) Et 
(151c) Ph 
(151) 
% Yield 
63 
10 
60 
71 
13 
24 
s 
% Yield 
76 
94 
86 
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The three triazoles and their thiosemicarbazide precursors were 
, all crystalline, reasonably easy to purify, and satisfactory spectro-
scopic and analytical data were obtained for each •. These facts, in 
conjunction with moderate to high yields, made this the most productive 
and convenient route to 1, 2, 4-triazoles that we studied. 
We then examined the analogous series of reactions with isocyanates 
hoping to produce semicarbazides (153) 53 and cyclise these to 1, 2, 4-
triazol-5-ones (154). 54 
RNCO 
ArNCO 
~1'\\\l\\l 
.,,,,, I 
CHp 
-
= Ar AHNHC~CNHAr 
11 11 
0 0 
(155) 
O~NHNHCNHR 
(153) ~ 
Et OH 
reflux 
These reactions were not as straightforward and did not proceed 
as we had envisaged (et refs. 53, 54). The hydrazide with ethyl- and 
methylisocyanate gave the expected semicarbazides (153, R = CH3 and Et 
respectively) on refluxing in ethanol but these were difficult to 
purify and crystallise. When n-butylisocyanate was employed in this reaction 
no pure products were obtained. 
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We tried to cyclise the ethyl-semicarbazide (153, R = Et) by refluxing 
in abs. ethanol with piperidine for 24 h. (identical conditions as with the 
sulphur analogue) but no pure products were obtained. Using pyrrolidine 
as the base and stepping up the reflux time to 5 days in ethanol only ' 
resulted in a 72% recovery of the starting material. 
The synthesis of the pheny~semicarbazide (153, R = Ph) proved 
troublesome. Treating the hydrazide with phenylisocyanate in refluxing 
abs. ethanol (the same conditions as for the ethyl-and methyl-semicarbazides) 
gave an intractable mixture from which neither starting material nor 
semicarbazide could be extracted. 
When the hydrazide was refluxed in toluene with an excess of 
phenylisocyanate a crystalline product was obtained but this was not the 
expected semicarbazide but a biuret (155), in which two moles of isocyanate 
had added. This compound and related compounds, together with their 
subsequent chemistry, are discussed in the next part (pp.ll0-127). 
The desired phenyl-semicarbazide (153, R = Ph) was eventually obtained. 
by reacting the hydrazide and the isocyanate in abs. ethanol at ambient 
temperature. The crystalline semicarbazide was isolated in good yield 
(67%). 
It is known that cyclisation of simpler acylsemicarbazides under 
alkaline or basic conditions gives triazolones whereas avoidance of these 
conditions leads to oxadiazolones. 101 b We had failed to cyclise our 
7a-thevinoylsemicarbazides in the presence of piperidine. We therefore 
heated them in xylene only, since the substrates themselves are bases. 
We found, however, in all three cases that the semicarbazides 
(153, R = CH3, Et and Ph) were each converted into the 1, 3, 4-oxadiazol-
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5-one (llOb) on thermolysis in xylene for 24 h. 
OANHNHCNHR 
~· 
(153) 
!:::. 
xylene 
~H 
0 
(110b) 
With (153, R = CH3) and (153, R = Et) the oxadiazolone was identified 
from the i.r. spectra of the crude products alone, but with (153, R =·Ph) 
the product was converted into the crystalline hydrochloride (llOa) 
identical with the sample made previously (p 69). The overall yield in 
this last reaction was good (61%). A similar synthesis has been reported 
in the literature in which the acylsemicarbazides (132) cyclise with loss 
of ammonia on thermolysis in biphenyl or N-chlorourea. 90 
R 
~-R' 
0 
( 132) ( 133) 
The reaction was reported not to work with an aliphatic R group,90a 
(in contrast to our thermolysis). 
In summary, our studies had produced four triazoles as substituents 
at the ?a-position of the 6, 14-endo-etheno-6, 7, 8, 14-tetrahydrothebaine. 
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Each was a 4-~substituted-triazol-{lH)-5-thione. The methyl-, ethyl-, 
and phenyl-substituents would provide a graduated increase in size for 
the analgesic structure-activity relationship studies whereas the N-amino-
derivative would, in contrast, provide a more polar molecule of similar 
size to the ~-methyl-analogue. 
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Part 4 Formation of 1, 3, 4-0xadiazol-5-ones via Derivatives of Biuret 
As we reported in-Part 3 on triazoles we were studying the formation 
of semicarbazide derivatives from the hydrazide (90) and isocyanates, and 
endeavouring to cyclise these in the presence of base to produce 1, 2, 
4-triazol-5-ones. 
We found this synthetic sequence unprofitable with our compounds 
and we were not able to convert the semicarbazides we produced into 
triazolones, although the analogous thiosemicarbazides had yielded triazol-
thiones satisfactorily. Indeed, obtaining the pure semicarbazides 
was in itself not easy, and of particular difficulty was the synthesis 
of the phenyl-semicarbazide (153, R =Ph). While the ethyl- and 
methylisocyanates reacted with the hydrazide (90) in refluxing ethanol to 
give, eventually, the required semicarbazides as crystalline material, 
use of phenylisocyanate under the same conditions unhappily produced 
only intractable mixtures. 
We therefore heated under reflux an excess of phenylisocyanate with 
the ?a-hydrazide (90) in dry toluene for 17h. This gave, after careful 
column chromatography, a small amount of a colourless crystalline compound 
m.p. 205-208°C. This was not the desired phenyl-semicarbazide (153, 
R = Ph) because the n.m.r. spectrum clearly showed the presence of two 
phenyl groups at a7.35. On the basis of spectroscopic evidence and 
microanalytical data we assigned the structure (156) to the compound. 
We obtained a better yield of (156) by refluxing excess·phenylisocyanate 
and the ?a-hydrazide in dry xylene for 24 h. (58% as against 8%). 
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Ph NCO 
CHp 
-
(90) 
CHp 
~NHNHRNHPh. 
0 
(153,R= Ph) ! PhNCO 
CHp = 
E Ph 
O~HNHfi~RNHPh 
0 0 
(156) 
It seemed likely that the phenyl-semicarbazide (153, R = Ph) was 
formed first and then underwent attack from a second molecule of phenylisocya-
nate to give (156). We subsequently showed this route was tenable after we had 
prepared the phenyl-semicarbazide (153, R = Ph) by simply shaking the ?a-
hydrazide with a slight excess of phenylisocyanate for 5 min. 
(67%). Treating the semicarbazide (153, R =Ph) with an excess of phenyliso-
cyanate in refluxing dry xylene gave (156) in a yield, (55%), (overall 37% 
from the ?a-hydrazide) comparable with that from the hydrazide and 
phenylisocyanate {58%). 
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This reaction is directly analogous to the formation of biurets 
(158) from ureas (157).lOla 
R NHCNHR + R'NCO 
11 
0 
(157) 
R NHCNHR CNHR 
11 11 0 0 
(158) 
Indeed,the compound (156) itself can be regarded as a substituted 
biuret. 
When the xylene solvent was not dried with sodium before use the 
only product from the hydrazide/phenylisocyanate reaction was~­
diphenyl-urea (159), m.p. 242°c. 104 This can easily arise from hydrolysis 
of some of the phenylisocyanatelOla, 102 to aniline which then condenses 
with PhNCO. 
0 
11 
PhNHCNHPh 
(159) 
! 
Ph NCO 
When E-chlorophenylisocyanate was used in lieu of phenylisocyanate 
the same series of reactions was found. Refluxing with the hydrazide 
(90) in abs. ethanol did not lead to any pure products. Reaction in 
sodium dried xylene led to a mixture of the biuret (160) and some ~-di­
~-chlorophenyl-urea (161), whilst reaction in non-dried xylene afforded 
~-di-£-Chlorophenyl-urea alone. 
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NICH3 dry xylene NCH3 
'wet' xylene 
j 6 
01\_NHNHC-N-CNHor; ~ Cl 
. 11 11 -
0 0 
(160) 
ctQNHgNHQct. 
(161 ) 
(+ (161)) 
Both the biurets (156) and (160) gave satisfactory elemental 
analyses. We noted, however,that in neither case could a molecular ion 
be detected in the mass spectrum, even though the compounds were run several 
times under different conditions. 
With the l-(7a-thevinoylamino)-3, 5-diphenylbiuret (156), m.wt. 
635, mass spectral analysis showed as the highest fragment ion m/e 
423 (43%) and an accurate mass measurement gave the composition as c23H25N3o5 
which corresponded to the oxadiazolone (llOb). This can be accounted for 
by loss of ~-diphenyl-urea (159) from the molecular ion and indeed this 
fragment, m/e 212 (5%), c13H12N2o, was also observed, giving a correct 
accurate measured mass. 
Supplementing the aforementioned decomposition we observed an ion 
at m/e 397 (14%) which accurate mass measurement showed to have the 
molecular formula of the starting hydrazide (90) (c22H27N3o4). This can 
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be produced by loss of two molecules of phenylisocyanate from the molecular 
ion and support for this came from the base peak, the accurate mass of 
which corresponded to the molecular formula of phenylisocyanate, m/e 119 (100%) 
c7H5No. These two alternative modes of fragmentation are illustrated in 
Scheme 8. Each fragmentation can be represented as a concerted cyclic 
electron movement involving 6 atoms. 
+. 
. + . 
CH3 
CH30 
-
m/e 397 
-
oANH ~~H I 
OYNH NH2 
'-----"' H 
/N"\fl, 2 X Ph NCO m/e119 Pti . Ph 
0 
(156) 
Ph + + . .
H I Ph 
" %, J.r-CONHPh ~ NHCONHPh jJ-:N' - "' N z::::::::: "'-NH m{e 212 0 ~ ')NH 
I; y 0 0 
mJe 423 
Scheme 8 
Metastable peaks corresponding to these fragmentations were not,observed. 
This does not, of course, imply that such fragmentations as are illustrated 
are not taking place but merely that they cannot be occurring in the field-
free region of the mass spectrometer. 
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The origin of the fragments could not be established by the mass 
spectral technique known as direct analysis of daughter ions (DADI), 103b 
unfortunately because this technique can only be applied when the molecular 
ion can be detected and this was not possible with our compound. 
Because of the ease of breakdown of the biuret in the mass spectra-
meter we had to use an alternative method for determining the molecular 
weight. We used vapour pressure osmometry and the value obtained, 694, 
agrees with the expected value, 635, within the error limits of this 
technique (10%). 
With the £-chlorophenylbiuret (160) a similar series of mass spectral 
fragmentations occurred. Again,the anticipated molecular ions at 703, 
705, and 707 in the ratio of 9:6:1 respectively were not detected. Fragme~ts 
corresponding to the hydrazide (90) m/e 397 (36%) and the oxadiazolone 
(llOb) m/e 423 (10%) were both present and accurate mass measurements 
confirmed their molecular formulae. The base peak was measured accurately 
and corresponded to £-chlorophenylisocyanate (162) m/e 153 (100%), c7H4No
35
cl. 
Peaks corresponding to ~-di-£-chlorophenyl-urea (161) as an isotopic 
cluster at m/e 279, 281 and 283 in the ratio of 9:6:1 respectively were 
not detected and therefore these must have been neutral fragments. Again, 
no metastable ions attributable to any of these decompositions were 
detected. 
Because of the ease of fragmentation of the biuret derivatives 
under electron impact we were very interested to attempt to reproduce these 
rearrangements under thermal conditions, as we had done with the benzylthiol 
esters of ~-acylcarbazinic acid (pp 78-82). 
Accordingly we proceeded to sublime the biurets (156) and (160} by 
heating them up to "' 250°C under vacuum ("' 0.1 mm Hg). 
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The material on the cold finger of the sublimation apparatus was 
separated by washing with chloroform. In the ~-chlorophenylbiuret example 
the chloroform insoluble material was found to be sym-di-~-chlorophenyl­
urea (161) by comparison of its i.r. spectrum to material prepared by a_ 
different route. On evaporation of the chloroform extract a colourless 
glass remained. Its infrared spectrum (Fig. 5) contained all the peaks 
present in an infrared spectrum of authentic 7a- (1, 3, 4-oxadiazol-(4H)-
5-one-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-tetrahydrothebaine (llOb, Fig. 6). 
A trace of ~-di-~-chlorophenyl-urea (161, Fig. 7) also remained present, 
as evidenced by an increased intensity of some coincident absorptions 
(at 1630, 1605, 1290 and 832 cm-1) and a peak at 1568 cm-1. These are all 
strong peaks in the urea spectrum. The two products had very similar 
characteristics in different chromatographic systems and could not be 
completely separated. 
Neither the ?a-hydrazide (90) nor ~-chlorophenylisocyanate were 
detected in the sublimation products so it is clear the thermal decomposit1on 
favours the oxadiazolone formation as was the case with the thermal benzyl-
mercaptan elimination from thebenzylthiol ester of 7a-thevinoylcarbazinic 
acid (p 80). 
The same behaviour was found on sublimation of the phenylbiuret 
(156). The chloroform insoluble material was shown to be ~-diphenyl­
urea by i.r. comparison to a sample made from aniline hydrochloride and 
urea by a literature method. 104 The chloroform soluble material showed 
all the features of the oxadiazolone (llOb) (Fig. 6) but again some 
additional peaks were detected and others were of increased intensity due 
to ~-diphenyl-urea impurity. Again, neither the hydrazide (90) nor 
the isocyanate were detected in the sublimations. 
I -
I - -
Fig. 5 The oxadiazolone (llOb) from sublimation of the bis-p-chlorophenylbiuret (160) 
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Fig. 6 The oxadiazolone (llOb) from the phosgene route. 
(161) 
600 
Fig. 7 sym-Di-p-chlorophenyl-urea (161) from sublimation of the p-chlorophenylbiuret (160) 
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·In the sublimation the mechanism of formation could involve an 
intramolecular type of process, e.g. as depicted in Scheme 8, which, 
at the temperature involved, could presumably be ionic or radical in 
character. Alternatively a base calalysed intermolecular process as 
shown in Scheme 9 could be occurring, the base being the ring-0 nitrogen 
centre of another molecule of the substrate (163). This is probably 
less likely under the conditions of sublimation of the solid. 
(163) 
Ar =Ph or -Qct 0 
11 
ArNHCNHAr 
Scheme 9 
CH30 
+ t~H 
0 
(110b) 
The smooth transformations of the biurets into the oxadiazolone 
(llOb) and the appropriate ~-diaryl-urea is in itself good supporting 
evidence for the structures of the biurets (156) and (160) themselves. 
The two possible alternative formulations for each of the molecules, 
namely (164) and (165) where the second molecule of arylisocyanate has 
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' added at the 1 and 2 positions of the semicarbazide respectively could 
not cyclise by an analogous mechanism to the 1, 3, 4-oxadiazolone and 
~-urea. 
CHj) 
-A I 2 34 
0/ 'NHNHCNHAr 
11 
0 
t ArNCO 1-position 
oAN-CNHAr I 11 
0 NH 0 
):Ar 
(164) 
ArNCO 
4-position CHj) 
ArNCO 
= Ar 
oANHNHCNCNHAr 
,, 11 
(163) 0 0 
oANH 
OV~-CNHAr 
T 8 
NHAr 
(165) 
Our method of forming a 1, 3, 4-oxadiazol-5-one from an ~-acylamino­
biuret appears not to have been reported hitherto. Three somewhat 
analogous reactions can be cited, two from the literature and one from 
our earlier work, each of which involves oxadiazolone formation by amino-
group elimination rather than, as in our case, by amido-group elimination. 
We summerize these in the table overleaf. 
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1, 3, 4-0xadiazol-(4H)-5-one formation by elimination of a nitrogen function 
Starting material Eliminated group Oxadiazolone yield Ref 
1. -CNHNHC-NAr.CO.NHAr 76-84% this 
11 11 
~-diaryl-urea 
thesis 
0 0 
N-acylaminobiuret 
2) -CNHNHC-NH2 11 11 
anmonia 87% 90b 
0 0 
1-acylsemicarbazide 
3) -CNHNHC-NHR primary amine 61- "' 90% this 
11 ~ thesis 0 
1-acyl-4-a 1 kyl (or 
aryl) semicarbazide 
4) -CNHNHC-NR2 secondary amine 97% 51 11 11 
0 0 
1-acyl-4, 4-dialkyl-
semi carbazide 
Because our synthesis of oxadiazolones from biuret derivatives is 
novel we were keen to apply the technique to less complex derivatives than 
the ones we had used, to examine the generality of the method. A search 
of the literature failed to unearth any simple ~-acylaminobiurets of 
structure (168) which would have been suitable precursors for our purpose. 
f 
R-CNHNHCNCNHR 
11 11 11 
0 tl 0 
(168) 
Accordingly, we had to synthesise such precursor biurets ourselves 
and this meant starting from simple hydrazides. 
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Initially we considered benzoic acid hydrazide (169} to be a suitable 
starting point and we endeavoured to convert this into ,the appropriate 
biuret (171) by refluxing with an excess of phenylisocyanate in dry 
xylene for 24 h., these being analogous conditions to those'we had used 
with the bridged thebaine hydrazide (90) in the production of biurets 
(156) and (160}. 
O CNHNH 11 2 0 Ph NCO O CNHNHCNHPh g B 
(169) (170) l PhNCO 
0 Ph CNHNHCNCNHPh 11 11 11 0 0 0 
(171) 
A substantial amount of a colourless crystalline compound was isolated 
from this reaction and its mass spectrum gave a molecular ion at m/e 255 
which corresponded to 4-phenyl-1-benzoylsemicarbazide (170) (c14H13N3o2). 
This is a known compound and our melting point, 211-212°C, matched the 
literature value {212°c105a). The yield of the semicarbazide was high 
(84%) and no trace of the biuret (171) could be detected. 
We therefore turned to an alicyclic hydrazide to represent a closer 
analogy to our system, using cyclohexane carboxylic acid hydrazide (174). 
We made this hydrazide from the corresponding acid, (172) ,via the methyl 
ester (173}. 
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0f10H 
. 0 
NHNHO 2 2 CNHNH 
EtOH ~ 2 
(172) (173) (174) 
The hydrazide had m.p. 156.5-158.5°C, in close agreement with the 
0 106 literature value, 158-159 C. The n.m.r. spectrum showed an 11 proton 
multiplet at ol.5 (C6H11 ) with exchangeable protons at <53.99 (NH2) ,and 
68.15 (NH). The i.r. spectrum contained a hydrazide carbonyl at 1630 cm-l. 
The hydrazide was then converted smoothly into the biuret (175) 
by refluxing it with an excess of phenylisocyanate in dry xylene. 
excess 
Ph NCO 
reflux 0f1NHNH2 
0 
( 174) dry xylene 
l PhNCO EtOH 
~NHNHCNHPh 11 0 0 
(176) 
0 Ph CNHNHCNCNHPh 11 11 ll 0 (175) 0 0 
!:::,. xylene 
The product (175) precipitated after several hours as a colourless 
crystalline compound m.p. 171-184°C from the boiling xylene. Its i.r. 
spectrum displayed NH (3345 cm-1) and carbonyl absorption (1732 and 
1695 cm-1), and the n.m.r. spectrum showed, in addition to an 11 proton 
multiplet (61.65, c6H11 ) and broad signals at ol0.03 (NH) and <510.30 
(2xNH), 10 phenyl protons ( 67 .28). The 1-cyclohexyl carbonyl amino-3, 5-
diphenylbiuret (175) also gave a satisfactory microanalysis. · 
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Mass spectral analysis of (175) was of interest. The expected 
molecular ion at m/e 380 only appeared on the UV chart at low resolving 
power when the sample pressure was high and the lower m/e values were 
overloaded. In consequence the mass of m/e 380 could not be measured 
accurately since the instrument's data system automatically deletes peaks 
with abundances less than 1% of the base peak. 
The base peak, at m/e 119, was measured accurately as c7H5NO, 
corresponding to phenylisocyanate. Two other important fragments were 
m/e 168 (7%) (C8H12N2o2), which corresponds to the oxadiazolone (177), 
and m/e 142 (21%) (C7H14N20) which corresponds to the starting hydrazide 
(174). These fragmentations are shown below. 
0 7H 
O~NH 
]""'-'--"" H N' [N pt( :){ "rh 
0 
mJe380 (<0·1%) 
H fh 
t1Jt-CONHPh 
KyNH 
0 1/ 
0 
m/e 380 (<0·1 l 
t 
+ 
• 
NHNH2 
m{e 142 (21 %) 
2 X PhNCO 
mJe 119 (100%) 
0;=~ 
oyNH 
0 
mfe 168 (7%) 
+ 
• 
+ 
. 
FhNHCONHPh 
mfe 212 . 
(not seen) 
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To differentiate the reaction conditions needed to give the biuret 
(175) from those to obtain the semicarbazide (176) we found that the 
latter could be formed at room temperature from one mole of phenyl isocyanate 
in ethanol. 
PhNCO o 8NHNH§NHPh 
(176) 
The semicarbazide crystallised as colourless needles, m.p. 201-201.5°C. 
The n.m.r. spectrum of this compound showed only 5 aromatic protons 
(o7.32) as well as 3 NH's (~7.87, 8.60 and 9.48) and an 11 proton multiplet 
at ol.5. A satisfactory microanalysis was given. 
Before proceeding to attempt the conversion of our simple biuret 
into 2-cyclohexyl-1, 3,4-oxadiazol-5-one we required a sample of this 
oxadiazolone prepared by an alternative unambiguous route. We therefore 
reacted the hydrazide (174) with phosgene and after work-up obtained a 
colourless oil with the i.r. characteristics expected for an oxadiazolone, 
i.e. NH (3290 cm-1) and C = 0 (1780 cm- 1 )~3aUnfortunately this oil was 
very difficult to crystallise. A satisfactory microanalysis was obtained 
on the oil. Furthermore the m.s. showed the required molecular ion for 
(177) at m/e 168. 
·OiNHNH2 
. 0 
(174) ( 177) 
When we attempted to produce the cyclohexyl-oxadiazolone by sublimation 
of the biuret (175) we found that only a small amount of material was 
collected on the cold finger of the sublimation apparatus. The i.r. 
showed this to be a complex mixture and the peak at 1780 cm-l was of very 
weak intensity showing that, at best, only minimal oxadiazolone formation 
was occurring. 
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For this reason we elected instead to try and effect the cyclisation 
by thermolysis in a solvent. 
We chose xylene as the solvent because of its high boiling point 
and refluxed the biuret (175) in sodium dried xylene for 17 h. On 
evaporation of the solvent an oil was given. This was washed with 
chloroform and insoluble material separated out which was identified by 
its i.r. spectrum as ~-diphenyl-urea (vmax (nujol), 3310, 1650, 1600 cm-1), 
PhNHCONHPh. Evaporation of the chloroform extract gave a colourless oil 
the i.r. spectrum of which (vmax' 1780 cm-1, C = 0) contained all the peaks 
of the i.r. spectrum of the 2-cyclohexyl-1, 3, 4-oxadiazol-5-one as prepared 
by the phosgene route mentioned above, although some impurities were present 
which could not be completely removed. 
The sample of the oxadiazolone from the biuret sublimation showed 
the expected molecular ion at m/e 168. In addition there were a few peaks 
of low intensity at higher m/e values which could not be counted. The 
impurities presumably accounted for the slight differences in the i.r. 
spectra of the two samples obtained by differing routes. The oxadiazolone 
from the biuret route could not be further purified even after careful t.l.c. 
Despite the purification difficulties met with our examples the 
new method of formation of oxadiazolones by the thermally induced cyclis-
ation of ~-acylaminobiurets has two advantages over the alternative 
phosgene route. Firstly, our route involves essentially neutral conditions 
whereas the phosgene method involves the production of two moles of HCl, 
and secondly, the isocyanates used are much less toxic than phosgene. 
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Part 5 Attempted Synthesis of 1, 3, 4-Thiadiazoles and 7e-Thevinoic Acid 
A. Attempted synthesis of 1, 3, 4-thiadiazoles 
1-Acylthiosemicarbazides have been cyclised under acid conditions to 
give 5-amino-1, 3, 4-thiadiazoles. 40 • 52 We attempted such a cyclisation 
with the phenyl-thiosemicarbazide (178) (the preparation of which was 
discussed on p.l04) by dissolving the compound in concentrated sulphuric 
.acid and stirring for 1 h. 
~ 
".Jf CHp 
-
oANHNHCNHPh 
11 
s 
(178) 
CHp 
~~ 
NHPh 
(179) 
After basification of the solution, extraction into chloroform gave 
no products whatsoever. This may have been because the 6, 14-endo-
ethenotetrahydrothebaine system was destroyed by the relatively severe 
reaction conditions. If that was the case then the use of a milder dehydratin, 
agent, such as acetyl chloride, may give a more positive result. 
We attempted another thiadiazole synthesis by refluxing the diacyl-
hydrazine (98b)with phosphorus pentasulphide in dry pyridine for 24 h. 63 
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cH
3 
pyridine 
reflux 
CH30 
~~ 
CH3 
(98b) (180) 
After work-up a brown oil containing a considerable amount of 
sulphur impurity was obtained. This was subjected to column chromato-
graphy over alumina but was still a brown oil. The infrared spectrum 
revealed an impurity present with a strong band at 1725 cm-1• The 
impurity could not be removed satisfactorily. Otherwise, the spectral 
data were in accord with the expected 5-methyl-1, 3, 4-thiadiazole (180). 
The n.m.r. showed no exchangeable protons and, in addition to methyl signals 
at o3.73 (C30CH3), o3.43 (c6ocH3) and o2.33 (NCH3), there was a methyl 
resonance at o2.61, in the typical range for a 5-methyl group of a 1, 3, 4-
thiadiazole ring e.g. o2.62 for 2-amino-5-methyl-1, 3, 4-thiadiazolelOBa and 
o2.73 for 2, 5-dimethyl-1, 3, 4-thiadiazole.lOBb The mass spectrum gave 
the expected molecular ion at m/e 437 (c24 H27 N3o3s). Furthermore, the 
i.r. showed the absence of NH of the starting material (98b). There was 
a peak of medium int~nsity at 1630 cm-l which compares favourably with the 
peak at 1640 cm-l (C = N) in 2-amino-5-methyl-1, 3, 4-thiadiazole. 109a 
The product was not obtained analytically pure. 
B. Attempted synthesis of 7~-thevinoic acid 
We record finally a brief attempt to obtain 7a-thevinoic acid from 
the ?a-nitrile. 
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Almost all of the publishedwork on Diels-Alder adducts of thebaine 
with unsymmetrical dieneophiles concerns the 7a-epimers. This is because 
in most of the Diels-Alder cycloadditions the small amounts (usually <5%) 
of 7s-isomer produced are not isolated. Also, the main products, the 
C-7a-epimers, normally retain their ?a-stereochemistry through successive 
transformations. 
However, in the Diels-Alder reaction between·thebaine and acrylonitrile 
the 7S-epimer has been isolated in a relatively large amount(~ 40%). 15 
(See also discussion p 15). We wished to use the 7S-nitrile to obtain a 
substantial amount of the 7s-hydrazide. This would permit routes to the 
C-7S-heterocyclic compounds to be pursued that had worked successfully 
with the ?a-hydrazide (90). If this were achieved, the pharmacological 
results for each pair of C-7 epimers would provide important evidence 
I 
about the role of C-7 stereochemistry in determining the analgesic activity. 
This correlation is so far unclear. 17a 
We envisaged hydrolysis of the 7s-nitrile to the 7s-acid (182) which 
could then be converted to either the acid chloride (183) or ester (89) 
and so to the 7s-hydrazide (91). 
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We produced the 7a- and 7a-nitriles by Diels-Alder reaction of 
thebaine and acrylonitrile15 and separated out some of the pure ?a-nitrile 
(lBlb) in 17% yield. The hydrolysis of neither epimer has been reported 
before. 
Earlier we reported the successful hydrolysis of the 7a-methyl 
thevinoate ester with concentrated hydrochloric acid (pl02). 
With the ?a-nitrile (18lb), however, we found starting material 
was recovered unchanged after 10 h. reflux in concentrated hydrochloric 
acid. Base catalysed hydrolysis was not attempted because the ?a-nitrile 
is known to rearrange in base. 31 
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Part 6 Pharmacology 
Thirtyseven of the new 6, 14-endo-ethenotetrahydrothebaine derivatives 
we prepared, including both the C-7 heterocyclic compounds and their open-
chain precursors, were eva~uated for analgesic activity by the 
Pharmaceutical Division of Reckitt and Colman Ltd., Hull. 
Df the 37 compounds evaluated, 18 carried open-chain substituents 
at position-7 of which two had la-stereochemistry and 16 had la-
stereochemistry. The remaining 19 compounds had a 7a-heterocyclic ring 
attached, of which four were 1, 2, 4-triazol-(lH)-5-thiones and 15 were 1, 3, l 
oxadiazoles. Of these latter 15, five had non-polar substituents at position-
S of the oxadiazole ring and the remaining ten carried polar C-5 substituents. 
The compounds were assessed pharmacologically by two tests namely, the 
Henderson and Forsaith writhing test .(Hand F),110 and the rat tail pressure 
test (RTP). 111 The former test involves the ability of the drug to reduce the 
number of writhes in mice following intraperitoneal injection of phenyl-£-
quinone. In the latter test the analgesia is measured by the abolition of 
the struggling or squeaking response to tail pressure. Of the two tests, the 
RTP test is generally taken as being the more important. 
All of the compounds were evaluated by the H and F test and most, 
particularly those showing significant activity, by the RTP test also. 
The compounds were administered by the subcutaneous route and the 
results are expressed as the Eo50 , the dose in mg/kg of body weight that 
produced a significant effect in 50% of test animals. 
The results are listed overleaf. 
(Numbers given in parenthesis are 95% confidence limits). 
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All the compounds had the structure as below. 
R 
A. Compounds with ?~-stereochemistry 
Entry No. Text No. R H and F test RTP test 
ro50 mg/kg E050 mg/kg 
1 (89) 
OAOCH3 
3.5 >10 
2 (91) 
OANHNH2 
2.9 >10 
B. Compounds with 7a-stereochemistr~ 
i) Substituents with a carbonyl attached to C-7 
3 (149) 
o-0-NH 2 
11.5 >10 
-4 (98b) 
c(ANHNHCCH3 
>30 
11 
0 
5 (98c) 
o'l'\.NHNHCEt 7.1 >10 
11 
0 
= 
6 (153, R=CH 3) c(ANH NHCNHCH3 8.0 ,.10 11 
0 
7 (153, R=Et) oANHNHfiNHEt >30 
0 
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Entry No. Text No. R H and F test RTP test f!!so mg/kg f!!so mg/kg 
-
"' 
8 (153, R=Ph) cf'""NHNHCNHPh 
11 
>30 
0 
9 (151a) O~NHNHf1NHCH 3 >30 
s 
10 ( 151 b) O~NHNHCNHEt 
11 
7.0 >10 
s 
11 (151c) O~HNHCNHPh 11 >30 
s 
-
12 ( 125) d~HNHCSCH2Ph >30 11 
0 
13 ( 120) oANHNHCS6 K<D 3 >30 
11 
s 
= 
~ /SCH 3 
14 ( 137) 0 NHN=C 0.48 1.42 
(as HI salt) 'scH3 (1.04-1.93) 
A pH3 
15 (100) 0 NHN=C >30 
'cH3 
§ x3 
16 (1 03a) oAN-N o >30 oyyo 
CH3 CH3 
17 (156) f Ph >30 o'~\NHNHCNCNHPh 
11 11 
0 0 
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Entry No. Text No. R 
. 18 (160) 
ii) 1, 2, 4-Triazol-5-thiones 
Entry No. Text No. 
19 (136) 
20 (152a) 
21 (152b) 
22 (152c) 
iii) 1, 3, 4-0xadiazoles 
R 
~ N 
Et-N' I 
/r-NH 
s 
~ N 
Ph-N' I 
!r--NH 
s 
a) With non-polar substituents at position 5 
23 ( 102a) FN ~ H 
24 (102b) ~~ N 
CH3 
25 (102c) ~~ 
H and F test 
@so mg/kg 
>30 
H and F test f!4o mg/kg 
1.8 
>30 
>30 
9.0 
10 
2.2 
1.6 
RTP test 
f!4o mg/kg 
RTP test f!4o mg/kg 
>30 
10 
>30 
>30 
14.5 
(9.86--21.3) 
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Entry No. Text No. R 
-= N 
26 (102d) ~~ 
27 
Ph 
~-N 
(l02e) E~ 
.e-toly( 
b) With polar substituents at position 5 
. 28 (llOa) 
29 (121) 
30 (123a) 
31 ( 123b) 
32 (123c) 
33 (122) 
34 (134a) 
= 
c(-==N /r-~H 
s 
~~ 
SEt 
~~ 
SCH(CH3J2 
(Het\ 
\salt) 
fl and F test f!4o mg/kg 
0.175 . 
3.2 
>30 
25 
3 
8.8 
4.3 
RTP test 
~0 mg/kg 
0.7 
(0.4--1.24) 
2.05 
( 1 .40--2. 99) 
>30 
>30 
>10 
>10 
>30 
>10 . 
. Entr~ No. Text No. 
35 ( 134b) 
36 (134c) 
37 ( lll) 
Comparative values are: 
Morphine sulphate 
codeine phosphate 
pentazocine lactate 
nalorphine 
morphine 
HO 
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R 
~==~ 
) N 
d 
l-9 ) ~ 
<;5 
FN ~~ 
2 
pentazocine 
H and F test 
~0 mg/kg 
3.6 
3.7 
24 
H and F test 
ro50 mg/kg 
0.64 
5.6 
2.3 
codeine 
nalorphine 
RTP test 
~0 mg/kg 
11.5 
(6.46-20.5) 
>10 
>10 
RTP test 
:@so mg/kg 
2 
14 
18 
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The most active of our compounds was the 5-phenyl-1, 3, 4-oxadiazole 
(l02d), entry~. with ED50 Hand F 0.175 mg/kg; RTP 0.7 mg/kg; followed by 
the ~. ~·-dimethyl dithi ocarbazate ( 137), entry .'!i· with Eo 50 H and F 0.48 mg/k' 
RTP 1.42 mg/kg; and then the 5-Q-tolyl-1, 3, 4-oxadiazole (102e), entry 27, 
~ith ED50 H and F 3.2 mg/kg; RTP 2.05 mg/kg. The first two, therefore, are 
slightly more active than mOI'phine and the third marginally less so, all 
three being more active than codeine. No other compound had an Eo50 value 
in the RTP test of less than 10 mg/kg. 
What was immediately apparent from the data was that the majority 
(10) of the 18 open-chain derivatives were not active (H and F test Eo50> 
30 mg/kg) whereas the majority (15) of the 19 heterocyclic derivatives were 
active (Hand F test Eo50<30 mg/kg). 
This suggests that flexibility (of the chain) is not necessarily an asse 
with regard to binding properties at the receptor site, and that the increased 
rigidity (from the heterocyclic ring) can be an asset. To make the point 
clearer we can compare the results for entry i (98b) with entry 24 (102b), 
and for entry l! (15lc) with entry 22 (152c), as shown. 
0~'--NH oy~H 
CH3 
entry !±_ (9 8b) 
Hand F, ED50 >3 0 
= ~NH Ph-y~H 
s 
entry 11 (151c) 
Hand F,ED50 >30 
~~ 
CH3 
entry 24 (1 02 b) 
2·2 
: N 
Ph-N' I 
{;--NH 
entry 22 (152c ) 
9·0 
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With both pairs the open-chain unit can adopt a conformation similar 
(though obviously not identical) to the heterocycle shown, and yet the 
analgesic activities differ markedly. As we have mentioned earlier, the 
advantage of increased rigidity was proposed by Bentley in reporting the 
original thebaine Diels-Alder studies. 15 • 44 
Clear exceptions to this trend are the two open-chain compounds which 
are dithiocarbazate derivatives (entries }land !il and we discuss these 
later. Of the six other open-chain compounds, with H and F ED50 values ~12, 
three do not apparently fit into any well defined trend (entries~.~ and }Q), 
so further work on related analogues would be needed. The remaining three, 
entries l• ~and~ are all small substituents, namely, co2cH3, CONHNH2 and 
CONH2, for which the flexibility/rigidity argument is irrelevant. It 
is most interesting to note, however, that two of these cases, entries 
land~. are 7a-substituents (C02CH 3 and CONHNH2). 
Comparison of the four 1, 2, 4-triazol-(lH)-5-thiones, entries~ 
to 22, with the 1, 3, 4-oxadiazol-(4H)-5-thione, entry 29, suggests it is 
only advantageous to have the triazolthione system when the nitrogen 
flanked by the two ring carbons carries a strongly polar group, viz. 
NH2 (entry ]1, Hand F E050 1.8 mg/kg), in contrast to CH3 (entry 20, 
Hand F Eo50 >30 mg/kg), or carries a benzene ring (entry 22, Hand F ED50 
9.0 mg/kg). 
The most well defined pharmacological trends were observed in the 
15 compounds of the 1, 3, 4-oxadiazole series. 
1, 3, 4-0xadiazoles with polar groups at position 5 of the heterocyclic 
ring i.e. those with oxygen, nitrogen, or sulphur containing substituents, 
did not exhibit pronounced activity but it can be seen that compounds 
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containing an exocyclic double bond at position-S, i.e. entries 28, 29 
and ~· are markedly less active than the remaining compounds with the 
fully aromatic oxadiazole ring, e.g. compare entry 29 with entry 30. 
Addition of a large polar group to the N-atom adjacent to the thione 
grouping of entry 29 worsens the situation. 
entry 29 ( 121 ) 
H and F, Eo50 2-s--mg/kg 
~ N cF~-CH-n r 2\_/ 
entry 33 (122) 
Hand F, Eo50 >30 mg/kg 
= N ~I }===N 
SCH3 
entry 30 ( 123a) 
3 mg/kg 
N-Alkyl-substituents at the 5-position generally gave slightly more 
active compounds than did ~-alkyl-substituents (compare entries 34, 35 
and 36 with 30, IL and 32). The most active was the 5-piperidyl-1, 3, 4-
oxadiazole (134b), entry 35, which showed a potency equivalent to codeine 
in the RTP test. 
With non-polar substitutents at C-5, entries 23 to 27, the analgesic 
activity increased with increasing size of the substituent, reaching a 
peak at phenyl and declining slightly on progression to ~-tolyl i.e. 
~-tolyl~Ph>Et>CH3>fl. 
It is particularly interesting that the most active compound, viz. 
the 7a-(5-phenyl-l, 3, 4-oxadiazol-2-yl) -6, 14-endo-etheno-6, 7, 8, 14-
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tetrahydrothebaine (102d), entry 26, bears considerable structural 
similarity to one of the most potent analgesics in the bridged thebaine 
series, the phenethyl carbinol (25b), in that it too possesses a benzene 
ring separated from C-7 by a three atom chain. 
CHp CH 
(102d) (25b) 
The result suggests that in the phenyl-oxadiazole (102d), the 
phenyl ring interacts with the analgesic receptor in the same way as the 
so-called F-ring in the phenethyl carbinol (see Fig. 2, p.2l,and Plate l,p.147): 
Probably the most interesting and unexpected result was the very 
marked activity of the open-chain~. i'-dimethyldithiocarbazate (137), 
entry ]1. It showed an Eo50 in the H and F test of 0.48 mg/kg and of 
1.42 mg/kg in the RTP test, both values being better than those for 
morphine. The other dithiocarbazate, viz. the potassium salt (120), 
entry ll• was also active in the H and F test (Eo50 3 mg/kg) but not in 
the RTP (E050 >30 mg/kg). 
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CHp 
CHp 
,-::~ )3CH3 0/ '-NH-N-C . 
'scH3 
entry 14 (13 7) 
,----A---.. 
,,,, 
CH 0 ,JI' 
3 = oANHNH~s8 Ke 
s 
entry 13 (120) entry 15 (100) 
The rOle of sulphur in (137) is clearly crucial since the analogous 
hydrazone (lOO), entry~. was shown to be inactive. 
Consideration of molecular models of this compound (137) and of 
methionine-enkephalin were most instructive. They revealed that one of 
the i-methyl groups in the dithiocarbazate (137) can be oriented in a 
similar position in space in relation to the aromatic A-ring of (137), as 
can the i-methyl group in methionine-enkephalin in relation to the phenyl 
·,_ 
moiety of the tyrosine residue, (see Fig. 8 overleaf,and Flate2;p.l47a). 
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methionine-enkephalin (137) 
Fig. 8 
We suggest that this structural similarity probably accounts for 
the relatively high analgesic activity of the dithiocarbazate in comparison 
with the other open-chain compounds. To show this similarity the methionine-
,enkephalin is constructed with a a-turn incorporated, that is, with the 
constraint of H-bonding present between the tyrosine C=O and the phenylalanine 
NH (i.e. between the first and fourth amino-acid units of the peptide). 
This conformation has been suggested before for methionine-enkephalin. 22c 
It is the tightest turn a peptide can make consonant with maintaining the 
normal trans-coplanar stereochemistry of each amide link. 
The alternative H-bonding possibilities are a a-turn between units 
2 and 5,or between units 1 and 5. The latter is the type present in the 
a-helix peptide conformation. In neither of these possibilities can the 
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steric similarity between methionine-enkephalin and the dimethyldithio-
carbazate (137) be well demonstrated. 
It is not possible to say whether the two most active analgesics 
we have synthesised are binding at different analgesic receptors but the 
considerable difference between the phenyl-oxadiazole substituent of (102d) 
and that in the dimethyldithiocarbazate derivative (137) suggests this may 
be the situation. 
In view of our structural comparison between methionine-enkephalin 
and the dimethyldithiocarbazate (137) we feel that it would be of interest 
to synthesise the bridged-thebaine derivative (184) with a methionine unit 
attached at C-7. 
To put the discovery into perspective it should be pointed out 
that the analgesic activity of (137) and (102d) should be capable of 
being increased substantially by structural modification to the endo-
ethenothebaine moiety. 
In the bridged thebaine series it is a general observation that 
C-3 demethylation leads to a large increase in analgesic potency,4a 
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and reduction of the etheno-bridge to ethane givesa further increase. 
·Also,modification of the ring-0 nitrogen substituent is beneficial, for 
example, replacing the ~-methyl group with ~-cyclopropylmethyl as in 
buprenorphine (28) (p 18 ). 
The difference can be illustrated by reference to the C-7 pyrazole 
compounds reported in the patent34 discussed in the Introduction (pp. 30-33). 
CHP 
CH 
Ph-rf I 
'N-
(185) 
200 mg/kg 
Dose to elicit analgesia 
(~rithing test) 
Ph-l I 
'N-
(186) 
ED50 0·01 mg/kg 
(writhing test) 
The N-cyclopropylmethyl-oripavine (186) is ~ 20,000 times more 
active than the related ~-methyl-thebaine (185). 34 
Hence, if our findings are to be further developed such structural 
modifications of the endo-ethenothebaine moiety would have to be introduced. 
To this end, we very briefly, and unsuccessfully, looked at the C-3 
demethylation of three of our active compounds, namely the ~. ~·­
dimethyldithiocarbazate (137), the unsubstituted 1, 3, 4-oxadiazole 
(102a) and the 5-ethyl-1, 3, 4-oxadiazole (102c). Demethylation was· tried 
using both boron tribromide112 and potassium hydroxide methods. 20 • 113 
Each time, however, a complex mixture of compounds was given which could 
, I 
I 
' 
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not be purified. The n.m.r. spectra of these crude products suggested 
that some ring opening of the bridged thebaine unit might have been 
taking place. 
f'l~te 1. Co~hrane 1"'1ole.c.uJar Models of c.ompoL<nd (2.5b), top, and 
C.OO'V'\fOW"\cl (1 Ol.d). 
-147a-
~ ------- --------- - -- --- ---
Plate 2.. Coc:hrane Molec.u.lar l"'lod.els of c.om.potAnol (137), top, 
and Met- en kephalin. 
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EXPERIMENTAL 
The following conditions apply unless otherwise stated. 
Melting points were taken on a kofler hot-stage apparatus and are 
uncorrected. Proton magnetic resonance spectra were recorded by a Varian 
EM360A spectrometer (60-MHz) and a Perkin-Elmer R32 spectrometer (90 MHz) 
in solutions ofdeuterochloroform and/or DMSOd6 with tetramethylsilane as 
internal reference. All protons which were assigned as NH or NH2 were 
exchanged by o2o unless otherwise stated. The following abbreviations are 
used in the presentation of these spectra: s = singlet, d = doublet, q = 
quartet, t = triplet, m= multiplet, br = broad. 
Infrared spectra were recorded as KBr discs, nujol mulls, thin 
films or chloroform solutions by means of a Perkin-Elmer 177 grating 
spectrophotometer and the quoted absorbances are strong except where 
indicated (m= medium, w =weak). The ultraviolet spectrum was recorded 
on a Unicam S.P. 800 spectrophotometer. Mass spectra were obtained on an 
A.E.I. MS12 machine. Accurate mass measurements were carried out by 
P.C.M.U. on an A.E.I. MS50 machine. Elemental analyses were performed 
by the University of Manchester and the University of Nottingham. The 
University of Manchester also determined molecular weights by osmometry 
using a Mechrolab Vapour Pressure-Osmometer with chloroform as solvent. 
Column chromatography was, unless otherwise stated, on neutral 
alumina (Camag) of Brockmann activity I. Preparative layer chromatography 
was also on alumina, 0.75 mm layer, Merck GF254 • Activity Ill alumina 
when used for column chromatography was obtained by adding water (6 g) 
to activity I alumina (lOO g). 
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Commerical grade solvents and reagents were used except for the 
following which were.purified as follows.· Xylene and diethyl ether were 
distilled and dried over sodium wire. Chloroform and dimethylformamide 
were distilled and stored over molecular sieve (3A). Pyridine was distilled 
and stored over KOH pellets. Dry ethereal HCl was prepared by passing 
dry (cone. H2so4) hydrogen chloride gas into diethyl ether purified as above •. 
Nomenclature 
The systematic nomenclature of bases in the 6, 14-endo-etheno-
6, 7, 8, 14-tetrahydrothebaine series is cumbersome. Accordingly the 
trivial name thevinone was assigned to the ketone (23). 18a · 
CHp 
cf'cH3 
(23) 
thevinone 
CH30 '/ 
CHp 
cf''-oH 
(184) 
thevinoic acid 
We have made use of this simplified nomenclature and all of our 
compounds with a carbonyl group attached to position 7 have been given 
names derived from thevinoic acid (184). 
Other systematic nomenclature adopted in the Experimental section 
relates to esters of hydrazonic acid,114 e.g. H2NN = CR , and to esters of I 
OEt 
carbazinic acid, e.g. H2NNHC-0Et. The numbering of biuret derivatives is 11 
0 
123 45 
H2NCNHCNH2• For the sake of uniformity and ease of cross reference we 11 11 
0 0 
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have numbered the triazole and oxadiazole rings throughout such that the 
carbon not attached to the C-7 position of the bridged thebaine ';s 
' 
numbered 5, although this may, in some cases,break the normal "lowest 
numbers" rule. 
CHp CHp 
,A )s::=-5-.-~N 
R 4 
:3 
V N2 HN I r, 
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EXPERIMENTAL 
Part 1 Synthesis of 1, 2, 4-Triazines 
7a- and 7B- Methyl thevinoate, (88) and (89) respectively. 
Thebaine (50g, 0.16 m) was refluxed in methyl acrylate (lOO ml, 
1.109 m) for 10 h. The excess acrylate was removed under reduced pressure 
until separation of solid matter began. The solid was recrystallised 
from MeOH when the la-methyl ester (88) was obtained as colourless 
prisms (54g, 85%, m.p. 148-149°C, lit. m.p. 15 148°C).v~ax (nujol), 
1740 cm-l (C = 0). 
n.m.r. 90 MHz (CDC1 3), ol.45 (lH, m., H8a); 2.39 (3H, s, NCH3); 
3.64 (3H, s, c6-0CH3); 3.69 (3H, s, c19-0CH3); 3.48 (3H, s, c3-0CH3); 
4.60 (lH, s, H5a).; 5.57 (lH, d, J9Hz, H17); 5.89 (lH, d, J9Hz, H18); 
6.60 (2H, m, H1 and H2). 
The mother liquors were evaporated to dryness, dissolved in chloroform 
and columned over alumina with chloroform eluant. From the second 50 ml 
fraction a solid was obtained which after three recrystallisations from 
MeOH gave the 7B-methyl ester (89) as short colourless needles (4g, 8% 
0 m.p. 187-189 C). 
vmax (nujol) 1740 cm-l (C = 0). 
n.m.r. 90 MHz (CDC1 3), ol.55 (3H, m, H8a +two other protons); 2.39 
(3H, s, NCH3); 3.58 (3H, s, c6-0CH3); 3.76 (3H, s, c19-0CH3); 3.84 (3H,s, 
c3-0cH3); 5.21 (lH, d, J=lHz, H5B); 5.49 (lH, d, J =9Hz, H17); 6.07 
(lH, dxd, J9Hz, J~lHz, H18); 6.60 (2H, m, H1 and H2). 
Found C, 69.6; H, 6.9; N, 3.5%, c23 H27 N05 
requires C, 69.5; H, 6.85; N, 3.5%. 
- 152 -
7a-Thevinoic acid hydrazide (90) 
A mixture of the ?a-methyl ester (88) (25g, 0.0629 m), lOO% hydrazine 
hydrate (150 ml, =3m), and 2-ethoxyethanol (90 ml) was refluxed for 
9 ~.cooled and poured into water (200 ml). The precipitated base (90) 
was collected and recrystallised from abs. EtOH to give colourless 
needles of the ?a-hydrazide (17g, 68%, m.p. 115-l20°C, raised to 
131-138°C after 3 recrystallisations from abs. EtOH, lit m.p. 38 
205°C). 
vmax (KBr), 3420 cm-l (shld. at 3270 cm-1) (NH and NH2), 1630 cm-l (C = 0). 
n.m .. r., 90 MHz, (CDC1 3), ol.57 (lH, m, H8); 2.40 (3H, s, NCH3); 
3.48 (2H, br, NH2); 3.66 (3H, s, c6-0CH3); 3.74 (3H, s, c3-0CH3); 
4.54 (lH, d, J =1Hz, H5 ~); 5.60 (lH, d, J9Hz, H17); 5.95 (lH,dxd, J9Hz,J=1Hz 
H18); 6.60 (2H, m, H1 and H2); 7.58 (lH, s, br, NH). 
Calcd. for c22 H27 N3 o4; C, 66.5; H, 6.8; N, 10.6%: 
Found, C, 66.0; H, 6.8; N, 10.4%. 
7a-Thevinoic acid hydrazide (91) 
The ?a-methyl ester (89) (1.5g, 0.00378 m) was boiled in lOO% 
hydrazine hydrate (5 ml, = 0.1029 m) and 2-ethoxyethanol (3.8 ml) for 
8 h. The reaction mixture was cooled and an equal volume of water was 
added. On scratching, the ?a-hydrazide (91} crystallised out as colourless 
needles which were filtered off and recrystallised from water containing 
a small amount of EtOH (0.54g, 36% m,p. l06°C). 
vmax (nujol), 3310 cm-l (br, NH and NH2), 1650 cm-1 (C = 0). 
n.m.r., 90 MHz, (CDC1 3), 61.52 (3H, m, H8a + 2 others); 2.37 (3H,' 
s, NCH3); 3.67 (3H, s, c6-ocH3); 3.84 (3H,s, c3-0CH3); 3.98 (2H, s, br, 
NH2); 4.97 (lH, d, Jl.5Hz, H56); 5.55 (lH, d, J9Hz, H17); 5.99 (lH, dxd, 
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J9Hz, Jl.5Hz, H18); 6.55 (2H, m, H1 and H2); 7.90 (lH, s, NH). 
Found C, 63.2; H, 6.8; N, 9.8%; c22 H27 N3 04• H20 
requires C, 63.6; H, 7.0; N, 10.1%. 
Attempted preparation of l-phenyl-2-(7a-thevinoyl)-hydrazine (94) 
The 7a~ethyl ester (88) (4g) was refluxed with phenyl-hydrazine 
(4.32g) in 2-ethoxyethanol (50 ml) for 7 days. The mixture was then 
evaporated to an oil and triturated with diethyl ether at 0°C. The 
starting ester (3.8g) was precipitated and no other product detected. 
Attempted preparationof 7a-thevinoic acid hydrazide (90) under dry conditions 
2-Ethoxyethanol was dried over anhydrous K2co3 and then fractionated 
after removal of the desiccant. The fraction b.p. 131-134°C/760 mm 
was used. 
The 7a~ethyl ester (88) (25g, 0.0629m), dried hydrazine, 100% 
hydrazine hydrate (150 ml) decanted from KOH (150g) after standing for 
18 days, and 2-ethoxyethanol (150 ml) were refluxed for 4 h. At this 
stage t.l.c. (Al 2o3/CHC1 3) showed $CVeral compounds but no starting 
material. Attempts to obtain pure compounds by column chromatography 
etc •. resulted in non-crystalline mixtures only. 
7a- and 7a- (5, 6-0iphenyl -1, 2, 4-triazin-3-yl) -6, 14-endo-etheno-
6, 7, 8, 14-tetrahydrothebaine (95a) and (95b) respectively. 
Benzil (0.264g, 0.001257 m) and the ?a-hydrazide· (90), 
(0.50g, 0.001259 m) were warmed in glacial acetic acid (10 ml) at· 
60°C for 5 min. Excess ammonium acetate (5g, 0.075 m) was then added 
and the solution refluxed for 0.5 h. The soln. was basified with 
sodium hydroxide soln. (to pH14) and extracted into chloroform which 
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was dried (MgS04) and evaporated to dryness in vacuo. The residue (130 mg) 
was separated on several 1 metre t.l.c. plates (0.75 mm alumina, eluted 
with 20% V/V ethyl acetate in toluene). The two major components were 
the la-triazine (95a) and the less polar 7a-triazine (95b). These were 
eluted off the plates with chloroform and were both obtained as non-
crystalline colourless solids. la-triazine (95a) (77.8 mg, 11%). 
n.m.r. 90 MHz (CDC1 3), o2.40 (3H, s, NCH3); 3.60 (3H, s, c6-0CH3); 3.85 
(3H, s, c3-ocH3); 4.93 (lH, s, H5a); 5.65 {lH, d, J9Hz, H17); 5.87 
(lH, d, J9Hz, H18); 6.60 (2H, m, H1 and H2); 7.4 (10 H, m, 2xPh). 
7a-triazine (95b) (31.7 mg, 4%) 
n.m.r. 90 MHz (CDC1 3), o2.40 (3H, s, NCH3); 3.62 (3H, s, c6-0CH3); 
3.85 (3H, s, c3-0CH3); 5.46 {lH, s, H5a); 5.61 (lH, d, J9Hz, H17); 
6.32 (lH, d, J9Hz, H18); 6.60 (2H, m, H1 and H2); 7.4 (10 H, m, 2xPh). 
7a- and 7a- (5, 6-Dimethyl -1, 2, 4-triazin-3-yl) -6, 14-endo-etheno 
-6, 7, 8, 14-tetrahydrothebaine, (96a) and (96b) respectively, and by-
product (97). 
Method as for 5, 6-diphenyl -1, 2, 4-triazines (95a) and {95b) 
but using diacetyl (O.l082g, 0.001259) instead of benzil. On attempted 
separation by preparative t.l.c. band 1 (least polar) was found to be 
a mixture of la-dimethyl triazine (96a) and 7a-dimethyl triazine (96b) 
by n.m.r. 
n.m.r., 90 MHz (CDC1 3), o2.38 (6H, s, 2xNCH3); 2.46 (3H, s), 2.54. 
(3H, s), 2.61 (3H, s), and 2.67 (3H, s) (methyl groups on triazine 
ring); 3.50 (6H, s, 2x C60CH3); 3.81 (6H, s, 2x c3ocH3); 4.84 (lH, s, 
H5a, a-epimer); 5.34 {lH, s, H5a, a-epimer); 5.51 - 6.31 (4H, m, H17 
and H18 olefinics); 6.60 (4H, m, H1 and H2 of both epimers). 
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Band 4, however, gave a crystalline solid (97) (60 mg, needles, 
m.p. 266-267°C from EtOH). 
"max (nujol), 3460 cm-l (shld at 3270 cm-1) (NH), 1675 cm-l (C = 0}. 
n.m.r. 90 MHz (CDC1 3), ~2.19 (3H, s, CH3 adjacent to C = 0}; 2.40 
(3H, s, NCH3); 3.73 (3H, s, br, c6ocH3); 3.86 (3H, s, c3-0CH3); 4.62 
(lH, s, H5 ~); 5.62 (lH, d, J9Hz, H17); 5.98 (lH, d, J9Hz, H18); 6.61 
(2H, m, H1 and H2); 9.02 (25%) and 9.71 (75%) (lH, br, NH). 
Accurate measured mass, 533.2630, c29 H35 N5 05 requires 533.2638. 
Found, C, 66.4; H, 6.5; N, 9.4%, c29 H35 N5 05 
requires,C, 65.3; H, 6.6; N, 13.1%: c25 H29 N3 o5 
requires C, 66.5; H, 6.5; N, 9.3%. 
The structure of this by-product is not known. 
l-Acetyl-2-(7a-thevinoyl)-hydrazine (98b) 
The la-hydrazide (90) (4.0g, 0.01008 m) was refluxed in glacial 
acetic acid (50 ml) for 1 h. The resulting soln. was basified with 
sodium hydroxide soln. to pH7 (checked by narrow range indicator 
paper) and extracted with chloroform. After drying (K2co3) and evaporation 
the residual gum was triturated with ethyl acetate/diethyl ether and the 
solid produced was recrystallised from ethyl acetate containing a small 
amount of MeOH. The N-acetylhydrazide (98b) was collected as colourless 
needles (3.9g, 88%, m.p. 153-156°C). 
"max (nujol), 3225 cm-l (br, NH), 1605 cm-1 (br, C = 0). 
n.m.r. 90 MHz, (CDC1 3), ~2.04 (3H, s, CH3 adjacent to C = 0); 2.38 
(3H, s, NCH3); 3.68 (3H, s, c6-0CH3); 3.84 (3H,s, c3-0CH3); 4.56 (lH, s, 
H5 ~); 5.57 (lH, d, J9Hz, H17 ); 5.94 (lH, d, J9Hz, H18), 6.59 (2H, m, 
'111 and H2) ; 9. 36 ( 2H, s, br, 2xNH) • 
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Found, C, 65.7; H, 7.1; N, 9.4%, c24 H29 N3 05 requires, C, 65.6; 
H, 6.65; N, 9.6%. 
1-Propionyl-2-(7~-thevinoyl)-hydrazine (98c) 
The 7~-hydrazide (90) (3.0g, 0.00756 m) was refluxed in propionic 
acid (50 ml) for lh., after which the solution was basified to pH7.5 
with ammonia solution and extracted into chloroform. The chloroform 
extract was dried (~co3 ) and evaporated to a colourless oil. Trituration 
of the oil with ethyl acetate gave the N-propionylhydrazide (98c) as short 
colourless needles (2.44g, 59%), recrys.from ethyl acetate as long 
colourless needles m.p. 128-131°C. 
v (nujol), 3215 cm-l (NH), 1608 cm-l (C = 0). 
max 
n.m.r. 90 MHz, (CDC1 3), ol.l6 (3H, t, J7Hz, CH3 of Et); 1.61 (lH, 
m, H8~); 2.32 (2H, q, J7Hz, CH2 of Et, partly obscured by o2.37)~ 
2.37 (3H, s, NCH3); 3.68 (3H, s, c6-0CH3); 3.84 (3H, s, c3-0CH3); 
4.57 (lH, s, H5a); 5.55 (lH, d, J9Hz, H17); 5.93 (lH, d, J9Hz, H18); 
6.58 (2H, m, H1 and H2); 9.60 (2H, s, br, 2xNH). 
Found, C, 65.1; H, 7.1; N, 9.1%, c25 H31 N3 05• O.SH20 
requires, C, 64.9; H, 7.0; N, 9.1%. 
1-Formyl-2-(7~-thevinoyl}-hydrazine (98a) 
The 7~-hydrazide (90) (l.Og, 0.00252 m) was refluxed in formic 
acid (10 ml) for 48 h. The solution was then basified to pH7 (with 
sodium hydroxide solution) and extracted into chloroform. After drying 
(K2co3) and evaporation the N-formylhydrazide (98a) was obtained as a 
colourless foam (0.57g, 53%) which resisted all attempts to crystallise 
it. 
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vmax (nujol), 3500 cm-1, 3260 cm-l (NH), 1710 cm-1, 1665 cm-l, 1635 cm-1 
(C = 0). 
n.m.r. 90 MHz, (CDC1 3), 62.36 (3H, s, NCH3); 3.68 (3H, s, c6-0CH3); 
3.83 (3H, s, c3-0CH3); 4.54 (lH, s, H5a); 5.67 (lH, d, J9Hz, H17); 
5.93 (lH, d, J9Hz, H18); 6.57 (2H, m, H1 and H2); 8.04 (80%) and 8.12 
(20%) (1 H total, H of formyl group); 9.35 (lH, s, NH). Only one NH 
was observed in the spectrum: the other may not have been picked up due 
to an indistict integral trace. 
Na(7a-Thevinoyl) acetone hydrazone (lOO) 
The ?a-hydrazide (90) (l.Og, 0.00252 m) was refluxed in acetone 
(50 ml) for 1 h. The solution was then evaporated under reduced pressure 
until solid began to precipitate. The hydrazone (lOO) was collected,by 
filtration (0.89g, 81%, colourless microcrystals m.p. 228-230°C from 
ethyl acetate). 
vmax (nujol), 3210 cm-l (NH), 1672 cm-l (C = 0). 
n.m.r. 90 MHz, (CDC1 3), ol.87 (3H, s, CH3 next to C = N); 2.08 (3H, s, 
CH3 next to C = N); 2.39 (3H, s, NCH3); 3.69 (3H, s, c6-ocH3); 3.86 
(3H, s, c30CH3); 4.61 (lH, s, H5a); 5.59 (lH, d, J9Hz, H17); 
5.93 (lH, d, J9Hz, H18); 6.60 (2H, m, H1 and H2); 8.49 (20%) and 9.28 
(80%) (lH total, NH). 
Found, C, 68,3; H, 7.1; N, 9.4%, c25 H31 N3 04 requires C, 68.6; 
H, 7.1; N, 9.6%. 
Accurate measured mass, 437.2314; c25 H31 N3 o4 requires 437.2315. 
- 158 -
Part 2 Synthesis of 1, 3, 4-0xadiazo1es 
7a-(1, 3, 4-0xadiazo1-2-y1)-6, 14-endo-etheno-6, 7, 8, 14-tetrahydrothebaine 
( l02a) 
The ?a-hydrazide (90) (2.0g, 0.00504 m) was refluxed in triethylortho-
fonnate (50 ml) for 24 h. The excess ortho-ester was removed under 
vacuum and the residue crystallised from ethanol to give the oxadiazole 
(102a) (1.4g, 70%,colourless plates m.p. 20l-203°C). 
-1 -1 
"max (nujol) 1632 cm (w), 1605 cm (w). 
n.m.r. 90 MHz (CDC1 3), 61.65 (lH, m, H8a); 2.38 (3H, s, NCH3); 3.55 
(3H, s, c6ocH3); 3.84 (3H, s, c3ocH3); 4.75 (lH, s, H5S); 5.67 (lH, d, 
J 9Hz, H17); 5.83 (lH, d, J 9Hz, H18); 6.70 (2H, m, H1 and H2); 8.43 
(lH, s, H of oxadiazole ring). 
Found, C, 68.0; H, 6.25; N, 10.1%, c23 H25 N3 04 
requires, c, 67.8; H, 6.2; N, 10.3%. 
?a-(5-Methyl-1, 3, 4-oxadiazol-2-yl) -6, 14-endo-etheno- 6, 7, 8, 14-
tetrahydrothebaine (l02b) via the ortho-ester route 
The ?a-hydrazide {90} (5.0g, 0.0126 m) was refluxed in triethylortho-
acetate (50 ml, ~ 0.378 m) for 24 h. The excess ortho-ester was removed 
in vacuo and the residue recrystallised from abs. ethanol to give the 
5-methyl -1, 3, 4-oxadiazole (102b) (4.54g, 86%, colourless rhombs, 
m.p. 204-205°C}. 
"max (nujol), 1640 cm-l (w), 1610 cm-1 (w), 1598 cm-1 (m). 
n.m.r. 60 MHz, {CDC1 3), 61.60 (1H, m, H8a); 2.35 (3H, s, NCH3); 
2.46 (3H, s, CH3 of oxadiazole); 3.50 (3H, s, c60CH3); 3.78 (3H, s·, c3ocH3); 
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4.68 (lH, s, H56);,5.58 (lH, d, J 9Hz, H17); 5.67 (lH, d, J 9Hz, H18); 
6.54 (2H, m, H1 and H2). 
Found, C, 68.0; H, 6.5; N, 9.8%, c24 H27 N3 04 
requires, C, 68.4; H, 6.5; N, 10.0%. 
7a-(5-Methyl-l, 3, 4-oxadiazol-2-yl) -6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (102b) from l-acetyl-2-(7a-thevinoyl) hydrazine {98b). 
The diacylhydrazine (98b) (400 mg, 0.000911 m) was refluxed in 
phosphorus oxychloride (20 ml) for 1 h. The solution was cooled and 
added in portions to ice (50g). This solution was neutralised with 
strong KOH solution (with cooling) to pH 7, then extracted into chloro-
form. The chloroform extract was dried (K2co3) and evaporated to give 
a foam. Most of the foam was taken up in hot diethyl ether and the 
ether was decanted off from a discoloured gum which remained. The ether 
was evaporated off to give a gum which on trituration with abs. ethanol 
gave colourless crystals of the 5-methyl-1, 3, 4-oxadiazole (102b) 
(0.139g, 35%, colourless rhombs m.p. 199-201°C from abs. EtOH). The 
sample had an identical ir spectrum to (l02b) as prepared by the ortho-· 
ester route described above, and the melting point was not depressed 
by admixture with a sample from that route. 
7a-(5-Ethyl-l, 3, 4-oxadiazol-2-yl) -6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (102c) 
The hydrazide (90) (2.0g, 0.00504 m) was refluxed in triethylortho-
propionate (50 ml) for 24 h. The solvent was evaporated in vacuo. and· 
the residual oil triturated with methanol to give crystals. These were 
filtered off and recrystallised from abs. ethanol to afford the 
5-ethyl-1, 3, 4-oxadiazole (102c) (0.92g, 42%, colourless rhombs, m,p. 
169-170°C). 
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vmax (nujo1), 1630 cm-1 (w), 1605 cm-1 (m). 
n.m.r. 60 MHz (CDC1 3), o1.40 (3H, t, J 7Hz, CH3CH2-); 
1.60 (1H, m, H8a); 2.45 (3H, s, NCH3); 2.87 (2H, q, J 7Hz, CH3CH2-); 
3.59 (3H, s, c6ocH3); 3.88 (3H, s, C30CH3); 4.75 (lH, s, H5 ~); 
5.70 (1H, d, J 9Hz, H17 ); 5.78 (lH, d, J 9Hz, H18); 6.64 (2H, m, H1 
and H2). 
Found, C, 68.9; H, 6.7; N, 9.6%, c25 H29 N3 04 
requires C, 68.9; H, 6.7; N, 9.65%. 
7a-(5-Phenyl-l, 3, 4-oxadiazol-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (102d) 
The 7a-hydrazide (90) (l.Dg, 0.002519 m) and trimethylorthobenzoate 
(6.4g, 0.03516 m) were refluxed in dry £-Xylene (20 ml) for 24 h. The 
solvent was removed in vacuo and methanol a~ded. The 5-phenyl-1, 3, 4-
oxadiazole (102d) crystallised out as colourless rhombs (m.p. 210-212°C) 
and was collected by filtration (~1.18g, ~100%). 
vmax (nujol) 1628 cm-l (w), 1604 cm-1 (w). 
n.m.r. 60 MHz (CDC1 3), ol.74 (lH, m, H8a); 2.37 (3H, s, NCH3); 
3.57 (3H, s, C60CH3), 3.83 (3H, s, c3ocH3), 4.75 (1H, s, H5~); 5.70 
(lH, d, J 9Hz, H17); 5.81 (lH, d, J 9Hz, H18); 6.60 (2H, m, H1 and 
H2); 7.46 (3H, m, aromatics of Ph); 7.95 (2H, m, aromatics of Ph). 
Found, C, 71.8; H, 6.0; N, 8.5%, c29 H29 N3 04 
requires C, 72.0; H, 6.05; N, 8.7%. 
7a-(5-p-Toly1-l, 3, 4-oxadiazol-2-y1)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (102e). 
The 7a-hydrazide (90) (2.0g, 0.00504 m) and trimethylorthO-£·toluoate73 
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(ll.Og, 0.056 m, b.p. 86-90°C/l mm Hg) were boilded in refluxing dry 
xylene (15 ml) for 24 h.' Excess solvent· was removed under vacuum on 
a hot water bath until solid began to appear. Diethyl ether (lOO ml) 
was then added and more solid was precipitated. This was filtered off 
and washed with diethyl ether to give the 5-£-tolyl-1, 3, 4-oxadiazole 
(102e) (0.56g). The filtrate was allowed to stand for several days 
and some of the starting hydrazide (90) crystallised out (0.50g 
collected by filtration). On standing for several more days additional' 
oxadiazole (102e) (0.47g) crystallised out. This gave a total of the 
5-p-tolyl-1, 3, 4-oxadiazole (102e) of 1.03g (55% based on recovered 
starting material, colourless rhombs, m-.p. 234-236°C from abs. EtOH). 
-1 -1 -1 -1 
"max (nujol), 1638 cm (w), 1625 cm (w), 1605 cm {w), 1595 cm {w). 
n.m.r. 60 MHz~ {CDC1 3), ol.6 {lH, m, H8a); 2.38 {6H, s, NCH3 and CH3 
of tolyl group); 3.55 {3H, s, c60CH3); 3.80 {3H, s, c3ocH3); 4.72 
{lH, s, H5S); 5.62 (lH, d, J9Hz, H17); 5.77 {lH, d, J9Hz, H18); 
6.56 {2H, m, H1 and H2); 7.15 {2H, m) and 7.80_ {2H, m, HAX protons of a 
£-disubstituted benzene). 
Found, C, 72.0; H, 6.4; N, 8.4%, c30 H31 N3 04 
requires C, 72.4; H,'6.3; N, 8.45%. 
1, 2, 2-Triacetyl-l-(7a-thevinoyl) hydrazine (103a) 
The diacylhydrazine (98b) {0.5g, 0.00114 m) was refluxed _in acetic 
· anhydride (25 ml) for 4.5 h. The solvent was then taken off in vacuo · 
and an oil remained. This was dissolved in diethyl ether and stored at 
-20°C for 2 days during which time crystals of the tetraacylhydrazine (103a) · 
appeared. These were collected by filtration {0.24g, 39%, colourless 
needles, m.p. 186-187°C). 
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vmax (nujol), 1725 cm-l (shld. at 1740 cm-l (C = 0). 
1H n.m.r. 90 MHz (CDC1 3), ol.35 (lH, m, Caa); 2.37 (6H, s), 2.41 
(3H, s) and 2.48 (3H, s, NCH3 and 3X CH3-~ = 0); 3.66 (3H, s, c60CH 3); 
3.85 (3H, s, C30CH 3); 4.48 (lH, s, H5a); 5.60 (lH, d, J 9Hz, H17); 
6.10 (lH, d, J 9Hz, H18) 6.60 (2H, m, H1 and H2). 
Accurate measured mass 523.2310, c28 H33 N3 07 requires 523.2319. 
m/e 524, 523, 347, 337 (base peak), 311, 190, 189, 162. 
Found, C, 64.1; H, 6.6; N, 7.9%, c28 H33 N3 o7 requires C, 64.2; H, 6.35; 
N, 8.0 %. 
15N n.m.r. (DMSO, CH3No2 external standard, (+0.0 ppm). Shifts to higher 
field are positive. Sample contained Cr (acac) 3.) + 191.6 ppm, 
+193.4 ppm, +200.4 ppm, +244.0 ppm. +352.4 ppm. 
Ethyl N-(7a-thevinoylamino)imidate (109). 
The la-hydrazide (91) (0.33g, 0.000831 m) was refluxed in 
triethylorthoformate (25 ml) for 24 h. The excess ortho-ester was 
removed in vacuo and the oily residue was dissolved in abs. ethanol 
(15 ml). The ethanol in turn was evaporated in vacuo and the residue, 
by now partly solid, was taken up in hot diethyl ether. Crystals of the 
la-hydrazone (109) separated out after several days and these were 
filtered off, (0.1424g, colourless microcrystals, m.p. 134-139°C). 
vmax (nujol), 3320 cm-l (NH), 1693 cm-l {C = 0), 1638 cm-l (C = N). 
n.m.r. 90 MHz (CDC1 3), o1.41 (3H, t, J 7Hz, CH3CH20); 2.38 (3H, s, br, 
NCH3); 3.57 (3H, s, br, c6ocH3); 3.83 (3H, s, c3ocH3); 4.18 (2H, q, 
J 7Hz, CH3CH20); 4.87 (lH, s, H5a); 6.59 (3H, m, H1, H2 and N = C~-OEt). 
+ Accurate mass measurements, M·, 453.2255, c25 H31 N3 05 
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requires, 453.2264. Base peak, 407.1854, c23 H25 N3 o4 requires 407.1845. 
7a-(1, 3, 4-0xadiazol-(4H)-5-one-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (110) from 7a-thevinoic acid hydrazide (90) and 
phosgene. 
The ?a-hydrazide (90) (S.Og, 0.0126 m) was dissolved in HCl 
solution (10 ml cone. HCl, 90 ml water) and phosgene was bubbled through 
for 5 h. The precipitated oxadiazolone monohydrochloride (llOa) was 
collected by filtration and recrystallised from ethanol-water (2.96g, 
51%, m.p. ~ 255°C decomp.). 
-1 e1 1 1 
vmax (nujol), ~ 2800 cm (br, NH), 1780 cm- (shld. at 1820 cm-) 
(C = 0), (n.m.r. compound insoluble). 
Found C, 60.5, H, 6.0; N, 9.0%, c23 H25 N3 o5• HCl requires c, 60.1; 
H, 5.7; N, 9.1%. 
The free base (llOb) was obtained from the hydrochloride salt 
(llOa) after basification with ammonium hydroxide and extraction into 
chloroform. Evaporation of the chloroform afforded the free base (llOb) 
in poor yield as a colourless glass which could not be crystallised. 
vmax (nujol), 3250 cm-l (br, NH), 1780 cm-l (shld. at 1815 cm-1) 
(C = 0). 
n.m.r. 90 MHz (CDC1 3), ~2.38 (3H,_ s, NCH3}; 3.59 (3H, s, C60CH3);, 
3.84 (3H, s, c3ocH3); 4.65 (lH, s, H5 ~); ~5.3-6.0 (2H, s, br, NH + 
impurity?); 5.60 (lH, d, J 9Hz, H17); 5.83 (lH, d, J 9Hz, H18); 6.59 
(2H, m, H1 and H2). 
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The free base (llOb), dissolved in the minimum amount of chloroform, 
could be converted back to the crystalline monohydrochloride (llOa) 
by treating with dry ethereal HCl. 
7a-(5-Arnino -1, 3, 4-oxadiazol-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (111). 
The 7a-hydrazide (90) (10.0 g, 0.0252 m) and cyanogen bromide (2.9 g, 
0.0275 m) were refluxed in methanol (125 ml) for 2h. The solvent was 
evaporated off in vacuo and water (125 ml) was added. The solution was 
basified (~ pH9) with cone. ammonia solution and extracted into chloroform, 
which was washed with water. Finally, the chloroform layer was dried 
(~co3 ) and evaporated to a pink oil. The oil was dissolved up in the 
minimum of hot methanol containing a small amount of water. After storing 
at -20°C for one day 5-amino-1, 3, 4-oxadiazole (111) crystallised out and 
was collected by filtration (5.27 g, 50%, colourless needles, m.p. 143-146°C). 
vmax (nujol) 3300 cm-land 3150 cm-1 (N-H), 1650 cm-l (C = N). 
n.m.r. 60 MHz (CDC1 3), o1.55 (lH, m. H80 ); 2.33 (3H, s, NCH3); 3.49 
(3H, s, c60CH3); 3.77 (3H, s, c30CH 3); 4.63 (lH, s, H5 ~); 5.54 (lH, d, 
J9Hz, H17); 5.59 (lH, d, J9Hz, H18); 5.73 (2H, s, br, NH2, overlaps with 
o5.59); 6.56 (2H, m, H1 and H2). 
Accurate mass measurement, 422.1955, c23 H26 N4 o4 
requires 422.1954 
Found, C, 64.3; H, 6.2; N, 13.0%, c23 H26 N4 04• 0.5 H20 
requires C, 64.0; H, 6.3; N, 13.0%. 
Attempted preparation of 7a-(1, 3, 4-oxadiazol-(4H)-5-one-2-yl)-6, 14-
endo-etheno-6, 7, 8, 14-tetrahydrothebaine (110b) via a diazonium salt (112). 
The 5-amino-1, 3, 4-oxadiazole (111) (1.5 g, 0.00355 m) was dissolved 
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in lN hydrochloric acid (9 ml, 0.315 g HCl, 0.00863 m) and the solution 
cooled to <10°C. A cool aqueous solution of sodium nitrite (0.35 g, 0.00507 m) 
was added slowly with stirring. The temperature was kept below l0°c. 
Five minutes after all the sodium nitrite had been added the cooling was 
removed and the solution allowed to come to room temperature (20°C}. 
After stirring for 3h. the solution had turned yellow. The reaction mixture 
was basified (cone. ammonia), and extracted into chloroform which after 
drying (K2co3) and evaporation afforded a discoloured glass, the ir 
spectrum of which was identical with that of the starting material (111), 
(0.71 g, 47% recovery). 
7a-(l, 3, 4-0xadiazol-(4H)-5-thion-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (121). Method 1. 
The 7a-hydrazide (90) (1.0 g, 0.00252 m) was added to a solution of 
potassium hydroxide (0.1414 g, 0.00252 m) in abs. ethanol (130 ml) at 
room temperature. An excess of carbon disulphide (1.0 g, ~ 0.0125 m) 
was quickly added and the mixture was refluxed until evolution of hydrogen 
sulphide ceased(~ 10 hJ. The solvent was taken off in vacuo and the 
residue dissolved in hot ethanol and filtered. The oxadiazolthione (121) 
crystallised out from the filtrate on cooling as colourless needles (0.77 g, 
60%, m.p. 258-260°C after three recrystallisations from ethanol). 
vmax (nujol) 3440 cm-1 (br, NH) 
n.m.r. 90 MHz (CDCl 3/DMSOd6 50:50) &1.59 (lH, m, H8a); 2.36 (3H, s, NCH3); 
3.53 (3H, s, c6ocH3); 3.80 (3H, s, c3ocH3); 4.73 (lH, s, H5e); 5.58 
(lH, d, J9Hz, H17); 5.76 (lH, d, J9Hz, H18); 6.59 (2H, m, H1 and H2). 
o2o exchange was not possible as the compound precipitated, therefore the 
NH proton could not be located. 
Accurate measured mass, 439.1543 c23 H25 N3 o4 S 
requires 439.1566 
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Found, C, 59.4; H, 5.8; N 8.9%, c23 H25 N3 04 S. 1.5 H20 
requires C, 59.2; H, 6.05; N. 9.0%. 
7a-(l, 3, 4-0xadiazol-(4H)-5-thion-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (121). Method 2. 
Carbon disulphide (6.0 g, 0.0789 m) and the 7a-hydrazide (90) 
(6.0 g, 0.0151 m) were boiled in refluxing dry pyridine (125 ml) for 20 h. 
The solvent was removed in vacuo and methanol (lOO ml) added to the dis-
coloured residue. Most of the material went into solution but some colour-
less crystals remained undissolved. After heating for 5 minutes on a 
steam bath further colourless cyrstals were precipitated out. These were 
filtered off and washed with methanol to afford the oxadiazolthione (121) 
(6.38 g, 96%, m.p. 248-252 °c) identical, (ir spectrum), with the product· 
from the method 1 above and pure enough for further use. 
V · -1 
max (nujol), 3440 cm (br, NH). 
Formation of the Mannich base 7a-(4-(4-morpholinomethyl)-l, 3, 4-oxadiazol-
(4H)-5-thion-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-tetrahydrothebaine (122). 
To a stirred suspension of the 1, 3, 4-oxadiazol-5-thione (121) 
(1.0 g, 0.00228 m) in ethanol (10 ml) was added formalin (0.19 ml of a 
40% w/v soln., ~ 0.0025 m) and morpholine (0.1986 g, 0.00228 m). Stirring 
was continued for 1 h. at room temperature and then the solution was 
refluxed for lh. The solvent was removed in vacuo and the residue columned 
on alumina (10 g, act I) and eluted with chloroform until a dark band 
reached the bottom of the column. Evaporation of the eluate and trituration 
with diethyl ether gave the rnorpholino-Mannich base (122) (0.28 g, 20%, 
colourless rhombs or plates m.p. l98-200°C from ethanol). 
vmax (nujol), 1628 cm-l (m). 
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n.m.r. 90 MHz (CDC1 3), o2.39 (3H, s, NCH3}; 2.78 (4H, t, CH2•s next to 
nitrogen-in morpholine ring}; 3.61 (3H, s, c6ocH3}; 3.70 (4H; t, CH2's 
next to oxygen in morpholine ring}; 3.86 (3H, s, c3ocH3}; 4.66 (lH, s, 
H5a}; 4.95 {2H, s, N-CH2 -N}; 5.67 (lH, d, J9Hz, H17); 5.89 (lH, d, J9Hz, 
H18}; 6.62 (2H, m, H1 and H2}. 
Found, C, 62.2; H. 6.4; N, 10.1%, c28 H34 N4 o5s 
requires C, 62.4; H, 6.4; N, 10.4%. 
7a-(5-Methylthio-l, 3, 4-oxadiazol-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (123a) 
Methyl iodide (5.0 g, 0.0352 m), the 1, 3, 4-oxadiazol-5-thione 
(121} (5.0 g, 0.0114 m} and methanol (50 ml} were refluxed for 1 h. The 
solvent was evaporated in vacuo and the residue recrystallised from 
methanol containing a small amount of water to give the 5-methylthio-1, 3, 4-
oxadiazole (l23a) (4.5 g, 87%, colourless needles m.p. 186-187°C}. 
vmax (nujol} 1632 cm-l (m), 1608 cm-l (m), 1583 cm-1 (m}. 
n.m.r. 90 MHz (CDC1 3: DMSOd6 50:50), ol.57 (lH, m, H8a}; 2.37 (3H, s, NCH3}; 
2.68 {3H, s, SCH 3); 3.50 (3H, s, c6ocH3); 3.79 (3H, s, c30CH3}; 4.81 
(lH, s, H5a); 5.63 (2H, s, br, H17 and H18}; 6.60 (2H, m, H1 and H2}. 
Accurate mass measurement, 453.1714, c24 H27 N3 o4 S 
requires 453.1721. 
Found, C, 61.0; H, 5.8; N, 8.8%, c24 H27 N3 04 S. H20 
requires C, 61.0; H, 6.2; N, 8.9%. 
7a-(5-Ethylthio-l, 3, 4-oxadiazol-2-yl}-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (123b} 
The 1, 3, 4-oxadiazol-5-thione (121} (1.0 g, 0.00228 m} and ethyl 
iodide (2.2 g, 0.0141 m} were refluxed in abs. ethanol for 2 h. After 
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' evaporating the solution to dryness in vacuo the solid residue was dissolved 
in the minimum amount of methanol and passed down an alumina column 
(30 g, act I) eluted with chloroform. The first lOO ml of eluant gave an 
oil on evaporation. The oil was dissolved in methanol and stored at 
-20°C. After several days the 5-ethylthio-1, 3, 4-oxadiazole (123b) 
crystallised out and was collected by filtration (0.54 g, 51%, colourless 
rhombs, m.p. 125-126°C from diethyl ether). 
"max (.nujol) 1630 cm-l (w), 1595 cm-l (m), 1572 cm-l (m). 
n.m.r. 60 MHz (CDC1 3), ol.43 (3H, t, J7.5Hz, CH3 CH2S-); 2.35 (3H, s, NCH3); , 
3.16 (>4H, m, CH3CH2 S-and other protons);3.53 (3H, s, c6ocH3); 3.80 
(3H, s, c30CH3); 4.73 (lH, s, H5 ~); 5.65 (lH, d, J9Hz, H17); 5.78 (lH, d, 
J9Hz, H18); 6.62 (2H, m, H1 and H2). 
Found C, 64.1; H. 6.2; N, 9.1%, c25 H29 N3 04 S 
requires C, 64.2; H, 6.25; N, 9.0%. 
7a-(5-Isopropylthio-1, 3, 4-oxadiazol-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (123c) 
The 1, 3, 4-oxadiazol-5-thione (121) (1.5 g, 0.00341 m) and 2-iodo-
propane (2.5 g, 0.0147 m) were refluxed in 2-propanol (50 ml) for 18 h. 
After evaporation of the solvent the residue was dissolved in chloroform 
and applied to the top of an alumina column (30 g, act I). This was eluted 
with 20% v/v chloroform in diethyl ether. After ~ 350 ml of eluant had 
passed through fractions were obtained which on evaporation and trituration 
with diethyl ether afforded the 5-isopropylthio-1, 3, 4-oxadiazole (123c) 
(0.62 g, 38%, colourless stout needles m.p. 142-144°C raised to 144-145°C 
after recrystallisation from abs. ethanol). 
-1 1 
"max (nujol), 1625 cm (w), 1603 cm- (w), 1578 cm-1 (m). 
n.m.r. 60 MHz (CDC1 3), ol.43 (6H~ d, J7Hz, (CH3)2 CH-); 
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1.65 (lH, m, H8a' partly obscured by ol.43); 2.34 (3H, s, NCH3); 3.51 
(3H, s, C60CH3); 3.77 (3H, s, C30CH3); 4.67 (lH, s, H51l); 5.60 (lH, d, 
J9Hz, H17); 5.70 (lH, d,·J9Hz, H18); 6.53·(2H, m, H1 and H2). 
Found, C, 64.8; H, 6.6; N, 8.7%, c26 H31 N3 04 S , 
requires C, 64.8; H, 6.5; N, 8.7%. 
Benzylthiol ester of Nll-(7a-thevinoyl) carbazinic acid (125) 
The oxadiazolthione (121) (3.0g, 0.00683 m) and benzyl bromide (6.0 g, 
0.0351 m) were refluxed in ethanol (125 ml) for 3 h. The colourless 
ppt. which had formed, (the hydrobromide salt of (125)), was filtered off 
-1 
and dried at the pump for several hours. (vmax (nujol), 3500 cm , 
-1 (f) -1 -1 3200 cm (NH and NH), 1715 cm , 1682 cm (C = 0)). 
The salt was added to water (50 ml), basified with cone. ammonia 
solution and extracted into chloroform. After drying (KzC03) and evaporation 
of the chloroform a colourless foam remained which was crystallised from 
abs. ethanol. The benzylthtol ester of Nll-(7a-thevinoyl) carbazinic acid (125 
was collected by filtration (1.16. g, 32%, colourless needles m.p. 120-123°c· 
from abs. ethanol). 
vmax (nujol), 3460 cm-1, 3250 cm-1 (NH), 1680 cm-1 (C = 0). 
n.m.r. 90 MHz, (CDC1 3), o1;57 (1H, m, H8a); 2.30 (3H, s, NCH3); 3.58 
(3H, s, c6ocH3); 3.73 (3H, s, c3DCH3); 4.03 (2H, s, SCH2Ph); 4.44. (lH, s, 
H51l); 5.48 (lH, d, J9Hz, H17 ); 5.83(1H, d, J9Hz, H18); 6.50 (2H, m, H1 and 
H2); 7.16 (5H, s, Ph). 
Found, C, 65.1; H, 6.8; N, 6.9%, c30 H33 N3 05 S. CH3CH20H 
requires C, 64.7; H, 6.6; N, 7.1%. 
Accurate mass measurement, m/e 423.1808, c23 H25 N3 o5 
requires 423.1794. Base peak m/e 124. 
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I 
The expected Mt at 547 was not detected. c23 H25 N3 05 corresponds to the 
oxadiozolone (llOb). m/e 124 corresponds to c6 H5 CH2 SH. 
Mol. wt. by vapour pressure osmometry, 585.7, c30 H33 N3 05 S requires 
547.7. 
(C30 H33 N3 05 S. CH3CH20H requires 593.7). 
7a-{l, 3, 4-0xadiazol-{4H)-5-one-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (llOb) by sublimation of the benzylthiol ester of Na-
(7a-thevinoyl) carbazinic acid (125). 
The S-benzyl open-chain compound (125) {0.0916 g, 0.000167 m). was 
sublimed in a small sublimation apparatus. A pressure of 0.05 mm Hg was 
maintained by the use of an oil pump and the temperature was taken 
rapidly up to ~325°C by the use of a glass wool packed isomantle. On 
reaching 325°C the heating was stopped. After the sublimation there was an 
unpleasant odour typical of a thiol (C6 H5 CH2 SH?). A colourless deposit 
was washed off the cold finger with distilled chloroform. After evaporation 
of the chloroform the oxadiazolone (llOb) remained as a glass, (0.0481 g, 68%, 
vmax (nujol) 1780 cm-1, (C = 0)), identical in i.r. spectrum to the product 
from the phosgene route, {pl63). 
The oxadiazolone was dissolved in chloroform and the hydrochloride 
(llOa) precipitated on addition of dry ethereal HCl. The solid (llOa) 
was filtered off and washed with cold abs. ethanol {0.0129, 17%, vmax 
(nujol) 1780 cm-l (C = 0)), ir spectrum identical to the product from the 
phosgene route, (pl63). 
Benzylthiol ester of Na-benzoylcarbazinic acid (128). 
2-Phenyl-1, 3, 4-oxadiazol-(4H)-5-thione {127)(1.0 g, 0.00561 m) and 
benzyl bromide (4.93 g, 0.0288 m) were refluxed in abs. ethanol (~98%) 
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for 3 h. The solvent was taken off in vacuo to leave an orange coloured 
oil. Diethyl ether (50 ml) was added and the grey solid which formed 
was filtered off. The filtrate was concentrated to an oil and columned 
on alumina, (30 g, act I), which was eluted first with diethyl ether (250 ml) 
and then chloroform (lOO ml). Evaporation of the chloroform eluant gave 
a yellow coloured paste. After taking up the paste in hot 30% ethanol 
in water the benzythiol ester of Ns-benzoylcarbazinic acid (128) crystallised 
out as pale yellow needles (0.86 g, 54%, m.p. 125-127°C). 
vmax (nujol), 3340 cm-1 (m), 3260 cm-1 (m) (NH), 1691 cm-1, 1653 cm-1 (C = 0). 
n.m.r. 60 MHz (CDC1 3: DMSOd6 75:25), &4.06 (2H, s, S-CH2-Ph); 7.17 (5H, s, 
I 
5CH2Ph); 7.45 (3H, m) and 7.86 (2H, m, Ph-C =D); 9.83 (2H, s, br, 2XNH). 
Mass spectrum (relative intensity) m/e 286 Mt (.;,1%), 163 (9%), 162 
(60%), 124 (42%), 118 (45%), 105 (24%), 92 (12%),91 (100%), 77 (8%). 
Found, C, 62.55; H, 4.8; N, 9.6%, c15 H14 N2 02 S 
requires C, 62.9; H, 4.9; N, 9.8%. 
2-Phenyl-1, 3, 4-oxadiazol-5-one (129) by the phosgene route 
Benzoic acid hydrazide (126) (2.0 g, 0.0147 m) was dissolved in 
hydrochloric acid solution (5 ml cone HCl, 45 ml water) and phosgene was 
bubbled through for 1 h. while the solution was stirred. The precipitated 
phenyl-oxadiazolone (129) was then filtered off (1.33 g, 56%, colourless 
needles m.p. l38-140°C, 136-l39.5°C after recrystallisation from water • 
. 83a · o l1t m.p. 138 C). 
-1 . -1 
vmax (nujol), 3240 cm , 3160 cm (NH), 1768 cm-1, 1745 cm-l {C = 0). 
-1 
vmax (CHC1 3), 1793 cm (C = O). 
Mass spectrum (relative intensity), m/e 162 (100% base peak), 118 {90%), 
105 {30%), 103 (15%), 91 (13%), 77 (24%). 
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2-Phenyl-1, 3, 4-oxadiazol-5-one (129) by sublimation of the benzylthiol 
ester of Ne-benzoylcarbazinic acid (128) 
The 5-benzyl open-chain compound (128) (0,.1027 g, 0.0003586 m) was 
sublimed in a small scale apparatus using a glass wool packed isomantle to 
take the temperature rapidly up to~ 260°C. The pressure was held at 
0.05 mm Hg by an oil pump. On reaching 260°C the heating was stopped. After 
sublimation the cold finger was washed with chloroform and upon evaporation 
this produced a yellow paste. This was taken up in hot water and a yellow 
oil separated. The clear solution was decanted off from (most) of the oil 
and on cooling colourless crystals and yellow lumps came out. The colourless 
needles of the oxadiazolone (129) were separated from the yellow impurity 
by hand picking. 
(129) (0.0115 g, 22%, colourless needles m.p. 138°C). 
1max (nujol), 3240 cm-1, 3160 cm-l (NH), 1776 cm-1, 1744 cm-l 
(C = 0). 
Mass spectrum (relative intensity), m/e 162 (30%), 124 (25%), 118 (34%), 
105 (14%), 103 (4%), 91 (100% base peak), 77 (30%), 65 (11%). m/e 124 is 
probably c6 H5 CH2 SH impurity. 
Benzyl Na-(7a-thevinoyl) dithiocarbazate hydrobromide (130a) and its free 
base (130b). 
Potassium Na-(7a-thevinoyl) dithiocarbazate (120) (6.0 g, 0.0117 m) 
and benzyl bromide (6.0 g, 0.0351 m) were refluxed in abs. ethanol (125 ml) 
for 10.5 h. After leaving to cool overnight colourless crystals of the 
hydrobromide (130a) were filtered off (2.04 g, 27%, colourless microcrystals 
m.p. 244-246°C). 
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"max (nujol), 3490 cm-l (m), 3210 cm-l (m) (NH), 2740 cm-l (m) (~H), 
1708 cm-1, 1680 cm-l (C = 0). 
n.m.r., compound insoluble. 
Mass spectrum (relative intensity), m/e 529 (1%), 423 (10%), 408 (4%), 1 
311 (11%), 255 (6%), 248 (5%), 229 (5%), 162 (3%), 124 (17%), 91 (100%, 
base peak), 82 (10%), 81 (4%), 80 (9%),79(5%). 
Found, C, 56.2; H, 5.3; N, 6.5; S, 10.3; Br, 12.8%, c30 H33 N3 04 s2. HBr 
requires, C, 55.9; H, 5.3; N, 6.5; S, 9.95; Br, 12.4%. 
Cone. ammonia solution (20 ml) was added to the salt (130a) (1.0 g, 
0.00155 m), and the mixture was extracted into chloroform. The chloroform 
was dried (K2co3) and evaporated in vacuo on a hot water bath to yield a 
colourless glass (vmax (CHC1 3) 3260 cm-
1
, 1776 cm-l, 1674 cm-1). The glass 
was dissolved in chloroform and put down a small alumina column (5 g, act I) 
which was eluted with chloroform. The first product off the column was the 
benzyl dithiocarbazate free base (130b) which was first collected as an oil 
and then crystallised by the addition of abs. ethanol (0.1575 g, 18% from 
1 g of salt, off-white microcrystals m.p. 112-115°C). 
-1 1 
"max (nujol), 3280 cm (~) (NH), 1680 cm- (C = 0). 
n.m.r. 60 MHz, (CDC1 3), 62.32 (3H, s, NCH3); 3.58 (3H, s, c6ocH3); 3.76 
(3H, s, C30CH3); 4.05 (2H, s, SCH2Ph); 4.47 (lH, s, H5 ~); 5.50 (lH, d, 
J9Hz, H17 ); 5.88 (lH, s, J9Hz, H18): 6.53 (2H, m, H1 and H2); 7.19 (5H, s, 
SCH2Ph); 7.80 (lH, s, br, NH); 8.47 (lH, s, br, NH). 
On further elution of the column with 5% methanol in chloroform 
a small amount (~20 mg) of a colourless oil, their spectrum of which 
-1 -1 (vmax' (CHC1 3), 3280 cm , 1779 cm ), was almost identical to that of the 
oxadiazolone (llOb) obtained from the hydrazide (90) and phosgene. This 
oil was probably the same compound with a small amount of some impurity. 
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7a-(l, 3, 4-0xadiazol-(4H)-5-one-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (llOb) by thermolysis of benzyl NB-(7a-thevinoyl) 
dithiocarbazate hydrobromide (130a) 
The benzyl dithiocarbazate hydrobromide (130a) {0.2617 g, 0.0004059 m) 
was refluxed in dry DMF {25 ml) for 6 h., during which time lead acetate 
paper at the top of the condenser turned black {H2s and c6H5CH2SH). The 
DMF was removed in vacuo and a yellow solid remained {vmax {nujol), 
3420 cm-1, 1773 cm-land 1640 cm-1). The solid was taken up in ethanol-
water and some inorganic material filtered off. The filtrate was basified 
{solid K2co3) and extracted into chloroform which after drying {K2co3) and 
evaporation afforded a colourless oil which was shown to be the oxadiazolone 
1 -1 {llOb) by its ir spectrum, {vmax {CHC1 3), 3250 cm- {m) (NH), 1773 cm 
-1 -1 (C = 0). Peaks corresponding to impurity were at vmax 1663 cm and 705 cm , 
{both strong). 
7a-(5-(l-Pyrrolidyl)-l, 3, 4-oxadiazol-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (134a). 
The 5-methylthio -1,3,4-oxadiazole (123a) {0.5 g, 0.001103 m) and 
pyrrolidine {2.0 g, 0.02817 m) were refluxed in dry .e.-xylene {25 ml) fo.r 
12 days. The solution was evaporated in vacuo,and the residue columned 
on alumina {40 g, act I) and eluted through with chloroform/pet. ether 
{3:1). Evaporation of the fractions followed by trituration of the residue 
with diethyl ether afforded the crystalline pyrrolidino-oxadiazole {134a) 
(0.32 g, 61%, stout colourless needles m.p. 232-234°C, raised to 234-235°C 
after recrystallisation from abs. ethanol). 
vmax (nujol), 1635 cm-l {C = N), 1575 cm-1 {C =C). 
n.m.r. 90 MHz, {CDC1 3), ol.64 {lH, m, H8a); 1.98 {~4H, m, 2x -CH2-cH2-N. 
of pyrrolidine ring); 2.37 {3H, s, NCH3); 3.45 {~4H, m, -cH2-cH2-N of 
pyrrolidine ring); 3.57 (3H, s, c6ocH3); 3.84 {3H, s, c3ocH3); 4.71 {lH,d, 
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J~Hz, H5a); 5.58 (lH, d, J9Hz, H17); 5.76 {lH, dxd, J9Hz and ~Hz, H18); 
6.58 (2H, m, H1 and H2). 
Found, C, 68.3; H, 6.7; N, 11.7%, c27 H32 N4 04 
requires C, 68.0; H, 6.8; N, 11.8%. 
7a-(5-(l-Piperidyl)-l, 3, 4-oxadiazol-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (134b) 
The 5-methylthio-1, 3, 4-oxadiazole (123a) (1.5 g, 0.003308 m) and 
piperidine (7.0 g, 0.08235 m) were refluxed in dry £-Xylene for 6 days. 
After evaporation of the solvent in vacuo the residue was taken up in 
chloroform and passed down an alumina column (50 g, act I) which was eluted 
with pet. ether- chloroform (3:1). After~ 400 ml of solvent had been 
passed down, fractions were collected which on evaporation and trituration 
with diethyl ether produced crystals of the piperidino-oxadiazole (134b) 
which were collected by filtration (0.62 g, 38% colourless needles m.p. 
208-210°C, m.p. 208-209°C after recrystallisation from abs. ethanol). 
"max (nujol), 1625 cm-l (C = N), 1575 cm-1 (C =C) 
n.m.r. 90 MHz {CDC1 3), ol.62 (~7H, m, 3xCH2 of piperidine ring plus H8a); 
2.39 (3H, s, NCH3}; 3.40 (~4H, m, 2xCH2 of piperidine ring adjacent toN); 
3.56 (3H, s, C60CH3); 3.83 {3H, s, c3ocH3); 4.71 {lH, s, H5a); 5.59 
{lH, d, J9Hz, H17}; 5.77 {lH, d, J9Hz, H18); 6.58 {2H, m, H1 and H2}. 
Found, C, 68.3; H, 7.1; N, 11.3%, c28 H34 N4 04 
requires C, 68.55; H, 7.0; N, 11.4%. 
7a-(5-(4-Morpholinyl}-l, 3, 4-oxadiazol-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (134c) 
The 5-methylthio-1, 3, 4-oxadiazole (134a) (1.5 g, 0.003308 m) and 
morpholine (7.0 g, 0.08046 m) were refluxed in dry £-Xylene for 6 days. 
The solvent was evaporated off under reduced pressure and the residue 
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dissolved in chloroform and passed through an alumina column (50 g act I) 
which was eluted with pet. ether- chloroform (3:1). After~ 450 ml 
of eluant had passed through the column fractions appeared which on 
evaporation and trituration with diethyl ether gave crystals of the 
morpho1ino-oxadiazole (134c) (0.74 g, 45%, colourless needles, m.p. 
210-212°C, m.p. 206-208°C after recrystallisation from abs. ethanol). 
vmax (nujo1), 1630 cm-l (C = N), 1575 cm-1 (C =C) 
n.m.r. 90 MHz, (CDC1 3), ol.63 (lH, m, H8a); 2.36 (3H, s, NCH3); 3.42 
(~4H, s, CH2's adjacent to N in the morpholine ring); 3.56 (3H, s, c6ocH3); 
3.78 (4H, m, CH2's next to 0 in the morpho1ine ring); 3.83 (3H, s, c3ocH3); 
4.71 (lH, s, Hse); 5.60 (lH, d, J9Hz, H17); 5.70 (1H, d, J9Hz, H18); 
6.58 (2H, m, H1 and H2). 
Found, C, 66.2; H, 6.8; N, 11.2%, c27 H32 N4 05 
requires C, 65.8; H, 6.55; N, 11.4%. 
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Part 3 Synthesis of 1, 2, 4-Triazoles 
Potassium Na-(7a-thevinoyl) dithiocarbazate (120). 
The 7a-thevinoic acid hydrazide {90) (3.0 g, 0.00756 m) was dissolved 
in an aqueous solution of potassium hydroxide (0.424 g, 0.00756 m) in 
ethanol {70 ml). Carbon disulphide (0.864 g, 0.0114 m) was then added 
and after stirring for 15 minutes a precipitate formed. The mixture was 
then heated to boiling {5 minutes) and cooled. After 1 h. the potassium 
salt (120) was collected by filtration as a colourless amorphous solid 
(3. 1 g, 80% m.p. 202-205°C) pure enough for further use. 
-1 -1 
vmax {KBr), 3420 cm {m) {NH), 1632 cm {C = 0). 
n.m.r. 90 MHz, {CDC1 3: DMSOd6, 25:75), o2.33 {3H, s, NCH3); 3.53 {3H, s, 
c6ocH3); 3.74 {3H, s, C30CH3); 4.62 {lH, s, H56 ); 5.45 {lH, d, J9Hz, 
H17 ); 5. 71 {1 H, d, J9Hz, H18); 6.53 {2H, m, H1 and H2); 9.5 {lH, s, br, 
NH); 10.23 {lH, s, br, NH). 
Found, C, 52.2; H, 5.1; N, 7.9%, C23 H25 N3 04 52 K.H20 
requires, C, 52.2; H, 5.4; N, 7.9%. 
7a-{4-Amino-l, 2, 4-triazol-(lH)-5-thion-3-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine {136) 
The potassium salt (120)(0.5 g, 0.000977m ) and lOO% hydrazine hydrate 
(0.15 g, 0.0030 m) were refluxed in water (5 ml) for 0.5 h. After'cooling 
the precipitated base was filtered off to give the 4-amino-1, 2, 4-triazol-
(lH)-5-thione (136) as colourless needles {0.044 g, 8%, m.p. 167-171°C 
from EtOH). 
-1 -1 
vmax (KBr), 3440 cm (shld. at 3200 cm ) (NH and NH2). 
A,: 249 nm (L 2.065 X 104) (EtOH). 
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n.m.r. 90 MHz (CDC1 3:DMSOd6), o2.39 (3H, s,!NCH3); 3.57 (3H, s, C60CH3); 
3.84 (3H, s, C30CH3); 4.70 (lH, s, H5a); 5.27 (2H, s, br, NH2); 5.65 
(lH, d, J9Hz, H17 ); 5.82 (lH, d, J9Hz, H18); 6.60 (2H, m, H1 and H2); 
"' 13.5 (lH, s, very broad, NH). 
Found, C, 58.7; H, 6.1; N,_l4.4%, c23 H27 N5 03 S.H20 
requires C, 58.6; H, 6.2; N, 14.85%. 
Preparation of the S, S'-dimethyl Na-(7a-thevinoyl) dithiocarbazate 
hydroiodide (137) and free base (138). 
The potassium dithiocarbazate salt (120) (7.0 g, 0.0137 m) and methyl 
iodide (7.0 g, 0.0493 m) were refluxed in methanol (125 ml) for 1 h. 
After evaporation of the solvent in vacuo the residue was recrystallised 
from methanol to give the hydroiodide (137) as colourless needles (7.2 g, 
82%, m.p. 211-213°C from MeOH). 
-1 -1 -1 vmax (nujol), 3380 cm (m), 3150 cm (m) (NH), 1678 cm (C = 0). 
n.m.r. 90 MHz, (CDC1 3: DMSOd6), o2.44 (3H, s, SCH3); 2.56 (3H, s. SCH3); ® 
3.21 (3H, s, br, N-CH3); 3.76 (3H, s, c60CH3); 3.85 (3H, s, c3ocH3); @ . 
4.2 (lH, m, br, NH, not exchanged by o2o); 4.95 (lH, s, H5a); 5.62 (lH, d, 
J9Hz, H17); 5.97 (lH, d, J9Hz, H18); 6.66 (2H, m, H1 and H2); 8.9 and 
10.41 (lH, NH). 
Accurate measured mass 501.1760, c25 H31 N3 o4 s2 
requires 501.1756 
m/e 127 (I), 128 (HI). 
Found C, 47.5; H, 5.3; N, 6.6%, c25 H32 N3 04 s2 I 
requires C, 47.7; H, 5.1; N, 6.7%. 
The compound is light sensitive and becomes yellow unless stored in the 
dark. 
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The hydroiodide {0.5 g, 0.000795 m) in water (25 ml) was basified 
to pH9 with dil. ammonia solution. The 5, S'-dimethyl Ne-(7a-thevinoyl) 
dithiocarbazate free base (138) was filtered off and recrystallised from 
methanol (0.12 g, 30% colourless needles m.p. 173-175°C). 
~max (nujo1),3190 cm-l {m) (NH), 1668 cm-1 (C = O). 
n.m.r. 90 MHz, (CDC1 3), 62.37 (3H, s, NCH3); 62.49 {6H, s, 2x5CH3);' 
'·· 
3.68 (3H? s, br, c6ocH3); 3.82 (3H, s, c3ocH3); 4.57 {lH, s, H5a); 5.49 
(lH, d, J9Hz, H17); 5.75 (lH, d, J9Hz, H18); 6.56 {2H, m, H1 and H2); 
' 8.80 and 9.75 {lH, NH). 
Accurate measured mass, 501.1760, c25 H31 N3o4 52 
requires 501.1756 
Found, C, 60.3; H, 6.6; N, 8.1%, c25 H31 N3 04 52 
requires C, 59.9; H, 6.2; N, 8.4% 
Formation of 7a-(4-amino -1, 2, 4-triazol-(lH)-5-thion-3-yl)-6, 14-
endo-etheno-6, 7, 8, 14-tetrahydrothebaine (136) from 7a-(5-amino-l, 
3, 4-oxadiazol-(4H)-5-thion-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-tetrahydro-
thebaine (121). 
The oxadiazol-5-thione (121) (0.5 g, 0.00114 m) (as prepared on pl65) 
was refluxed with a large excess of 100% hydrazine hydrate (5.0 g, 0.10 m) 
in water {20 ml) for 4 h. The solution was extracted into chloroform which 
was then dried (Mg 504) and evaporated in vacuo to give an oil. Trituration 
of the oil with methanol afforded the amino-triazole (136) as colourless 
needles (0.072 g, 14%, m.p.l68- 171°C) identical (ir and mixed m.p.) with 
the sample prepared by the different method above (pl77). 
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Ethyl 7a-thevinoate {148) 
Thebaine {4) {10.0 g, 0.032 m) was refluxed in ethyl acrylate 
{125 ml, "' 1.15 m) for 8 h. Evaporation of the excess acrylate in vacuo 
produced a gum. The gum was dissolved in methanol and after a few minutes 
ethyl 7a-thevinoate {148) crystallised out {2.0 g, 15%, colourless prisms 
m.p. l29-132°C, lit. 15 m.p. 123-124°C). Attempts to crystallise out more 
of the adduct only gave polymeric material. 
. -1 
vmax {nuJol), 1740 cm {C = 0). 
n.m.r. 60 MHz {CDC1 3), ol.21 {3H, t, J7Hz, CH3 CH2-); 2.34 {3H, s, NCH3); 
3.58 {3H, s, c60CH3); 3.76 {3H, s, C30CH3); 4.07 {2H, q, J7Hz, CHj 
CH2-); 4.55 {lH, s, H5 ~); 5.46 {lH, d, J9Hz, H17); 5.77 {lH, d, J9Hz, 
H18); 6.53 {2H, m, H1 and H2). 
7a-Thevinoic acid {146) 
The methyl ester {88) {49 g, 0.123 m).was heated in cone. 
hydrochloric acid {250 ml) at 95°C on a steam bath for 3 h. The solution 
was filtered hot and cooled in ice.. The 7a-thevinoic acid hydrochloride 
{146) spearated out as colourless prisms which were filtered off and washed 
with ice-water {40 g, 74%, m.p. 244-248°C, lit.15 m.p. 246-247°C). 
-1 ® -1 
vmax {nujol), 3500-2700 cm {OH and NH), 1735 cm {C = 0) 
n.m.r. {compound insoluble) 
7a-Thevinoyl chloride {147)15 
7a-Thevinoic acid {146) {10 g, 0.023 m), thionyl chloride {10 ml, 
0.138 m, freshly distilled from linseed oil, b.p. 78-79°C) and dry benzene 
{125 ml) were heated at reflux on a steam bath for 2 h. The volatile 
substances were evaporated off in vacuo and the 7a-thevinoyl chloride 
{147) remained as a fawn coloured solid. 
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"max (nujol), 2700 cm-l (m) (~H), 1790 cm-l (C = O). 
Conversion of 7a-thevinoyl chloride (147) into ethyl 7a-thevionate (148) 
7a-Thevinoyl chloride (147) (2 g) was refluxed in dry ethanol 
(25 ml) for 0.5 h. The solvent was evaporated in vacuo and saturated 
sodium carbonate solution {50 ml) was added to the residue. The free base 
was extracted into chloroform which was dried (K2co3) and then concentrated 
in vacuo to an oil. The oil was passed down a short alumina column 
(10 g, act I) from which the pure ethyl 7a-thevinoate (148) was obtained 
·(colourless prisms m.p. 129-131°C from methanol). This ester was identical 
to the product from the Diels-Alder reaction of thebaine and ethyl acrylate 
with respect to i.r., n.m.r., m.p., and mixed m.p. 
7a-Thevinamide (149) 
Concentrated ammonia solution was added dropwise to 7a-thevinoyl 
chloride hydrochloride (147) (4.0 g, 0.00913 m). When all the powdered 
solid had come into contact with the base a further portion of cone. 
ammonia {20 ml) was added and the reaction mixture left overnight. The 
organics were extracted into chloroform which after drying (K2co3) and 
evaporation yielded a brown gum. This was taken up in the minimum amount 
of chloroform and passed down an alumina column (25 g, act Ill) eluted, 
also, with chloroform. One fraction from the column on evaporation 
afforded a colourless oil. This was dissolved in water-methanol and 
after concentration under v~cuum 7a-thevinamide (149) crystallised out 
as the hydrate (0.40 g, 11%, colourless needles m.p. l04-106°C). 
"max (nujol), 3610 cm-l (m) (H20), 3450 cm-1 (m), 3390 cm-l (m) (NH2), 
1680 cm-l (C = 0). 
n.m.r. 90 MH (CDC1 3), ol.58 (lH, m, H8a); 2.41 {3H, s, NCH3); 3.66 {3H, s, 
c6ocH3); 3.84 (3H, s, c30CH3); 4.58 {lH, s, H5e); 5.58 {lH, d, J9Hz, H17); 
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5.92 (2H, d, J9Hz, H18 and s, br, NH); 6.25 (lH, s, br, NH}; 6.58 (2H, m, 
H1 and H2). 
Found, C, 65.7; H, 6.85, N, 6.8%, c22 H26 N2 o4.H20 
requires C, 66.0; H, 7.05, N, 7.0%. 
4-Methyl-l-(1a-thevinoyl) thiosemicarbazide (15la} 
The 7a-hydrazide (90) _(4.0 g, 0.01 m) and methylisothiocyanate (0.8 g, 
0.014 m) were refluxed in abs. ethanol (50 ml) for 3 h. On cooling colourless 
crystals were precipitated. These were filtered off after 1 h. to give 
the methyl-thiosemicarbazide (15la) (3.58 g, 76%, colourless rhombs m.p. 
216-219°C from abs. ethanol). 
vmax (KBr), 3350 cm-l (NH), 1720 cm-l (C = 0), 1635 cm-l (w), 1605 cm-l (w). 
n.m.r. 90 MHz (CDC1 3: DMSOd6), ol.56 (lH, m, H8a); 2.35 (3H, s, NCH3); 
3.11 (3H, d, J5Hz, NHCH3, became a singlet on o2o exchange); 3.73 (3H, s, 
c6ocH3); 3.82 (3H, s, c3ocH3); 4.59 (lH, s, H5 ~); 5.60 (lH, d, J9Hz, H17); 
5.87 (lH, d, J9Hz, H18); 6.59 (2H, m, H1 and H2); 7.27 (lH, m, br, NH; 
CH3); 8.48 (lH, s, br, NH); 9.05 (lH, s, br, NH) • 
. Found, C, 60.8; H, 6.4; N, 11.8%, c24 H30 N4 04 S 
requires C, 61.25; H, 6.4; N, 11.9% 
4-Ethyl-l-(7a-thevinoyl) thiosemicarbazide (15lb). 
The 7a-hydrazide (90) (4.0 g, 0.01 m) and ethylisothiocyanate (0.953 g, 
0.011 m) were refluxed in abs. ethanol (50 ml) for 2 h. The clear solution 
was cooled rapidly to 15°C and crystals of the ethyl-thiosemicarbazide (15lb) 
were precipitated. These were collected by filtration (4.59 g, 94%, 
colourless needles m.p. 149-154°C, raised to 174-177°C after recrystallis-
ation from abs. ethanol). 
~ax (nujol) 3500 cm-l (m), 3290 cm-l (m) (NH), 1695 cm-1 (C = O). 
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n.m.r. 90 MHz, (CDC1 3), 151.22 (3H, t, J7Hz, CH3CH2NH); 2.36 (3H, s, NCH3); 
3.70 (2H, q, J7Hz, CH3CH2NH, overlaps with the signal at o3.73); 3.73 
(3H, s, C60CH3); 3.83 (3H, s, c3ocH3); 4.63 (lH, s, Hse); 5.60 (lH, d, J9Hz, 
H17); 5.82 (lH, d, J9Hz, H18); 6.58 (2H, m, Hl and Hi); 7.18 (1H;-m, br;c 
NH-CH2CH3); 8.45 (lH, s, br, NH); 8.78 (lH, s, br, NH). 
Found, C, 61.8; H, 6.5; N, 11.5%, c25 H32 N4 04 S, 
requires C, 62.0; H, 6.7; N, 11.6%. 
4-Phenyl-l-(7a-thevinoyl) thiosemicarbazide (15lc) 
The hydrazide (90) (2.0 g, 0.00504 m) and phenylisothiocyanate (0.74 g, 
0.00548 m) in abs. ethanol (50 ml) were refluxed for 40 minutes. On 
cooling colourless crystals of the phenyl-thiosemicarbazide (15lc) separated 
out and were filtered off (2.32 g, 86%, long colourless needles from abs. 
ethanol-chloroform m.p. 153-154°C). 
vmax (nujo1), 3550 cm-l (w, br), 3280 cm-l (NH), 1685 cm-1 (C = 0), 1638 cm-l 
(m), 1605 c:m-1 (m). 
n.m.r. 90 MHz, (COC1 3), ol.59 (lH, m, H8a); 2.33 (3H, s, NCH3); 3.60 (3H, 
s, c6ocH3); 3.80 (3H, s, c3ocH3); 4.56 (lH, s, H5e); 5.54 (lH, d, J9Hz, 
H17); 5.84 (lH, d, J9Hz, H18); 7.35 (6H, m, br, NH-Ph); 8.81 (lH, s, br, 
NH); 9.14 (lH, s, very br, NH). A o2o exchanged spectrum was not possible 
as the compound precipitated out on the addition of o2o. 
Found, C, 65.3; H, 6.1; N, 10.7%, c29 H32 N4 04 S, 
requires, C, 65.4; H, 6.1; N, 10.5%. 
7a-(4-Methyl-l, 2, 4-triazol-(lH)-5-thion-3-yl)-6, 14-endo-etheno-6, 7, 8, 
14-tetrahydrothebaine (152a). 
The methy1-thiosemicarbazide (15la) (l.Og, 0.00213 m) and piperidine 
(0.8 g, 0.00941 m) were refluxed in abs. ethanol (25 ml) for 7 h. After 
the mixture had stood for several hours the methyl-triazole (152a) 
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0 
crystallised out as colourless plates (0.61 g, 63%, m.p. 301-304 C from 
abs. ethano 1 ) • 
vmax (nujol), 3450 cm-l 
1608 cm-l (w). 
-1 -1 (m, br), 3100 cm (m, br) (NH), 1636 cm (w), · 
n.m.r. 90 MHz, (CDC1 3: DMSOd6), 62.41 (3H, s, NCH3 of thebaine); 3.54 (3H, 
s, NCH3 of triazole ring); 3.62 (3H, s, C60CH 3); 3.85 (3H, s, C30CH3); 
4.59 (lH, s, H5e); 5.69 (lH, d, J9Hz, H17); 5.87 (lH, d, J9Hz, H18); 6.57 
(2H, m, H1 and H2); 11.8 (lH, s, br, NH). 
The sample was dried at 140°C for 8 h. at <0.05 mm Hg pressure over 
P2o5 before the n.m.r. spectrum was run, to remove any water. 
Found, C, 63.5; H, 6.2; N, 12.3%, c24 H28 N4 03 S. 
requires C, 63.7; H, 6.2; N, 12.4%. 
7a-(4-Etfiyl-l, 2, 4-triazol-(lH)-5-thion-3-yl)-6, 14-endo-etheno-6, 7, 8, 
14-tetrahydrothebaine {152b). 
The ethyl-thiosemicarbazide (15lb) (1.0 g, 0.00206 m) and piperidine 
(0.8 g, 0.00941 m) were refluxed in abs. ethanol (25 ml) for 72 h. On 
cooling crystals formed. The solution was stored at -20°C overnight and 
the crystalline ethyl-triazole (152b) collected by filtration (0.68 g, 
71%, fine colourless needles m.p. 239-240°C from abs. ethanol). 
vmax (nujol), 3580 cm-1 (w), 1640 cm-l (w), 1610 cm-1 (w), 1580 cm-1 (m). 
n.m.r. 90 MHz, (CDC1 3), ol.37 (3H, t, J7Hz, CH3CH2N); 1.75 (lH, m, H8a); 
2.39 (3H, s, NCH3); 3.52 (3H, s, C60CH3); 3.83 (3H, s, C30CH3); 4.24 (2H, 
q, J7Hz, CH3CH2N); 4.57 (lH, s, H5e); 5.70 (lH, d, J =9Hz, H17); 5.93 
(lH, d, J =9Hz, H18); 6.60 (3H, m, H1 and H2 and s, br, NH). 
Found, C, 63.9; H, 6.5; N, 11.9%, c25 H30 N4 03 S 
requires C, 64.35, H, 6.5, N, 12.0%. 
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7a-(4-Phenyl-l, 2, 4-triazol-(lH)-5-thion-3-yl)-6, 14-endo-etheno-6, 7, 8, 
14-tetrahydrothebaine (152c). 
Piperidine (0.8 g, 0.00941 m) and the phenyl-thiosemicarbazide (15lc) 
(1.0 g, 0.00188 m) were refluxed in abs. ethanol (25 ml) for 48 h. The 
solvent was evaporated off in vacuo and the residue dissolved in chloroform 
and passed down an alumina columna (30 g, act I) that was eluted with 
chloroform. After 100 ml of solvent had run through fractions were obtained 
which after evaporation and trituration with abs. ethanol afforded the 
phenyl-triazole (152c) (0.23 g, 24%, colourless needles, m.p. 274-276°C 
from ethyl acetate). 
vmax (nujol), 2790 cm-l ( br), 1632 cm-l (w), 1600 cm-1 (w), 1572 cm-1 
(w). 
n.m.r. 90 MHz, (CDC1 3), 62.37 (3H, s, NCH3); 3.51 (3H, s, c6ocH3); 3.83 
(3H, s, c3ocH3); 4.22 (lH, s, Hsal; 5.68 (lH, d, J9Hz, H17); 6.00 (lH, d, 
J9Hz, H18); 6.59 (2H, m, Hl and H2); 7.5 (5H, m, Ph-N). 
Found, C, 67.4; H, 5.9; N, 10.8%, c29 H30N4 03S 
requires C, 67.7; H, 5.9; N, 10.9%. 
4-Methyl-l-(7a-thevinoyl) semicarbazide (153, R =CH~ 
The 7a-hydrazide (90) (2.0 g, 0.00504 m) and methylisocyanate 
(0.33 g, 0.00579 m) were heated under reflux in abs. ethanol (50 ml) 
for 2.5 h. The solvent was evaporated in vacuo and the oily residue 
dissolved in ethyl acetate and stored at -20°C. After 2 days colourless 
crystals of the methyl-semicarbazide (153, R = CH~ separated out and 
were filtered-off (2.32 g, 95%, recrystallised from abs. ethanol, with 
difficulty, as colourless needles m.p. 148-152°C). 
vmax (nujol), 3360 cm-l (m), 3270 cm-l (m) (NH), 1735 cm-1, 1675 cm-1 
(C = 0). 
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n.m.r. 90 MHz, (CDC1 3), 62.36 (3H, s, NCH3 of thebaine); 2.77 (3H, d, J5Hz, 
NHCH3, collapsed to a singlet on o2o exchange after one day); 3.69 (3H, s, 
c60CH3); 3.83 (3H, s, c3ocH3); 4.58 {lH, s, H51!); 5.58 (lH, d, J9Hz, H17); _ 
5.88 {lH, d, J9Hz, H18); 6.05 (lH, m, br, NH-CH3); 7.48 {lH, s, br; NH); 
8.88 {lH, s, br, NH). 
Accurate measured mass, 454.2173, c24 H30 N4 05 
requires 454.2216. 
m/e (relative intensity), 454 (2%, Mt), 423 (60%), 408 (28%), 397) (29%), 
338 (27%), 311 (100%, base peak), 255 (52%), 229 {37%), 162 {35%). 
Found, C; 62.0; H, 6.5; N, 12.0%, c24 H30 N4 05• 0.5H20 
requires C, 62.2; H, 6.7; N, 12.1%. 
4-Ethyl-l-{7a-thevinoyl) semicarbazide {153, R = Et) 
The 7a-hydrazide (90) (4.0 g, 0.01 m) and ethylisocyanate (0.82 g, 
0.0116 m) were refluxed in abs. ethanol {50 ml) for 5 h. The solvent was 
evaporated off in vacuo and the residue (a colourless foam) was dissolved 
in the minimum amount of hot.methanol and then stored at -20°C. After 
10 days crystals had appeared in the solution and these were filtered off 
and washed with a little cold methanol to afford the ethyl-semicarbazide 
(153, R =Et) (2.18 g, 48%, colourless needles m.p. l37-141°C, raised to 
142-144°C after recrystallisation from abs. ethanol). 
vmax (nujol), 3500 cm-1 (m), 3300 cm-1, 3270 cm-1 (NH), 1690 cm-1 (br) 
{C = 0). 
n.m.r. 60 MHz, {CDC1 3), ol.lO {3H, t, J7Hz, CH3-CH2-N); 2.36 {3H, s, NCH3); 
3.08 (several H, m, CH3-cH2-N and other protons); 3.64 (3H, s, c6ocH3); 
- -
3.82 (3H, s, C30CH3); 4.54 {lH, s, H51!); 5.42 {lH, d, J9Hz, H17); 5.76 
(lH, d, J9Hz, H18); 5.98 (lH, m, NH-CH2-CH3); 6.53 (2H, m, Hl and H2); 7.3~ 
(lH, s, br, NH); 8.76 {lH, s,br, NH). 
Found, C, 64.4; H, 6.85; N, 11.9%, c25 H32 N4 05 
requires C, 64.1; H, 6.9; N, 12.0%. 
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4-Phenyl-l-(7a-thevinoyl) semicarbazide (153 R = Ph) 
To a solution of the ?a-hydrazide (90) (3.0 g, 0.00756 m) in cold 
abs. ethanol (125 ml) was added phenylisocyanate (0.99. 9, .0.00832 m) and the 
solution was shaken for 5 minutes and then concentrated in volume under 
reduced pressure. Water was added and immediate precipitation occurred. 
The precipitate was taken up by the addition of hot ethanol and on cooling 
the phenyl-semicarbazide (153, R = Ph) crystallised out and was collected 
by filtration (2.62 g, 6/%, colourless plates m.p. 152-l55°C from ethanol-
water (70:30)). 
vmax (nujol), 3280 cm-l (m) (NH). 1665 cm-l (C:= 0), 1600 cm-1, 760 cm-1, 
700 cm-1• 
n.m.r. 60 MHz, (CDC1 3), o2.30 (3H, s, NCH3), o3.59 (3H, s, c6ocH3); 
3.79 (3H, s, C30CH3); 4.54 (lH, s, H5S); 5.48 (lH, d, J9Hz, H17); 5.77 
(lH, d, J9Hz, H18); 6.55 (2H, m, H1 and H2); 7.20 (5H, m, Ph); 7.94 and 
8.05 (2H, br, 2xNH); 9.00 (lH, s, br, NH). 
m/e, 516 (Mt, not detected), 423, 408, 397, 338, 222, 162, 119, 93 (base 
peak). 91. 
Found, C, 64.9; H, 6.4; N, 10.1%, c29 H32 N4 o5.H20 
requires C, 65.15; H, 6.4; N, 10.5%. 
7a-(l. 3, 4-0xadiazol-(4H)-5-one-2-yl)-6, 14-endo-etheno-6, 7. 8, 14-
tetrahydrothebaine (llOa) by cyclisation of 7a-thevinoy1semicarbazides (153). 
The pheny1-semicarbazide (153, R =Ph) (0.1843 g, 0.0003567 m), was 
refluxed in dry xylene (25 ml) for 24 h. Evaporation of the xylene in vacuo 
afforded a brown glass (vmax (CHC1 3), 1775 cm-
1). The glass was dissolved 
in the minimum amount of chloroform and dry ethereal HCl was added. A 
gummy precipitate formed. The solvents were evaporated in vacuo and the 
residue taken up in hot diethyl ether-ethanol. From this solution 
' discoloured crystals of the oxadiazolone hydrochloride (llOa) were 
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. 0 
collected by filtration (0.0994 g, 61%, spheres, m.p. ~ 270 C decomp.). 
. -1 
vmax (nUJOl), 17.80 cm (C = 0), identical with the spectrum of the 
sample made previously (p163). 
The methyl-(153, R = CH3) and ethyl-(131, R =Et) semicarbazides 
produced the oxadiazolone when refluxed in xylene in the same way. In 
each case the product was identified by examination of the i.r. spectrum 
of the crude product after evaporation of the xylene, (vmax (nujol), 
1780 cm-1 (C = 0) in both cases). 
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Part 4 Formation of 1, 3, 4-0xadiazol-5-ones via Derivatives of Biuret 
• 
l-(7a-Thevinoylamino)-3, 5-diphenylbiuret (156) from 7a-thevinoic·acid 
hydrazide (90) and excess phenylisocyanate. 
The ?a-hydrazide (90) (2.0 g, 0.00504 m) and phenylisocyanate (4.0 g, 
0.0336 m) were refluxed in sodium dried xylene (50 ml) for 24 h. The 
solution (by then orange coloured) was evaporated to dryness, the residue 
dissolved in the minimum of chloroform, and then applied to the top of 
an alumina column which was eluted with pet. ether/chloroform (50:50). 
After~ 150 ml of solvent had passed through the column fractions containing 
dissolved solid appeared. After evaporation of the solvent the residues 
were taken up in hot abs. ethanol and after storing at -20°C overnight the 
diphenylbiuret (156) crystallised out and was collected by filtration 
(1.87 g, 58%, colourless needles m.p. 205-208°C from abs. ethanol). 
vmax (nujol), 3410 cm-l (m), 3295 cm-l (m) (NH), 1740 cm-1, 1700 cm-1, 
1685 cm-1 (C =0). 
n.m.r. 90 MHz (CDC1 3), 62.33 (3H, s, NCH3); 3.59 (3H, s, C60CH3); 3.83 
(3H, s, c3ocH3); 4.66 (lH,s, H5~); 5.66 (lH, d, J9Hz, H17); 5.87 (lH, d, 
J9Hz, H18); 6.58 (2H, m, H1 and H2); 7.35 (lOH, m, 2xPh); 8.25 (lH, s, br, 
NH); 9.77 (2H, s, br, 2xNH). 
Found, C, 67.9; H, 5.9; N, 11.0%, c36 H37 N5 06 
requires C, 68.0; H, 5.9; N, 11.0%. 
Accurate measured masses, 423.1784, c23 H25 N3 05 
requires 423.1785: 397.1996, c22 H27 N3 04 
requires, 397 ._2001: 212.0931, c13 H12 N2 0 
requires, 212.0949: 119.0371, c7 H5 NO requires 119.0371. 
m/e, 635 (Mt, not detected), 423 (43%), 397 (14%), 212 (5%), 119 (100%) 
Molecular wt. (osmometry). 694, c36 H37 N5 o6 requires 635. 
- 190 -
l-(7a-Thevinoylamino)-3, 5-diphenybiuret (156) from 4-phenyl-l-(7a-
thevinoyl) semicarbazide (153, R = Ph) and phenylisocyanate. 
The phenylsemicarbazide (153, R = Ph) (0.65 g 0.0126 m) and 
phenylisocyanate (0.85 g, 0.00714 m) were refluxed in sodium dried xylene 
(50 ml) for 24 h. The xylene was evaporated in vacuo and the remaining 
oil put down a short alumina column (15 g, act I) which was eluted with 
chloroform. The biuret came off the column in a pale yellow band which 
on evaporation gave an oil. The oil was crystallised from abs. ethanol 
to yield the diphenylbiuret (156) as colourless needles m.p. 203-205°C not 
depressed by admixture of a sample from the route above. The n.m.r. and 
i.r. spectra were identical to those given by the sample from the route 
above. (0•4363g,55~.) 
l-(7a-Thevinoylamino)-3, 5-bis(p~chlorophenyl) biuret (160) from 7a-
thevinoic acid hydrazide (90) and excess p-chlorophenylisocyanate 
The ?a-hydrazide (90) (2.0 g, 0.00504 m) and R-chlorophenylisocyanate 
(5.5 g, 0.0358 m) were refluxed in sodium dried xylene (50 ml) for 20 h. 
On cooling crystals formed. After 3 h. they were filtered off (1.55 g, 
vmax 1638 cm-1, 1600 cm-l, identical to that of ~-di-R-chlorophenyl-urea 
prepared by the method below ~191). The filtrate was evaporated to 
dryness, dissolved in the minimum amount of chloroform and put down an 
alumina column (50 g, act I) eluted with pet. ether/chloroform (50:50). 
The fractions were evaporated and dissolved in abs. ethanol. From one 
fraction the p-chlorophenylbiuret (160) crystallised (0.37 g, 10%, colourless 
needles m.p. 19l-193°C from ethano1~chloroform). 
vmax (nujo1), 3350 cm-l (m) (NH), 1720 cm-1, 1675 cm-1 (C = 0). 
n.m.r. 60 MHz (CDC1 3), o2.32 (3H, s, NCH3); o3.54 (3H, s, C60CH3); o3.80 
(3H, s, c3ocH3); 4.62 (lH, s, H5e); 5.63 (lH, d, J9Hz, H17); 5.79 (lH, d, 
J9Hz, H18); 6.57 (2H, m, H1 and H2); 7.25 (8H, m, aromatics of R-chlorophenyl groups); 8.05 (lH, s, br, ~H), 9.70 (2H, s, br, 2xNH). · 
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Found, C, 61. 1; H, 5.0; N, 9.8%, c36 H35 N5 06 Cl 2 
requires C, 61.4; H, 5.0; N, 9.9% 
Accurate measured masses, 423.1799, c23 H25 N3 05 
requires 423.1785: 397.2001, c22. H27 N3 o4 requires 397.2001 152.9982, 
c7 H4 N0
35cl requires 152.9982. 
m/e 707(1), 705(6), 703(9) (Mt, not seen), 423(10%) 397(36%), 153(100%). 
sym-Di-p-chlorophenyl-urea (161) 
£-Chlorophenylisocyanate (10.92 g, 0.0714 m) was refluxed in water 
(50 ml) for 1 hr., when ~-di-£-chlorophenyl-urea (161) had formed as a 
colourless solid and was filtered off and washed with water, copious 
amounts of diethyl ether, chloroform, and then dried at the pump. (6.5 g, 
65%, colourless prisms m.p. 306-309°C, lit. m.p. 306-307°c. 107 ) 
vmax (nujol), 3310 cm-l (NH), 1638 cm-l (C = 0), 1600 cm-1 1568 cm-1• 
Mt = 279, 281, 283 (9:6:1). 
Formation of 7a-(l, 3, 4-oxadiazol-(4H)-5-one-2-yl)-6, 14-endo-etheno-
6, 7, 8, 14-tetrahydrothebaine (llOb) by sublimation of l-(7a-thevinoylamino) 
-3, 5~bis(p-chlorophenyl) biuret (160). 
Before the sublimation both the biuret and the sublimation apparatus 
were thoroughly dried. 
The £-chlorophenyl biuret (160) (0.0573 g, 0.0000813 m) was sublimed 
in a small apparatus, the pressure being maintained at~ 0.1 mm Hg by the 
use of an oil pump. The temperature was taken up quickly to ~ 250°C. 
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The cold finger was washed with chloroform and the washings were 
filtered and the filtrate evaporated to dryness. The oxadiazolone (llOb) 
was obtained as a glass (0.0289 g, 84%). 
(\lmax (nujol) 1780 cm-l (shld at 1815 cm-l) (C = 0)), containing a trace. 
of ~-di-R-chlorophenyl-urea. 
The colourless solid which remained on the cold finger was identified 
b . . ( -1 -1 . . y 1ts 1.r. spectrum, \)max' 1630 cm , 1600 cm ), as ~-di-£-chlorophenyl-
urea {161) {0.0098 g, 43%). 
Formation of 7a-(l, 3, 4-oxadiazol-(4H)-5-one-2-yl)-6, 14-endo-etheno-6, 7, 
8, 14-tetrahydrothebaine (llOb) by sublimation of l-(7a-thevinoylamino)-3, 
5-diphenylbiuret {156). 
As with the previous experiment both the biuret and the sublimation 
apparatus were dried before use. 
The diphenylbiuret (156) (0.12g7 g, 0.000204 m) was sublimed in. a 
small apparatus at~ 0.1 mm Hg pressure using an oil pump. The temperature 
was taken rapidly up to ~ 250°C. 
The colourless residue on the cold finger was dissolved in chloroform 
and the insoluble residue filtered off. This insoluble residue was 
identified as ~-diphenyl-urea (159) by its ir spectrum. 
. -1 -1 (\lmax (nuJol), 1650 cm , 1600 cm ) (0.0282 g, 65%). 
On evaporation of the filtrate the oxadiazolone (llOb) was obtained 
as a glasso(0.0661 g, 76%). Their spectrum (\lmax (nujol), 1780 cm-1 
(shld at 1815 cm-1) (C = O)) was identical in most respects to that of the 
oxadiazolone (llOb) prepared by reaction of the 7a-hydrazide {90) with 
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phosgene. 
Benzoic acid hydrazide (169) 
Ethyl benzoate (60.0g, 0.37 m) and lOO% hydrazine hydrate (60.0 g, 
0.4 m) were refluxed in abs. ethanol (150 ml) for 24 h. The solution was 
concentrated in volume until solid started to precipitate. Diethyl ether 
(200 ml) was added and the precipitated crystals of benzoic acid hydrazide 
(169) were filtered off. The filtrate was concentrated in volume, diethyl 
ether (200 ml) added, and further crystals of the hydrazide were collected 
by filtration. This procedure was repeated several times until the total 
crop of benzoic acid hydrazide (169) was 26.0 g (48%, colourless plates 
m.p. 112-ll3°c, lit. 105b m.p. 112.5). 
. -1 -1 -1 -1 
vmax (nujol), 3320 cm , 3200 cm (NH), 1665 cm (C = 0), 1620 cm ; 
. 109b -1 l1t. , 3330, 3200, 1665, 1620 cm • 
Reaction of phenylisocyanate and benzoic acid hydrazide (169) 
Benzoic acid hydrazide (169) (1.0 g, 0.008065 m) and phenylisocyanate 
(6.4 g, 0.0538 m) were refluxed in sodium dried xylene (40 ml) for 24 h. 
The refluxing solution always contained a suspended solid. The solution 
was filtered hot when crystals of 4-phenyl-1-benzoyl-semicarbazide (170) 
were collected (1.64 g, 84%, colourless rhombs m.p. 2ll-212°C. lit. m.p. 
212ocl05a) 
vmax (nujol), 3320 cm-l (m), 3180 cm-l (m) (NH), 1725 cm-1, 1675 cm-1 
(C = 0). 
Mt 255. 
The filtrate was examined carefully but no trace of the biuret 
(171) could be obtained. 
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Cyclohexane carboxylic acid hydrazide (174) 
Cyclohexane carboxylic acid (172) (25.0 g, 0.195 m) was refluxed 
with cone. sulphuric acid (0.5 g) in methanol {lOO ml) ~for.S h. ~.'The,~-".-... ~· "" 
solution was added to water (250 ml), basified (solid K2co3).and extracted 
into diethyl ether (4 x lOO ml). After drying {MgS04) the ether was 
evaporated to give cyclohexane carboxylic acid methyl ester (173) as a 
colourless oil with a pleasant odour (26.9 g, 97%). 
vmax (thin film), 1740 cm-1 (C = 0). 
Cyclohexane carboxylic acid methyl ester (173) (26.9 g, 0.189 m) 
and 100% hydrazine hydrate (36.5 g, 0.73 m) were refluxed in 2-ethoxyethanol 
{50 ml) for 20 h. On cooling, colourless crystals of cyclohexane carboxylic 
acid hydrazide (174) formed. These were collected by filtration and 
recrystallised from abs. ethanol {6.1 g, 23%, long colourless needles, 
0 • 106 . 0 
m.p. 156.5-158.5 C, 11t. m.p. 158-159 C). 
vmax (nujo1), 3320 cm-1, 3220 cm-1 (w) (NH and NH2), 1630 cm-1 (C = 0). 
n.m.r. 60 MHz {CDC1 3/DMSOd6, 50:50), ol.~ (11H, m, c6H11 ); 3.99 {2H, s,br, 
NH2); 8.15 (1H, s, br, NH). 
1-Cyclohexylcarbonyl ami no-3, 5-diphenylbiuret {175) 
Cyclohexane carboxylic acid hydrazide (174) (1.0 g, 0.00703 m) 
and pheny1isocyanate (5.63 g, 0.0472 m) were refluxed in sodium dried 
xylene for 18 h. At the end of this time it was noticed that colourless 
needle-like crystals had formed in the xylene. On cooling further crystals 
formed and these were filtered off and washed with, successively, cold 
xylene (lOO ml), hot water (lOO ml) and hot ethanol (75 ml) to give the 
cyclohexylbiuret (175) (0.77 g, 29%,colourless needles m.p. 171-184°C). 
vmax (nujol), 3345 cm-l (m) (NH), 1732 cm-1, 1695 cm-1 {shld. at 1685 cm-1) 
(C = 0), 1605 cm-1• 
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n.m.r. 60 MHz (DMSOd6/COC1 3), 61.65 (llH, m, c6H11 ); 7.28 (lOH, m, 2xPh); 
10.03 (lH, s, br, NH); 10.30 (2H, s, br, 2xNH). Precipitated on attempted 
o2o exchange. 
Found, C, 65.9; H, 6.3; N, 14.5%, c21 H24 N4 03 
requires C, 66.3; H, 6.4; N, 14.7%. 
Accurate measured masses, 168.0900, c8 H12 N2 o2 
requires 168.0899: 142.1106, c7 H14 N2 0 
requires 142.1106: 119.0372, c7 H5 NO requires 119.0371. 
mfe, 380 (Mt >0.1%), 168(7%), 142(21%), 119(100%). 
1-Cyclohexylcarbonyl-4-phenyl-semicarbazide (176) 
• . ~ :;. • >-'-' - - --·-
Cyclohexane carboxylic acid hydrazide (174) (1.0 g, 0.00704 m) 
was suspended in abs. ethanol (25 ml) and phenylisocyanate (0.84 g, 0.00706 m) 
was added. On agitating all the solid dissolved up.and after~ 1 min. 
precipitation occurred. The 1-cycbhexylcarbonyl-4-phenyl-semicarbazide (176) 
was collected by filtration (1.77 g, 96%, fine colourless needles m.p. 
201-201.5°C). 
vmax (nujol), 3365 cm~ 1 (m), 3250 cm-l (m) (NH), 1720 cm-l (m), 1655 cm-1 
(C = 0), 1610 cm-l (m). 
n.m.r. 60 MHz (OMSOd6 +trace COC1 3), 61.5 (llH, m, c6H11 ); 7.23 (5H, m, Ph); 
7.87 (lH, s, br, NH); 8.60 (lH, s, br, NH); 9.48 (lH, s, br, NH). Precipitate' 
on attempted o2o exchange. 
Found, C, 64.5; H, 7.6; N, 15.8%, c14 H19 N3 02 
requires C, 64.3; H, 7.3; N, 16.1%. 
2-Cyclohexyl-1, 3, 4-oxadiazol-(4H)-5-one (177) from cyclohexane carboxylic 
acid hydrazide (174) and phosgene. 
Cyclohexane carboxylic acid hydrazide (174) (1.0 g, 0.00703 m) was 
dissolved in hydrochloric acid solution (1:10 cone. HCl soln/water, 40 ml) 
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and phosgene was bubbled through the stirred solution at a brisk rate for 
1 h. The reaction mixture was then cooled to <5°C, basified {solid K2co3) 
to pH8, and extracted into chloroform. After drying {Mgso4) evaporation 
of the chloroform gave the 2-cyclohexyl-1, 3, 4-oxadiazol-5-one {177) as a 
colourless oil {0.93 g, 79%). 
vmax {thin film), 3290 cm-l {NH), 1780 cm-1 {C = 0). 
Found, C, 56.6; H, 7.3; N, 16.5%, C8 H12 N2 02 
requires, C, 57.1; H, 7.2; N, 16.7%. 
Mt = 168. 
2-Cyclohexyl-1, 3, 4-oxadiazol-{4H)-5-one {177) from thermolysis of 1-
cyclohexylcarbonylamino-3, 5-diphenylbiuret {175). 
The cyclohexylbiuret {175) {0.100 g, 0.000263 m) was refluxed in 
sodium dried xylene {25 ml) for 17 h. The xylene was evaporated off 
in vacuo and a colourless oil remained {vmax {thin film), 1780 cm-1, 
1650-1600 cm-1). When chloroform was added to the oil some colourless 
crystals formed and these were filtered off. An i.r. 
{nujol), 3310 cm-l, 1650 cm-1, 1600 cm-1) showed this 
~-diphenyl-urea {159) {0.0449 g, 80%). 
spectrum {v 
max 
compound to be 
The chloroform filtrate was evaporated in vacuo to give 2-cyclohexyl-1, 
3, 4-oxadiazol-{4H)-5-one {177) {0.0223 g, 50%), the i.r. spectrum of 
which {vmax {thin film), 3290 cm-l {NH), 1780 cm-l {C = 0}) was identical 
in most respects to that from a sample prepared by the phosgene route 
above. Mt = 168. 
The oxadiazolone {177) could not be completely freed of impurity 
even after careful attempts at preparative t.l.c. 
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Part 5 The Synthesis of 1, 3, 4-Thiadiazoles and 7~Thevinoic Acid 
A. Attempted synthesis of 1, 3, 4-thiadiazoles 
Attempted preparation of 7a-(5-phenylamino-l, 3, 4-thiadiazo1:.2.:.yl)"-6,' ~ · 
14-endo-etheno-6, 7, 8, 14-tetrahydrothebaine (179). 
4-Phenyl-l-{7a-thevinoyl) thiosemicarbazide (178) (1.5 g, 0.0028 m) 
was added in small portions to cone. sulphuric acid (20 ml) at 0°C with 
stirring. After 15 min. most of the base had dissolved up. The ice-bath 
cooling was removed and the solution allowed to warm to room temperature. 
After 1 h. the solution was basified to pH8 with NaOH solution (with 
care and cooling). The mixture was added to water (200 ml) and the combined 
aqueous sol uti on was extracted into chloroform. After drying (K2co3), 
evaporation of the chloroform in vacuo yielded no products. 
Synthesis of 7a-(5-methyl-l, 3, 4-thiadiazol-2-yl)-6, 14-endo-etheno-6, 7,·8, 
14-tetrahydrothebaine (180). 
l-Acetyl-2-(7a-thevinoyl) hydrazine (98b.) (1.0 g, 0.00228 m) and 
phosphorus pentasulphide (1.0 g, 0.0045 m) were refluxed in dry pyridine 
(25 ml) for 24 h. After reflux the soln. was poured into water (lOO ml), 
and extracted into chloroform (3 x 50 ml ). After drying (K2co3) and 
evaporation a brown residue remained. (T.l.c. indicated several compounds). 
This residue was dissolved in chloroform and passed down an alumina column 
{20 g, act I) which was eluted with chloroform- pet. ether (50:50). 
Several of the fractions yielded elemental sulphur on evaporation but one 
. gave the 5-methyl-1, 3, 4-thiadiazole (180) as a brown oil. 
vmax (nujol), 1725 cm-1 (impurity?), 1630 cm-1 (m) (C = N). 
n.m.r. 60 MHz (CDC1 3), 61.47 (lH, m, Haa); 2.33 {3H, s, NCH3); 2.61 (3H, 
s, CH3 of thiadiazole ring); 3.43 (3H, s, c6ocH3); 3.73 (3H, s, c3ocH3); 
4.68 (lH, s, H5 ~); 5.62 (lH, d, J9Hz, H17); 5.70 (lH, d, J9Hz, H18); 6.53 
(2H, m, H1 and H2). 
Mt ~ 437. 
- 198 -
When chloroform was added to this oil elemental sulphur precipitated 
out. This was filtered off, the. chloroform evaporated and the process 
repeated several times but the oil could not be crystallised. A solid 
picrate or hydrochloride could not be induced to form. 
B.· ·Attempted preparation of 7e-thevinoic acid 
7e-Cyano-6, 14-endo-etheno-6, 7, 8, 14-tetrahydrothebaine {18lb) 
Thebaine (25 g, 0.0804 m) was refluxed in acrylonitrile (90 ml) 
for 4 h. The excess dieneophile was evaporated in vacuo and the residue 
crystallised, with difficulty, by the addition of methanol, cooling and 
scratching. The crystals formed were recrystallised from methanol to 
give colourless 'needles m.p. 195-197°C (~10 g, mostly the least polar 
7_il-epimer on t. l.c.). These were recrysta 11 i sed from methanol containing 
~ 20% chloroform to yield the pure 7e-nitrile (18lb) (4.9 g, 17%, colourless 
needles, m.p. 195-197°C, l.it. 15 m.p. 196-197°C). 
vmax (nujol), 2250 cm-l (m) (C = N), (lit.15 2230 cm-1). 
The mother liquors were combined to provide the ?a-nitrile but 
this was not rigorously purified. 
Attempted hydrolysis· of 7e-cyano-6, 14-endo-etheno-6, 7, 8, 14-tetrahydro-
thebaine {18lb) 
The 7e-nitrile (18lb) (1.0 g, 0.00275 m) was refluxed in cone. hydro-
chloric acid solution (10 ml) for 8 h. The clear solution was then 
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basified to pHlO with NH40H solution, extracted into chloroform {3 x 30 ml), 
which after drying {K2co3), and evaporation gave the starting material 
{18lb) as a colourless foam {0.8072, 80% recovery), identified .by its ir 
-1 
spectrum, vmax {nujol), 2250 cm {C • N). 
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Part 6 Pharmacology 
Attempted c3-0-demethylations 
Attempted demethylation of S, S'-dimethyl Ns-(7a-thevinoyl) dithiocarbazate 
hydro iodide' {137) with BBrJ..o. 
~·~'-Dimethyl Ns-(7a-thevinoyl) dithiocarbazate (137)(2.2g, 0.0035 m) 
in dichloromethane (20 ml) was added to a stirred solution of boron tribromide 
(5.0 g, 0.020 m) in dichloromethane (lOO ml) at -20 to -30°C during 2 min. 
A precipitate formed immediately. The reaction mixture was maintained 
between -20 and -30°C for 1 h., then poured into a mixture of crushed ice 
(25 g) and cone. •88 ammonia (7 ml). The mixture was stirred at = 0°C. for 
0.5 h. during which time most of the precipitate dissolved up. The whole 
reaction mixture was filtered and the organic layer separated. The aqueous 
layer was extracted into chloroform and the combined organic layers after 
drying (K2co3) and evaporation gave a colourless glass which could not be 
characterised. 
Attempted demethylation of 7a-(5-ethyl-l, 3, 4-oxadiazol-2-yl)-6, 147 
endo-etheno-6, 7, 8, 14-tetrahydrothebaine (102c) with BBr3• 
a) 7a-(5-Ethyl-l, 3, 4-oxadiazol-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (102c) (1.52 g, 0.0035 m) in dichloromethane (20 ml) was 
added to a stirred solution of boron tribromide (5.0 g, 0.020 m) in 
dichloromethane (lOO ml) at -20 to -30°C during 2 min. A precipitate formed 
immediately. Jhe reaction mixture was maintained at~ -30°C for 1 h., 
then poured into a mixture of crushed ice (25 g) and cone. •88 ammonia (7 ml). 
The mixture was stirred at ~ 0°C for 0.5 h. during which time most of the 
precipitate dissolved up. The whole reaction mixture was filtered and the 
organic layer separated. The aqueous layer was extracted into chloroform 
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and the combined organic layers, after drying (K2co3) and evaporation, 
gave a colourless glass which could not be characterised. 
b) 7a-(5-Ethyl-l, 3, 4-oxadiazol-2-yl)-6, 14-endo-etheno-6,·7,· 8, · 
14-tetrahydrothebaine (102c) (1.52 g, 0.0035 m) in dichloromethane (20 ml) 
was added to a stirred solution of boron· tribromide (5.0 g, 0.020 m) in 
dichloromethane (lOO ml) at -20 to -30°C during 2 min. A precipitate 
formed immediately. The reaction mixture was stirred for 20 min. at 
~ -30°C and then poured into a mixture of cone. ·88 ammonia (7 ml) and 
crushed ice (25 g). After 3 min. the solution was filtered, and the 
organic layer separated, dried (K2co3),and evaporated to give a colourless 
glass. T.l.c. (Al 203/CHC1 3) and n.m.r. showed this to be a mixture of 
compounds. The products could not be separated, even after careful 
column chromatography. 
c) 7a-(5-Ethyl-l, 3, 4-oxadiazol-2-yl)-6, 14-endo-etheno-6, 7, 8, 
14-tetrahydrothebaine (102c)· (1.0 g, 0.0023 m) was dissolved in dichloro-
methane (75 ml) and cooled to -60°C.· To the stirred solution was added 
boron tribromide (3.0 g, 0.012 m) by syringe through a septum. A colourless 
ppt. formed immediately. The mixture was allowed to warm to~ -30°C, 
maintained at that temperature for 1 h., then cooled to -60°C. Methanol 
(~ 3 ml) was then added to break up the precipitate. The cooling was 
then removed and saturated NaHC03 solution (lOO ml) was added. The organic 
layer was separated. The aqueous layer was extracted with dichloromethane 
and.the combined organic extracts dried (K2co3) and evaporated to give 
a colourless foam. 
The foam was dissolved in the minimum amount of methanol and 
passed down an alumina column (30 g, act Ill) eluted with methanol: 
dichloromethane (1:19). The first material off the column was the starting 
material, the 5-ethyl-1, 3, 4-oxadiazole (102c) (0.23 g, 23% recovery). 
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Further elution afforded only mixtures of compounds (by t.l.c. and n.m.r.) 
which could not be separated. 
Attempted demethylation of 7a-(5-ethyl-l, 3, 4-oxadiazol-2-yl)-6, 14, endo-
etheno-6, 7, 8, 14-tetrahydrothebaine (102c) with KOH. 
7a-(5-Ethyl-l, 3, 4-oxadiazol-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-
tetrahydrothebaine (102c) (2.0 g, 0.0046 m) was added to a solution of 
potassium hydroxide (2.5 g, 0.0446 m) in diethylene glycol (12.5 ml) at 
210°C. After 0.5 h. at this temperature the reaction mixture was poured 
into water (70 ml). Saturated ammonium chloride solution (140 ml) was 
added to this but no precipitate was given. The solution was extracted 
into chloroform which on evaporation yielded a reddish gum. T.l.c. 
(Al 203/CHC1 3) indicated at least three products, all more polar than the 
starting material which was not present. The gum was subjected to column 
chromatography on alumina (50 g, act I, eluted with CHC1 3), but all the 
fractions obtained from the column were mixtures. 
Attempted demethylation of 7a-(l, 3, 4-oxadiazol-2-yl)-6, 14-endo-etheno 
-6, 7, 8, 14-tetrahydrothebaine (102a) with KOH. 
7a-(l, 3, 4-0xadiazol-2-yl)-6, 14-endo-etheno-6, 7, 8, 14-tetra-
hydrothebaine (102a) (2.0 g, 0.0049 m) was added to a solution of potassium 
hydroxide (2.5 g, 0.0446 m) in diethylene glycol (12.5 ml) at 160°C. 
After 3 min. the solution was removed from the heat. Dilution of a test 
portion with water (lOX volume) gave a homogeneous solution. Saturated 
ammonium chloride solution (~ 80 ml) was added to the bulk and precipitation 
occurred. The precipitate was filtered off. Examination by t.l.c. showed 
this to contain several compounds. Attempts at purification by recrystallis-
ation from ethanol, water, 2-ethoxyethanol or mixtures of these solvents 
were all unsuccessful. 
- 203 -
REFERENCES 
1. E.L. May and L.J. Sargent, 'Morphine and its Modifications'_. in_ 
"Analgetics", ed. G. de Stevens, Academic Press, New York and 
London, 1965, Chapter 4. 
2. K.W. Bentley, Endeavour, 1964, 23, 97. 
3. U. Weiss, J. Amer. Chem. Soc., 1955, 77, 5891. 
4. {a) J.W. Lewis, K.W. Bentley,and A. Cowan, Annual Rev. of Pharmacology, 
1971, Jl. 241-270. 
(b) as for ref. 4a, p.253. 
5. {a) S.H. Synder, Scientific American, 1977, 236, {No 3), p.44. 
{b) D. Lednicer and LA. Mitscher, "The Organic Chemistry of Drug 
Synthesis", Wiley, New York, 1977, p.239. 
6. M. Gates and T.A. Montzka, J. Med. Chem., 1964, z, 127. 
7. A. Grewe and A. Mondon, Chem. Ber., 1948, ~. 279. 
8. W. Leimgruber, E. Mohacsi, H. Baruth, and L.O. Randall, Advances 
in Biochemical Psychopharmacology, 1974, ~. 45. 
9. M.C. Braude, L.S. Harris, E.L. May, J.P. Smith and J.E. Villarreal, 
Advances in Biochemical Psychopharmacology, 1974, ~. 51-62. 
- 204 -
10. E.L. May and J.G. Murphy, J. Org. Chem., 1955, 20, 257. 
11. (a) I. MonkoviE, C. Bachand and H. Wong, J. Amer. Chem. Soc., 1978, 
100, 4609. 
(b) D.C. Palmer and M.J. Strauss, Chem. Rev., 1977, 77, 1. 
12. E.L. May and J.H. Ager, J. Org. Chem., 1959, 24, 1432. 
13. S. Archer, N.F. Albertson, L.S. Harris, A.K. Pierson and J.G. Bird, 
J. Med. Chem., 1964, z, 123. 
14. 0. Eisleb, Chem. Ber., 1941, 74, 433. 
15. K.W. Bentley and D.G. Hardy, J. Amer. Chem. Soc., 1967, 89, 3267. 
16. K.W. Bentley and J.C. Ball, J. Org. Chem., 1958, 23, 1720. 
17. (a) K.W. Bentley, J.W. Lewis and A.C.B. Smith, J.C.S. Perkin I, 
1972. 870. 
(b) I. Fleming, "Frontier Orbitals and Organic Chemical Reactions", 
Wiley, 1976, p. 121 ff. 
(c) as for ref. 17(b), p. 106 ff. 
18. (a) K.W. Bentley, D.G. Har:dy, and B. Meek, J. Amer. Chem. Soc., 1967, 
89, 3273. 
- 205 -
(b) M.J. Powell, Ph.D. thesis, Loughborough University of Technology, 
1978, p. 220; T.A. Crabb and J.R. Wilkinson, J.C.S. Perkin I, 1977, 
953. 
19. (a) A.H. Beckett, Progr. Drug. Res., 1959, l• 455. See pages 519-530. 
(b) A.H. Beckett and A.F. Casey, J. Pharm. Pharmacol., 1954, ~. 
986. 
20. K.W. Bentley and D.G. Hardy, J. Amer. Chem. Soc., 1967, 89, 3281. 
21. J.W. Lewis, Advances in Biochemical Psychopharmacology, 1974, ~. 123. 
22. (a) J. Hughes, T.W. Smith, H.W. Kosterlitz, L.A. Fothergill, B.A. Morgan, 
and H.R. Morris, Nature, 1975, 258, 577. 
(b) J.K. Chang, B.T.W. Fong, A. Pert and C.B. Pert, Life Sciences, 
1976 • .!§_, 1473. 
(c) A.F. Bradbury, D.G. Smyth and C.R. Snell, Nature, 1976, 260, 
165. 
23. (a) R.C.A. Frederickson, Life Sciences, 1977, £L, 23: S.H. Snyder, 
Nature, 1975, 257, 185; S.H. Snyder, Chem. Eng. News, 1977, ~. 
26; A. Goldstein, Science, 1976, 193, 1081; J.W. Lewis and M.J. Ranee, 
Pharmaceutical Journal, 1978, 221, 395. 
(b) J.W. Lewis and M.J. Ranee, Pharmaceutical Journal, 1979, 222, 
61. 
(c) K.J. Chang and P. Cuatrecasas, J. Biol. Chem., 1979, 254, 2610. 
- 206 -
24. J.F. Collins, Annual Reports on the Progress of Chemistry, 1976, 
73, 417; E.J. Simon, 'The opiate receptors',in "Receptors in Phannacology" 
ed. by J.R. Smythies and R.J. Bradley, 1978, Marcel Dekker Inc., 
New York, Chapter 8, p. 257. ---- - - · · ---- --
25. (a) J. Pless, W. Bauer, F. Cardinaux, A. Closse, D. Hauser, R. Huguein, 
D. Roemar, H-H. Buescher, and R.C. Hill, Helv. Chim. Acta., 1979, 
62, 398. 
(b) B. von Graffenried, E. Del Pozo, J. Roubicek, E. Krebs, W. Poeldinger, 
P. Bunneister and L. Kerp. Nature, 1978, 272, 729. 
26. B.P. Rogues, C. Garbay-Jaureguiberry, R. Oberlin, M. Anteunis and 
A.K. Lala, Nature, 1976, 262, 778; C.R. Jones, W.A. Gibbons and 
V. Garsky, Nature, 1976, 262, 779. 
27. A.P. Feinberg, I. Creese and S.H. Snyder, Proc.Natl. Acad. Sci. USA, 
1976, 73, (No 11), 4215. 
29. (a) W.R. Martin, C.G. Eades, J.A. Thompson,R.E. Huppler and P.E. Gilbert, 
J. Phannac. Exp. Ther., 1976, 197, 517; P.E. Gilbert and W.R. Martin, 
J. Phannac Exp. Ther.; 1976, 198, 66. 
(b) J.A.H: Lord, A.A. Waterfield, J. Hughes and H.W. Kosterlitz, 
Nature, 1977, 267, 495. 
(c) Reckitt and Colman, report to the D.H.S.S., 1978, cited in ref. 23b. 
- 207 -
30. K.W. Bentley, D.G. Hardy and B. Meek, J. Amer. Chem. Soc., 1967, 
89. 3293. 
31. K.W. Bentley, D. G. Hardy, H.P. Crocker, D. I. Haddlesey and P.A~ ·Mayor, --·· · 
J. Amer. Chem. Soc., 1967, 89, 3312. 
32. K.W. Bentley and J.C. Ball, J. Org. Chem., 1958, 23, 1725. 
33. K.W. Bentley, 'The morphine alkaloids' in "The Alkaloids", ed. R.F. 
Manske, Academic Press, New York, 1971, Vol. 13, pp.S0-104. 
34. (a) J.J. Brown and R.A. Hardy, British Patent, 1, 243, 838 (1968), 
(Chem. Abs., 1971, 75, 49392s). 
(b) J.J. Brown and R.A. Hardy, Belgian Patent, 724, 258 (1969); 
USA Patent 3474 102 (1969); (Chem. Abs., 1970, 72, 21816x). 
35. J. P. Horwitz, 'The 1, 2, 4-and 1, 2, 3-triazines', in "Heterocyclic 
Compounds" Vol. 7, ed. R.C. Elderfield, Wiley, New York, 1961, pp. 720-
778. 
36. R. Metze, Chem. Ber., 1955, 88, 772; 
ibid.. 1956, 89, 2056; 
ibid.. 1958, ~. 1861. 
38. K.W. Bentley, D.G. Hardy and A.C.B. Smith, J. Chem. Soc. (C), 1969, 
2235. 
- 208 -
39. R.W. Young and K.H. Wood, J. Amer. Chem. Soc., 1954, 77, 400. 
40. W.R. Sherman, J. Org. Chem., 1961, 26, 88. 
41. A. Shafiee, I. Lalezari, M. Mirrashed and D. Nercesian, J. Heterocyclic 
Chem: , 1977, .!1• 567. 
42. M.M. Kochlar, J. Heterocyclic Chem., 1972, ~. 153. 
43. M.T. Wu, J. Heterocyclic Chem., 1972, ~. 31. 
44. K.W. Bentley and D.G. Hardy, Proc. Chem. Soc., 1960, 220. 
45. L.C. Behr, '1, 3, 4-0xadiazoles', in "The Chemistry of Heterocyclic 
Compounds", Vol. 17, ed. R.H. Wiley, New York, 1962, pp. 263-282. 
46. M.P. Hutt, E.F. Elslager .. and L.M. Werbel, J. Heterocyclic Chem., 
1970,1,511. 
47. (a) E. Klingsberg, J. J!mer. Chem. Soc., 1958, 80, 5786. 
(b) J.C. Dacons and M.E. Sitzmann, J. Heterocyclic Chem., 1977, .!1• 
1151. 
48. H.L. Yale, K. Losee, J. Martins, M. Holsing, F.M. Perry and J.Bernstein, 
J. J!mer. Chem. Soc., 1953, ]]_, 1933. 
49. C. Ainsworth, J. J!mer. Chem. Soc., 1955, 77, 1148. 
50. J.H. Boyer, "Monocyclic triazoles and benzotriazoles" in "Heterocyclic 
Compounds" Vol. 7, ed. R.C. Elderfield, Wiley, New York, 1961, 
pp. 425-461. 
- 209 -
51. H.L. Yale, K.A. Losee, F.M. Perry, and J. Bernstein, J. Amer; Chem. 
Soc., 1954, 76, 2208. 
52. E. Hoggarth, J. Chem. Soc., 1949, 1163. 
53. N.P. Buu-Hoi', N.D. Xuong and N. H. Ham, J. Chem. Soc., 1956, 2160. 
54. H. Gehlen and W. Schade, Naturwissenschaften, 1959, 46, 667; (Chem. Abs., 
58, 6827 g). 
55. E. Hoggarth, J. Chem. Soc., 1952, 4811. 
56. E. Ajello, 0. Migliara and V. Sprio, J. Heterocyclic Chem., 1972, ~. 
1169. 
57. S.G. Boots and C.C. Cheng, J. Heterocyclic Chem.; 1967, i• 272. 
58. J.R. Reid and N.D. Heindel, J. Heterocyclic Chem., 1976, ~. 925. 
59. W.R. Shennan, 'The thiadiazoles' in "Heterocyclic Compounds" Vol. 7, 
ed. R.C. Elderfield, Wiley, New York, 1961, pp. 587-626. 
60. C. Ainsworth, J. Amer. Chem. Soc., 1958, 80, 5201. 
61. M. Baron and C.V. Wilson, J. Org. Chem., 1958, 23, 1021. 
62. W. Walter and K.J. Reubke, 'The chemistry of the thiohydrazide group', 
in "The Chemistry of Ami des". ed. J. Zabicky, Wiley Interscience, 
London, 1970, pp. 484-485. 
- 210 -
63. R.L.N. Harris and J.L. Huppatz, Aust. J. Chem., 1977, 30, 2225. 
64. W. Fulmor, J.E. Lancaster, G.O. Morton, J.J. Brown, C-.F.--Howell ,:: _, -----~--,~------""" 
C.T. Nora and R.A. Hardy, Jr., J. Amer. Chem. Soc., 1967, 89, 3322. 
65. L.M. Jackman and s. Sternhall in "Applications of Nuclear Magnetic 
Resonance Spectroscopy in Organic Chemistry" 2nd. edition, Pergamon 
Press, Oxford, 1969, p. 334. 
66. W. Nagata, T. Terasawa, and K. Tori, J. Amer. Chem. Soc., 1964, 86, 
3746. 
67. E. Hoggarth, J. Chem. Soc., 1949, 1160. 
68. For preparation of dry hydrazine see R.G. Taborsky, J. Org. Chem., 
1961, 26, 596. 
69. (a) R.A. Reed, "Hydrazine and its derivatives", R.I.C. Lecture 
Series, No. 5, 1957. p.l2. 
(b) M.H. Palmer, "The Structure and Reactions of Heterocyclic Compounds", 
Arnold, London, 1967, p.lOl. 
70. L.F. Fieser and M. Fieser, Reagents for Organic Synthesis, Vol. 1, 
Wiley; .1967, p. 838. 
71. Handbook of Chemistry and Physics, 57th edition, ed. R.C. Weast, 
CRC Press, Cleveland, Ohio, 1976-77, p. D-149. 
72. Supplied by Aldrich Chemical Co. 
- 211 -
73. H. Kwart and M.B. Price, J. Amer. Chem. Soc., 1960, 82, 5123. 
74. S.M. McElvain and J.W. Nelson, J. Amer. Chem. Soc., 1942, 64, 1825. 
75. For a review of ortho-ester synthesis see R.H. DeWolfe, "Carboxylic 
Ortho Acid Derivatives", Academic Press, New York and London, 1970, 
pp. 1-133. 
76. P.A.S. Smith, "Open-Chain Nitrogen Compounds" Vol. 2, Benjamin, New 
York, 1966, p.l95. 
77. J. Zabicky, "The Chemistry of Ami des", Wiley Interscience, London, 
1970, p. 556. 
78. Houben-Weyl's Methoden der Organischen Chemie, Vol X/2, ed. 
E. MUller, Georg Thieme Verlag, Stuttgart, 1967, pp. 167-168. 
79. (a) R. Stoll~. Chem. Ber., 1899, 32, 796. 
(b) J.A. Young, W.S. Durrell and R.D. Dresdner, J. Amer. Chem. Soc., 
1962, 84, 2105. 
80. (a) Aldrich Library of I.R. spectra, No. 397G. 
(b) Aldrich Library of I.R. spectra, No. 397F. 
(c) Aldrich Library of I.R. spectra, No. 440E. 
81. (a) For a review of nitrogen n.m.r. see M. Witanowski and G.A. Webb, 
"Nitrogen NMR", plenum press, London, 1973. 
- 212 -
(b) as for ref. 8la, p.l74. 
(c) as for ref. 8la, p.l96. 
(d) as for ref. 8la, p. 167. 
(e) as for ref. 8la, pp.62-63. 
82. (a) M. Witanowski, L. Stefaniak, and G.A. Webb, Annual Reports on NMR 
Spectroscopy, 1977, z, pp.ll7-244. 
(b) as for ref. 82a, pp.l36-137. 
(c) as for ref. 82a, pp. 144-145. 
83. (a) M. Golfier and R. Milcent, Bull. Soc. Chim. France, 1973, 254. 
(b) A. Stempel, J. Zelauskas and J.A. Aeschlimann, J. Org. Chem., 1955, 
20, 412. 
84. W.R. Sherman and A. von Esch, J. Org. Chem., 1962, 27, 3472. 
85. G. Werber and F. Maggio, Ann. Chim. (Rome), 1962, 52, 747; (Chem. Abs., 
1963, 58, 3417 g). 
86. J-F. Giudicelli, J. Menin and H. Najer, Bull. Soc. Chim. France, 1968, 
.!.!.· 4568: 
87. (a) H.L. Yale and K. Losee, J. Med. Chem., 1966, 2• 478. 
(b) I. Munkovie, H. Wong, A.W. Prico, Y.G. Perron, I.J. Pachter and 
B. Belleau, Canad. J. Chem., 1975, 53, 3100. 
- 213 -
88. (a) J. March. "Advanced Organic Chemistry", McGraw-Hill-Kogakusha, 
Tokyo, 2nd. edition, 1977, p.21. 
(b) H. Heaney and A.P. Price, Chem. Comm .• 1971, 894; -R.-1lonnett and -
R.F.C. Brown, Chem. Comm ••. l972. 393. 
89. A. Dornow and K. Bruncken, Chem. Ber •• 1949, 82, 121. 
90. (a) A. Hetzheim and K. Mockel, Advances in Heterocyclic Chemistry. 1966, 
1. pp.l88-189. 
(b) A. Dornow and S. Lupfert. Arch. Pharm •• 1955, 288, 311; 
(Chem. Abs •• 1957, 51, 6614d). 
91. (a) K.T. Potts and R.M. Huseby, J. Org. Chem •• 1966, n. 3528. 
(b) R. Robinson. J. Chem. Soc •• 1909, 95, 2167. 
92. (a) W.E. Stewart and T.H. Siddal Ill, Chem Revs •• 1970, 70, 517. 
(b) as for ref. 92a, p 537. 
93. (a) H. Kessler, Angew. Chem. Internat. Ed., 1970, 2_, 219. 
(b) as for ref. 93a, p 222. 
94. (a) J.B. Lambert. "organic Structural Analysis: Collier-Macmillan. 1976, 
p.ll6. 
(b) as for ref. 94a. p. 119. 
- 214 -
95. A. Jaeschke, H. Muensch, H.G. Schmid, H. Friebolin and A. Mannschreck, 
J. Molecular Spectroscopy, 1969, ~. 14. 
96. J.K.M. Sanders and D.H. Williams, J. Amer. Chem. Soc., 1971, 93, 641. 
97. (a) B.C. Mayo, Chem. Soc. Rev., 1973, !• 49. 
(b) as for ref. 97a, pp.66-67. 
(c) as for ref. 97a, p.63. 
(d) as for ref. 97a, p.72. 
(e) as for ref. 97a, p.51. 
98. N. Dennis, A.R. Katritzky and S.K. Parton, J. Chem. Soc. Perkin I, 
1974, 750. 
100. R.J. Abraham and P. Loftus, "Proton and Carbon-13 NMR Spectroscopy", 
Heyden, London, 1978, p. 115 ff. 
101. (a) I.T. Millar and H.D. Springall, "A Shorter Sidgwick's Organic 
Chemistry of Nitrogen", Clarendon Press, Oxford, 1969, pp.360-361. 
(b) M.H. Palmer, "The structure and reactions of Heterocyclic Compounds", 
Arnold, London, 1967, p.391. 
- 215 -
102. J.R. Traynor, Ph.D. Thesis, University of Aston in Birmingham, 1973, 
pp.71-72. 
103. {a) R.S. Budhram, Ph.D. Thesis, Loughborough University of--Technology, 
1978, pp.91 and 163. 
(b) as for ref. 103a, p.84. 
104. A. Vogel, "Practical Organic Chemistry" Longmans, Green, London, 3rd 
edition, 1956, p.645. 
105. {a) Beilsteins Handbuch der Organischen Chemie, Basic series, ~. 383. 
(b) Beilsteins Handbuch der Organischen Chemie, Basic series,~· 319. 
106. S. Olsen and E-M. Enkemeyer, Chem. Ber., 1948, 81, 359. 
107. I. Heilbron and H.M. Bunbury ,{eds.), "Dictionary of Organic Compounds", 
Vol. 2, Eyre and Spottiswoode, London, 1953, p.995. 
108. {a) Aldrich library of NMR spectra, Vol. 8, 49B. 
{b) as for ref. 108a, 48C. 
109. {a) Aldrich library of IR spectra, 10750. 
(b) as for.. ref. l09{a), 947C. 
110. L.C. Henderson and J. Forsaith, J. Pharmacol. Exptl. Therap., 1959, 
125. 237. 
- 216 -
111. A.F. Green and P.A. Young, Brit. J. Pharmacol. Chemother., 1951, i• 572. 
112. K.C. Rice, J. Med. Chem., 1977, 20, 164. 
113. K.W. Bentley, D.G. Hardy, J.W. Lewis, M.J. Readhead and W.I. Rushworth, 
J. Chem. Soc. (C). 1969, 826. 
114. P.A.S. Smith, "Open-Chain Nitrogen Compounds", Vol. 2, Benjamin, New 
York, 1966, p,l74. 
I 
I 
I 
I 
